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Abstract 
 
Gout is a common form of inflammatory arthritis that is caused by the precipitation of 
monosodium urate crystals (MSU) in the joints.  The acute form of gout is associated 
with sudden painful inflammatory episodes characterised by a large infiltration of 
neutrophils.  The involvement of monocytes and macrophages is also recognised to be 
important, although the exact roles of monocytes and macrophages in gout need to be 
clarified.  The overall objective of this thesis was to investigate the contributions of 
neutrophils, monocytes and macrophages to acute gouty inflammation. 
 
To determine whether the presence of other cells may be affecting neutrophil activation 
in gout inflammation, human blood neutrophils were stimulated with MSU as a purified 
population and in a mixed white blood cell population.  The half-life of neutrophils in 
culture increased from 10h in purified neutrophil cultures to >24h in mixed cell cultures.  
The increase in viability was associated with large increases in cytokine production 
(TNFα, IL-1β, IL-6, IL-8) in mixed cell cultures.  Exposure of neutrophils to media 
conditioned by MSU-stimulated mononuclear cells improved both neutrophil viability 
and stimulated the IL-8 production from neutrophils to a greater extent than direct 
contact with MSU.  Exposure to conditioned media also primed MSU-stimulated 
neutrophil superoxide responses.  High superoxide production was also observed when 
serum was lowered to <10%.  These results indicate that neutrophil activation in gout 
largely occurs via soluble factors present in the pro-inflammatory environment, rather 
than by direct contact with MSU alone. 
 
Polygodial, a compound derived from the plant, Horopito (Pseudowintera colorata), and 
a number of structurally related sesquiterpene dialdehydes were tested for their potential 
to suppress neutrophil activation in gout.  Polygodial inhibited MSU- and PMA-
stimulated neutrophil superoxide production in vitro with IC50 values of 0.78µM and 
0.16µM respectively.  This activity was largely dependent on the dialdehyde 
functionality but was enhanced by the presence of ring hydroxyl groups.  The removal 
of hydroxyl groups was also associated with an increased cytoxicity.  Polygodial and 
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VI 
two other sesquiterpene dialdehyde compounds inhibited neutrophil superoxide 
production in an MSU model of acute gout, while Polygodial and a second compound 
also inhibited neutrophil recruitment. These studies confirm Polygodial and two 
structurally related sesquiterpene dialdehyde as potential anti-inflammatory compounds 
for potential use in gout. 
 
To confirm whether monocytes and/or macrophages were important in the onset of gout, 
resident macrophages and MSU-recruited monocytes were studied in a peritoneal model 
of MSU-induced inflammation.  Gr-1+,7/4- monocytes were recruited to MSU-induced 
inflammation within 4h, however high cytokine production (IL-1β, TNFα, IL-6, MCP-
1) in the peritoneum preceded peak monocyte infiltration.  Infiltrating monocytes did 
not produce high amounts of IL-6 and TNFα, nor were they able to produce pro-
inflammatory cytokines when re-stimulated with MSU ex vivo.  However, resident 
macrophages exhibited production of IL-1β, TNFα and IL-6 following exposure to 
MSU ex vivo.  Depletion of macrophages in vivo by clodronate liposomes led to a 
reduced recruitment of neutrophils and a lowered production of IL-1β and IL-6 without 
affecting the recruitment of monocytes.  These data identify macrophages, rather than 
monocytes, as key cells in initiationing and driving of inflammation in acute gout. 
 
The lack of responses from MSU-stimulated monocytes led to the question of what 
function, if any, was being exhibited by monocytes during MSU-induced inflammation.  
Therefore, the phenotype and corresponding function of monocytes was profiled over 
the course of MSU-induced inflammation.  Newly recruited monocytes were small in 
size and expressed high levels of Gr-1 and 7/4, low levels of F4/80 and CD80.  Over 
48h the expression of Gr-1 and 7/4 was lost, while the expression of CD80 increased.  
These changes were associated with an increase in cell size, phagocytic capacity, and 
the production of pro-inflammatory cytokines in response to MSU.  Changes in 
phenotype indicated differentiation into immature and then resident-like macrophages, 
and this was confirmed by PKH26-labelling infiltrating monocytes, which acquired an 
F4/80hi, resident macrophage phenotype after 3 to 5 days.  Differentiation into 
macrophages was associated with an increased uptake of apoptotic neutrophils both in 
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vivo and following ex vivo incubation.  The phagocytosis of apoptotic neutrophils was 
associated with a reduced production of IL-1β following stimulation with MSU ex vivo.  
These results indicate that MSU-recruited monocytes are not pro-inflammatory cells in 
gout, rather, they differentiate into resident macrophages over 3 to 5 days, and may over 
time aid in the resolution of gouty inflammation through the clearance of apoptotic 
neutrophils, a process that also suppresses further inflammatory responses. 
 
Together, the results of this thesis indicate that macrophages are key pro-inflammatory 
cells in gout contributing to neutrophil recruitment and cytokine production; that 
recruited neutrophils are activated by soluble mediators produced by MSU-activated 
cells, as well as by low serum environments; and that recruited monocytes are capable 
of both mediating the resolution of MSU-induced inflammation and replenishing the 
local resident macrophage population.  These results provide a more clear model of the 
cellular events that occur during acute gout in humans that to date have been limited by 
a lack of in vivo–based studies. 
Table of Contents 
 
VIII 
Table of Contents 
 
Acknowledgements     II 
Abstract     V 
Table of Contents     VIII 
List of Figures     XVI 
List of Tables     XX1 
List of Abbreviations     XXII 
 
Chapter 1.  General Introduction     1 
 
1.1 A history of gouty disease       2 
1.2 Monosodium urate crystals       3 
1.3 Acute gouty arthritis        5 
1.4 Chronic gout         7 
1.5 Uric acid          7 
1.6 Loss of uricase         9 
1.7 Gout risk factors         12 
 1.7.1 Gender         12 
 1.7.2 Diet         12 
 1.7.3 Genetic and race-related risk      13 
 1.7.4 An aging population       14 
1.8 Co-morbid diseases        14 
1.9 Treatment and management of gout      15 
 1.9.1 Diet         15 
 1.9.2 Anti inflammatory drugs      16 
 1.9.3 Uric acid lowering drugs      16 
 1.9.4 Limitations of current therapies      18 
1.10 Cellular inflammation in acute gout inflammation    18 
 1.10.1 Initiation of gout inflammation     19 
 1.10.2 The necessity of MSU recognition by immune cells as   19 
Table of Contents 
 
IX 
  a “danger signal” 
 1.10.3 Innate cell recognition of MSU to induce an inflammatory  20 
  response. 
 1.10.4 Production of cytokines by MSU-stimulated innate cells  21 
  1.10.4.1 IL-1β and the inflammasome    22 
 1.10.5 Resolution in gout       23 
 1.10.6 Key innate cells in gout      24 
 1.10.7 Neutrophils        25 
  1.10.7.1 Neutrophil recruitment     25 
  1.10.7.2 Recruitment of neutrophils in gout    27 
  1.10.7.3 Activation and survival of neutrophils in inflammation 28 
  1.10.7.4 Production of superoxide     29 
  1.10.7.5 Collateral damage through excessive ROS production 31 
 1.10.8 Neutrophil investigation      31 
 1.10.9 The mononuclear phagocyte system     33 
 1.10.10 Monocytes        33 
  1.10.10.1 Monocytes in gout      36 
 1.10.11 Macrophages        39 
  1.10.11.1 Macrophages in gout     40 
 1.10.12 Using research models to investigate gout     40 
  1.10.12.1 Murine peritoneal model of gout    41 
  1.10.12.2 Murine air pouch model     41 
1.11 Aims of this study        42 
 
Chapter 2.  Materials and Methods      43 
 
2.1 Reagents          44 
 2.1.1 Sesquiterpene dialdehydes      46 
2.2 Antibodies          46 
2.3 Kits          47 
2.4 Disposables         48 
Table of Contents 
 
X 
2.5 Buffers and Media        48 
2.6 Preparation of MSU        51 
2.7 Endotoxin levels         51 
 2.7.1 Limulus amebocyte lysate (LAL) assay tested    51 
 2.7.2 Purchased reagents       52 
2.8 Isolation of cell types        52 
 2.8.1 Human neutrophils       52 
 2.8.2 Human peripheral blood mononuclear cells    52 
 2.8.3 Total human white blood cells      53 
 2.8.4 Enrichment of naïve mouse peritoneal lymphocytes and   53 
  macrophages 
 2.8.5 Enrichment of peritoneal mast cells     54 
 2.8.6 Sorting of murine leukocyte populations    54 
2.9 Cell lines and culture        54 
 2.9.1 Human umbilical vein endothelial cells (HUVEC)   54 
 2.9.2 RAW 264.7 cells       55 
 2.9.3 Culture of primary mouse mesothelial cells    55 
2.10 Histology         56 
 2.10.1 Morphological stain for differential cell counts   56 
 2.10.2 Hematoxylin and Eosin (H&E) staining of peritoneal tissue  56 
 2.10.3 Visualisation of MSU crystal and cell clumping   57 
 2.10.4 Immunofluorescent histology of resident peritoneal macrophages 57 
 2.10.5 Staining of visceral peritoneal tissue     58 
2.11 Measurement of superoxide production      58 
 2.11.1 PMA stimulation of neutrophils     58 
 2.11.2 MSU stimulation of neutrophils     59 
 2.11.3 Serum stimulation of neutrophils     59 
 2.11.4 Superoxide production by ex vivo murine peritoneal neutrophils 60 
 2.11.5 Luminol chemiluminescence      60 
2.12 Viability stains         61 
 2.12.1 Trypan blue        61 
Table of Contents 
 
XI 
 2.12.2 Neutrophil trypan blue assay for sesquiterpene dialdehyde  61 
  compounds 
 2.12.3 Annexin-V and propidium iodide (PI) double staining  61 
 2.12.4 Measuring the effect of sesquiterpene dialdehyde compounds on 62 
  neutrophil viability by annexin-V/PI staining 
2.13 Cytokine analyses        62 
2.14 Human neutrophil, mononuclear cell and white blood cell experiments 63 
 2.14.1 Neutrophil and WBC apoptosis and viability assay   63 
 2.14.2 Neutrophil and WBC soluble cytokine production   63 
 2.14.3 Preparation of conditioned media     63 
 2.14.4 Intracellular IL-8 staining of neutrophils    64 
 2.14.5 Measuring the effect of soluble mediators on neutrophil viability 64 
 2.14.6 Measuring the effect of soluble mediators on MSU-stimulated 64 
  superoxide production 
2.15 Phagocytosis assays        65 
 2.15.1 Phagocytosis of fluorescent beads     65 
 2.15.2 Peroxidase staining for phagocytosed neutrophils   65 
2.16 Animal studies         66 
 2.16.1 Ethical approvals       66 
 2.16.2 Mice         66 
 2.16.3 MSU-induced peritonitis      66 
 2.16.4 Thioglycollate-induced peritonitis     67 
 2.16.5 Testing of sesquiterpene dialdehyde compounds in the in vivo 67 
  gout model 
 2.16.6 PKH26 experiments       67 
 2.16.7 Preparation of clodronate-loaded liposomes    67 
 2.16.8 Clodronate liposome depletion of resident macrophages  68 
2.17 Intracellular staining of ex vivo cells      68 
2.18 Restimulation Assays        68 
2.19 Whole peritoneal tissue and peritoneal leukocyte culture   69 
2.20 Cytokine production from macrophages following uptake of neutrophils 69 
Table of Contents 
 
XII 
2.21 Inter-experiment variability       70 
2.22 Image analyses and editing       70 
2.23 Statistical analysis        70 
 
Chapter 3.  Neutrophil activation in MSU-induced inflammation 71 
 
3.1 Introduction         72 
3.2 Results          78 
 3.2.1 Measuring neutrophil superoxide production    78 
 3.2.2 Superoxide production by MSU-stimulated neutrophils is  81 
  affected by human serum concentration. 
 3.2.3 The effect of MSU on neutrophil viability and IL-8 production 85 
 3.2.4 The effect of mixed cell populations on MSU-induced neutrophil 88 
  activation 
 3.2.5 The effect of soluble mediators on neutrophil activation   92 
  and function 
  3.2.5.1 Neutrophils survival is improved by MSU-induced  93 
  soluble mediators and does not require cell-cell contact 
  3.2.5.2 Neutrophil IL-8 production is activated by MSU-induced 93 
  soluble mediators 
  3.2.5.3 MSU-induced soluble mediators prime human  98 
  neutrophils to produce superoxide 
 3.2.6 Neutrophil activation and viability in vivo    98 
3.3 Discussion         104 
 
Chapter 4.  Inhibiting neutrophil inflammation using sesquiterpene 
dialdehydes            109 
 
4.1 Introduction           110 
 4.1.1 Neutrophil infiltration and superoxide production in gouty  110 
  inflammation 
4.2 Results          112 
Table of Contents 
 
XIII 
 4.2.1 Inhibition of neutrophil superoxide production by    112 
  sesquiterpene dialdehydes 
 4.2.2 Structure-activity related inhibition of PMA-induced superoxide 112 
  production 
 4.2.3 Structure-activity related inhibition of MSU-induced superoxide 114 
  production 
 4.2.4 Cytotoxic activity of sesquiterpene dialdehydes   115 
 4.2.5 Inhibition of neutrophil superoxide production in vivo  119 
 4.2.6 Additional anti-inflammatory activities of sesquiterpene  121 
  dialadehyde compounds 
  4.2.6.1 Sesquiterpene dialdehydes compounds inhibit superoxide 121 
  production by endothelial cells 
  4.2.6.2 Sesquiterpene dialadehyde compounds inhibit  126 
  pro-inflammatory cytokine production in MSU-stimulated 
  macrophages 
4.3 Summary and Conclusion       127 
 
Chapter 5.  Macrophages in the initiation of acute gout  131 
 
5.1 Introduction         132 
5.2 Results          134 
 5.2.1 Characterising the murine peritoneal model of acute gout.  134 
 5.2.2 Production of pro-inflammatory cytokines by cells stimulated with 141 
  MSU crystals 
  5.2.2.1 Investigating cytokine responses of purified monocytes 144 
  and neutrophils to MSU stimulation 
  5.2.2.2 Identifying cells that produce pro-inflammatory cytokines 147 
  after exposure to MSU crystals 
 5.2.3 Investigating activation of macrophages following exposure to 150 
  MSU. 
Table of Contents 
 
XIV 
  5.2.3.1 Effect of macrophage depletion in vivo   154 
 5.2.4 Differential cytokine production by peritoneal leukocytes and  160 
 peritoneal epithelial cells  
5.3 Discussion         163 
 
Chapter 6.  Profiling monocyte differentiation in acute MSU-induced 
inflammation         170 
 
6.1 Introduction         171 
6.2 Results          173 
 6.2.1 Monocytes differentiation in vivo     173 
  6.2.1.1 Mononuclear phagocyte morphology    175 
  6.2.1.2 Expression of the dendritic cell marker CD11c  178 
  6.2.1.3 Tracking monocyte differentiation through cell labelling 178 
 6.2.2 Functional changes in differentiating monocytes   183 
  6.2.2.1 Production of pro-inflammatory cytokines in response 183 
  to MSU 
 6.2.3 Investigating phagocytic capacity     192 
  6.2.3.1 Expression of CD206      192 
  6.2.3.2 Functional phagocytic bead assay    192 
  6.2.3.3 Phagocytic capacity of differentiating monocytes  194 
 6.2.4 Investigating the effect of neutrophil uptake on monocyte responses 199 
  6.2.4.1 Monocyte phagocytosis of apoptotic cells   200 
  6.2.4.2 The uptake of apoptotic neutrophils leads to macrophage 201 
  quiescence 
 6.2.5 Monocyte-macrophages in the resolution of inflammation  205 
6.3 Discussion         207 
 
Chapter 7.  General Discussion        215 
 
7.1 Investigating mononuclear phagocyte function using in vivo models  216 
7.2 Macrophages and the induction of gout inflammation    217 
Table of Contents 
 
XV 
7.3 Monocytes in gouty inflammation      220 
7.4 Resolution of gouty inflammation      223 
7.5 Neutrophils in gout        223 
7.6 Inhibiting superoxide production as a therapy for gouty inflammation  227 
7.7 Dissecting the roles of inflammatory cells in gout    228 
7.8 Future directions         229 
7.9 Conclusion         231 
 
Chapter 8.  References        235 
 
Appendix          253 
 
List of Figures 
 
XVI 
List of Figures 
 
Chapter 1.  General Introduction 
 
Figure 1.1 Monosodium urate crystals.       4 
Figure 1.2 Acute and chronic gout.       6 
Figure 1.3 Simplified uric acid production and excretion.    8 
Figure 1.4 Schematic of urate handling in the kidney.     10 
Figure 1.5 Steps catalysed by xanthine oxidase (XO) in the breakdown of   17 
 purines into uric acid. 
Figure 1.6 The formation of reactive oxygen species is dependent on superoxide. 30 
Figure 1.7. Equations outlining the reactions in the formation of ROS and  32 
 the enzymes involved  
Figure 1.8 A proposed model for the involvement of monocytes and   37 
 macrophage in acute gout. 
 
Chapter 3.  Neutrophil activation in MSU-induced inflammation 
 
Figure 3.1 The NADPH oxidase enzyme.      74 
Figure 3.2 Current model of neutrophil activation in gout.    77 
Figure 3.3 MSU stimulated production of superoxide by human neutrophils. 79 
Figure 3.4 The effect of different media conditions on background superoxide  80 
 production by human neutrophils. 
Figure 3.5 The effect of serum on the production of superoxide by human  83 
 neutrophils. 
Figure 3.6 The effect of non-autologous serum on the production of superoxide 84 
 by human neutrophils. 
Figure 3.7 The effect of MSU on neutrophil viability and cytokine production. 86 
Figure 3.8 The effect of other leukocytes on MSU-stimulated neutrophil   90 
  viability. 
List of Figures 
 
XVII 
Figure 3.9 The effect of soluble mediators derived from MSU-stimulation on  94 
 neutrophil viability. 
Figure 3.10 The effect of soluble mediators derived from MSU-stimulation on  96 
 neutrophil IL-8 production. 
Figure 3.11 Histogram comparing the effect of soluble mediators and MSU on  99 
 neutrophil IL-8 production. 
Figure 3.12 The effect of MSU-stimulated soluble mediators on neutrophil  100 
 superoxide production. 
Figure 3.13 Production of superoxide by MSU recruited neutrophils.  102 
Figure 3.14 Neutrophil viability over the course of the acute gout response. 103 
Figure 3.15 Proposed model of neutrophil activation in gout.   107 
 
Chapter 4.  Inhibiting neutrophil inflammation using sesquiterpene 
dialdehydes 
 
Figure 4.1 Sesquiterpene compound structures     111 
Figure 4.2 The effect of sesquiterpene compounds on neutrophil viability after 116 
 30 minutes. 
Figure 4.3 The effect of sesquiterpene compounds on neutrophil apoptosis. 117 
Figure 4.4 The effect of sesquiterpene compounds on neutrophil    120 
 inflammation in vivo. 
Figure 4.5 The effect of serum on superoxide production from HUVECs.  123 
Figure 4.6 The effect of sesquiterpene compounds on superoxide production by 124 
 HUVECs. 
Figure 4.7 The effect of DMSO on MSU-stimulated cytokine production.  128 
Figure 4.8 The effect of sesquiterpene compounds on MSU-stimulated cytokine 129 
 production. 
 
Chapter 5.  Macrophages in the initiation of acute gout 
 
Figure 5.1 Identification of cell types involved in the MSU crystal   135 
 response in vivo. 
List of Figures 
 
XVIII 
Figure 5.2 Morphology of cells expressing the myeloid antigens 7/4   137 
 and Gr-1. 
Figure 5.3 MSU induces cellular infiltration and cytokine production in vivo. 138 
Figure 5.4 IL-6 production by cells infiltrating the peritoneum in response  142 
 to MSU. 
Figure 5.5 TNFα production by cells infiltrating the peritoneum in response 143 
 to MSU. 
Figure 5.6 Infiltrating leukocytes are unresponsive MSU.    145 
Figure 5.7 Leukocytes infiltrating in response to thioglycollate are   146 
 unresponsive MSU. 
Figure 5.8 MSU-elicited monocytes and neutrophils are unresponsive MSU. 148 
Figure 5.9 Macrophages are the major producers of MSU-induced   149 
 pro-inflammatory cytokines in lavaged cells of naïve mice. 
Figure 5.10 Resident macrophages disappear from the peritoneal lavage   151 
 following MSU administration. 
Figure 5.11 MSU crystals become associated with cells as clumps in vivo.  152 
Figure 5.12 Resident macrophages associate with MSU crystals in vitro.  153 
Figure 5.13 Resident macrophages adhere to the epithelial membrane in   155 
 response to MSU. 
Figure 5.14 Resident macrophages are a source of pro-inflammatory cytokines 156 
 in response to MSU. 
Figure 5.15 Depletion of resident macrophages inhibits MSU-induced  157 
 neutrophil infiltration. 
Figure 5.16 Depletion of resident macrophages inhibits MSU-induced  159 
 cytokine production. 
Figure 5.17 Differential production of pro-inflammatory cytokines by  161 
 peritoneal leukocytes and membrane following MSU exposure. 
Figure 5.18 Mesothelial cells produce MCP-1 in response to MSU.  164 
List of Figures 
 
XIX 
Chapter 6.  Profiling monocyte differentiation in acute MSU-induced 
inflammation 
 
Figure 6.1 Marker expression on monocytes over the course of an   174 
 MSU-induced acute inflammatory response. 
Figure 6.2 Morphology of mononuclear phagocytes over the course of the  176 
 MSU-induced acute inflammatory response. 
Figure 6.3 Cell width of mononuclear phagocytes over the course of the  177 
 MSU-induced acute inflammatory response 
Figure 6.4 Expression of the dendritic cell marker CD11c over the course of an 179 
 MSU-induced acute inflammatory response. 
Figure 6.5 PKH26 labelling of mononuclear phagocytes.    180 
Figure 6.6 Marker expression on PKH26+ monocytes over the course of an 181 
 MSU-induced acute inflammatory response 
Figure 6.7 F4/80 expression on differentiating monocytes over the course of an 182 
 MSU-induced acute inflammatory response 
Figure 6.8 Responsiveness of peritoneal exudate cells to MSU restimulation 185 
Figure 6.9 Stimulation of sorted macrophage populations ex vivo   186 
Figure 6.10 In vivo restimulation with a second injection of MSU   188 
Figure 6.11 Hematoxylin and Eosin staining of peritoneal tissue   191 
Figure 6.12 Expression of the mannose receptor CD206 on F4/80+ cells over 193 
 the course of an MSU-induced acute inflammatory response. 
Figure 6.13 Optimisation of bead concentration for use in the phagocytosis assay 195 
Figure 6.14 Phagocytosis of fluorescent beads by monocyte-macrophages  196 
Figure 6.15 Enumeration of beads taken up by monocyte-macrophages  197 
Figure 6.16 Phagocytic capacity of macrophages from mice 72h after in vivo 198 
 MSU treatment 
Figure 6.17 Peroxidase staining of peritoneal exudate cells    202 
Figure 6.18 Percentage of myeloperoxidase positive (MPO+) monocyte-  204 
 macrophages in peritoneal exudate cells
List of Figures 
 
XX 
Figure 6.19 IL-1β production from peritoneal leukocytes following neutrophil 206 
 uptake 
Figure 6.20 TGFβ levels in the peritoneum over the course of an MSU-induced 208 
  inflammatory response. 
Figure 6.21 Summary of the phenotypic and functional changes during the 209 
 differentiation of monocytes to macrophages over the course of  
 MSU-induced inflammation.  
 
Chapter 7.  General Discussion 
 
Figure 7.1 Model of acute gouty inflammation     232 
 
 
List of Tables 
 
XXI 
List of Tables 
 
Table 1.1. Expression levels of selected markers on resident and inflammatory 35 
 monocytes expression markers. 
 
Table 4.1 IC50 values of sesquiterpene compounds based on PMA- and   113 
MSU-stimulated superoxide production by neutrophils. 
 
Table 4.2 A comparison of sesquiterpene IC50 values for neutrophil superoxide 118 
production with sesquiterpene TC50 values. 
 
Table 4.3 Comparison of IC50 values of the sesquiterpene compounds from 125 
HUVEC superoxide production, with IC50 PMA- and  
MSU-stimulated neutrophil production. 
 
Table 5.1 Cell composition of the peritoneum during an inflammatory response 140 
  to MSU crystals. 
 
Table 6.1 Differential cell counts in peritoneal cells from naïve mice and from 187 
mice treated with MSU i.p. for 48h. 
 
 
List of Abbreviations 
 
XXII 
List of Abbreviations 
 
ADP  Adenosine diphosphate  
AMP  Adenosine monophosphate 
ASC Apoptosis-associated speck-like protein containing a caspase recruitment 
domain 
ATP  Adenosine triphosphate 
bFGF  Bovine fibroblast growth factor 
BSA  Bovine serum albumin 
CBA  Cytokine bead array 
Clodronate Dichloromethylenediphosphonic acid disodium salt 
CNS  Central nervous system 
ddH20  Double-distilled (MilliQ) water 
DIC  Differential interference contrast 
DMSO  Dimethyl sulfoxide 
D-PBS  Dulbecco’s Phosphate-Buffered Saline  
DPI  Diphenyleneiodonium chloride 
EGF  Epidermal growth factor 
FACS  Fluorescence activated cell sorter 
FBS  Fetal bovine serum 
FGF  Fibroblast growth factor 
fMLP  formyl-methionyl-leucyl-phenylalanine 
G-CSF  Granulocyte colony stimulating factor 
GLUT9 Glucose transporter 9 
GM-CSF Granulocyte macrophage colony stimulating factor 
HBSS  Hank's balanced salt solution 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
HuSer  Human serum 
HUVEC Human umbilical vein endothelial cells 
IFNγ  Interferon gamma 
IL-1β  Interleukin-1 beta 
List of Abbreviations 
 
XXIII 
KC  Kertinocyte-derived chemokine 
L. monocyto-  Listeria monocytogenes 
          genes  
LPS  Lipopolysaccharide 
M199  Medium 199 
MCP-1 Monocyte chemoattractant protein-1 
M-CSF Macrophage colony stimulating factor 
MIP  Macrophage inhibitory protein 
MMP-1 Matrix metalloproteinase-1 
MRP4  Multidrug resistence protein 4 
MSU  Monosodium urate 
NACHT NAIP (neuronal apoptosis inhibitory protein), CIITA (MHC class II  
transcription activator), HET-E (incompatibility locus protein from 
Podospora anserina) and TP1 (telomerase-associated protein) 
NADPH Nicotinamide adenine dinucleotide phosphate (reduced) 
NALP3 NACHT-leucine rich repeat-pyrin domain-containing protein-3  
(NALP)-3 (cryopyrin) 
NLR  Nod-like receptors 
NOX  Nicotinamide adenine dinucleotide phosphate oxidase 
OAT  Organic anion transporter 
PBMC  Peripheral blood mononuclear cells 
PBS  Phosphate buffered saline 
PFA  Paraformaldehyde 
PSGL1 P-selectin glycoprotein ligand 1 
Phox  Phagocytic oxidase 
PI  Propidium iodide 
PMA  Phorbol 12-myristate 13-acetate 
PMN  Polymorphonuclear cells 
PMS  1-methoxy-5-methylphenazinium methylsulfate 
RANKL Receptor activator of nuclear factor kappa B 
RBC  Red blood cells 
List of Abbreviations 
 
XXIV 
TG2  Transglutaminase-2 
TBS  Tris buffered saline 
TNFα  Tumor necrosis factor alpha 
TLR  Toll-like Receptor 
TREM  Triggering receptor expressed on myeloid cells 
SLC22A12 Solute carrier 22 (organic anion/cation transporter), member 12 
URAT-1 Urate transporter-1 
WBC  White blood cells 
WST-1 2-1[2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-Disulfophenyl)-2H-
tetrazolium, monosodium salt] 
 
  
1 
 
Chapter 1 
General Introduction 
 
Chapter 1: General Introduction 
 
2 
Chapter 1 
General Introduction 
 
1.1 A history of gouty disease 
Gout is a form of arthritis with a documented history spanning several thousands of 
years.  Observed by the ancient Egyptian medical practitioner Imhotep as early as 
2640BCE (Schwartz, 2006), it was also described several centuries later by the Greek 
physician Hypocrates (400BCE), the father of modern medicine, who referred to it as 
podagara, or “the unwalkable disease” (Nuki and Simkin, 2006).   
 
The pre-eminence of gout in historical texts is due not only to its enduring incidence but 
also to its prevalence among the wealthy and those of high society.  Several kings and 
notable historical figures are included in the cadre of sufferers: from Alexander the 
great, to Henry VIII, Christopher Columbus, Leonardo DaVinci, Isaac Newton, 
Benjamin Franklin (Johnson and Rideout, 2004).  The pedigree of sufferers often led to 
the erroneous notion that gout was a natural and unavoidable affliction of high breeding 
that correlated with a person’s level of intelligence (Porter and Rousseau, 1998).  
Despite this belief, it did not escape observation that it was the lifestyle rather than the 
pedigree of the rich that was the likely cause for the disease.  In fact, it was often said 
that gout was a punishment for “old men…after passing the best part of their life in ease 
and comfort, indulging freely in high living, wine and other generous drinks.” 
(Sydenham, 1683) 
 
In the present day, gout is no longer restricted to the circles of affluent society.  In fact, 
the striking increase in the number of gout sufferers across the full range of socio-
economic groups highlights the emergence of gout as a common disease in western 
society.  Gout prevalence in the US increased from 2.9/1000 in 1990 to 5.2/1000 in 1999 
(Wallace et al., 2004).  Another based on research in England during the same period, 
placed prevalence at 9.5/1000 (Harris et al., 1995).  An even more impressive rise was 
observed in New Zealanders of European descent, which increased from 3.1/1000 in 
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1958 to 29/1000 in 1992 (Lennane et al., 1960, Klemp et al., 1997).  These statistics 
reflect a global trend clearly indicating that gout is on the rise worldwide. 
 
The alarming acceleration of gout incidence has emphasised the need for a deeper 
understanding of gout as a disease.  The following pages aim to provide an overview of 
what is currently known about gout.  This review will describe the cause, symptoms and 
stages of gout; discuss the known risk factors and management practices; and outline 
key background information on the cellular events known to be involved in gouty 
inflammation.  Finally, the research questions of this thesis will be presented.  These 
questions will address some of the important unknown aspects of cellular inflammation 
in gout.  Ultimately, it is the goal of this thesis to provide a significant advance in the 
understanding of the cellular events that characterise gout inflammation. 
 
1.2 Monosodium urate crystals 
Although needle-like crystals were observed in gout afflicted joints as early as the 17th 
century (Gibson et al., 1984), it was not until the 1960s that these crystals, called 
monosodium urate or MSU, were experimentally confirmed as the inducing agent in a 
gout attack by Faires and McCarty.  Using MSU they had prepared synthetically, they 
injected crystals into the synovial space of their own knees.  The result was a full-blown 
gout attack (Faires and McCarty, 1962). 
 
MSU crystals are the biological form of crystallised uric acid.  They are needle-like in 
appearance and have the ability to split incident light; a quality called birefringence that 
is observed microscopically using plane polarised light (Fig. 1.1).  MSU crystals can be 
identified in synovial fluid extracted from joints affected by gout even after the gout 
attack has resolved and there is no clinical evidence of inflammation (Pascual, 1991, 
Pascual and Jovani, 1995). Thus, once uric acid has precipitated in the joint it takes a 
long time for MSU crystals to be redissolved by the body as soluble uric acid. 
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Figure 1.1. Monosodium urate crystals.  Monosodium urate crystals (MSU) as 
visualised under a microscope in normal (top) and polarised (bottom) light fields. 
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1.3 Acute gouty arthritis 
In 1683, the physician Thomas Sydenham provided what is now the classic description 
of gout.  Speaking from his own experience, he described: 
 
“The victim goes to bed and sleeps in good health.  About two o’clock in the morning, 
he is awakened by a severe pain in the great toe; more rarely in the heel, ankle or 
instep.  This pain is like that of a dislocation, and yet the parts feel as if cold water were 
poured over them.  Then follows chills and shiver and a little fever.  The pain, which at 
first moderate, becomes more intense.  After a time this comes to full height, 
accommodating itself to the bones and ligaments of the tarsus and metatarsus.  Now it is 
a violent stretching and tearing of the ligaments – now it is a gnawing pain and now a 
pressure and tightening.  So exquisite and lively meanwhile is the feeling of the part 
affected, that it cannot bear the weight of bedclothes nor the jar of a person walking in 
the room.” (Sydenham, 1683) 
 
This description underpins the major aspects of acute gout: that it occurs suddenly, in 
one or more joints, and is extremely painful.  During a gouty episode the affected joint 
exhibits all of the classic symptoms of inflammation (Fig. 1.2A).  The joint swells and 
reddens as vascular permeability increases, allowing fluids to drain into the area.  This 
inflammatory reaction is accompanied by intense pain and heat in the affected joint.  
The symptoms of oedema, rubor, heat and pain, will continue for several days, marking 
the rich influx of neutrophils – a key cell in gout – along with monocytes and other pro-
inflammatory leukocytes into the area.  Even in the absence of therapy, the 
inflammatory symptoms will subside within 7-10 days (Poor and Mituszova, 2003).  
The abrupt onset and spontaneous resolution of gout are characteristic of this acute 
response.  In terms of frequency of acute attacks, 60% of individuals who experience 
their first gout attack experience a second attack within the space of a year (Ferraz and 
O'Brien, 1995).   
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Figure 1.2. Acute and chronic gout.  Pictures of joints from patients with (A) acute 
gout and (B) chronic tophaceous gout.  The white arrow indicates the MSU crystals of a 
tophus that has ruptured through the skin and caused ulceration.  Pictures used with 
permission from PHARMAC, NZ. 
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1.4 Chronic gout 
Sufferers of acute gout may experience periodical attacks for several years over which 
time these attacks can become more frequent and severe.  This increase in intensity can 
be accompanied by the formation of lumps or nodules, called tophi: collections of MSU 
crystals and immune cells that have accumulated in the joints or soft tissue (Fig. 1.2B). 
The formation of tophi around the joints leads to polyarticular bone erosions and 
deformations (Nakayama et al., 1984).  The development of chronic gout is often 
debilitating, with some individuals never experiencing complete freedom from ongoing 
pain.  In addition, individuals will continue to experience periodic attacks of 
inflammation, known as gout flare. 
 
1.5 Uric acid 
The greatest predictor of gout risk and development is the concentration of uric acid in 
the serum.  Uric acid levels commonly fall into the range of 2.4 - 6.0 mg/dL in women 
and 3.4 - 7.0mg/dL in men (Dincer et al., 2002).  Clinical hyperuricemia is diagnosed 
when serum uric acid exceeds 7mg/dL.  At this elevated level the uric acid load 
approaches the solubility limit, moving individuals into a high risk category of 
contracting gout (Campion et al., 1987).  
 
Uric acid is routinely generated in the body as a breakdown product of purines (Poor 
and Mituszova, 2003).  Purines are an essential building block in many essential 
proteins, enzymes, structures and energy carrying molecules including DNA, NAD, 
NADP and ATP.  The purine requirements of the body can mostly be synthesised 
endogenously and maintained through purine recycling and salvage pathways (Murray, 
1971).  Anything that increases the rate of purine synthesis or breakdown, such as 
surgery, increased cell turnover, cell damage and necrosis, or high intake of fructose or 
alcohol (Section 1.7.2), potentially affects serum uric acid level. Purines can also come 
from exogenous sources through the intake of purine rich foods such as seafood and 
meat (Section 1.7.2).  A simplified version of the causes of uric acid generation is shown 
in Fig. 1.3. 
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Figure 1.3.  Simplified uric acid production and excretion.  Both dietary and 
metabolic sources contribute to the overall purine pool within the body.  Excess and 
unsalvageable purines are broken down into uric acid, which is excreted through the 
kidney (70%) and intestine (30%).  When the uric acid load becomes too high, MSU 
crystals may begin to form in the joint.  Adapted from Roddy, Zhang et al. 2007. 
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In humans, renal excretion is the main process for uric acid extinction, accounting for 
approximately 70% of uric acid excretion. The remainder of urate is excreted through 
the intestine into the faeces (Fig. 1.3).  Together these two paths are entirely responsible 
for controlling uric acid excretion in humans (Poor and Mituszova, 2003). 
 
Kidney urate handling is a key contributor to high serum uric acid (Terkeltaub et al., 
2006).  In the kidney, uric acid handling is a multi-step process that results in the 
excretion of only 10% of the uric acid filtered through the kidney.  Urate in the blood is 
filtered at the glomeruli and is almost completely reabsorbed into the bloodstream in the 
upper section of the kidney tubules.  Urate is then re-secreted into the tubules followed 
by post-secretory re-absorption before urate is finally excreted in the urine (Fig. 1.4).  
This multi-step process is controlled by a number of transport proteins (e.g. URAT-1, 
OAT-1, OAT-3 and MRP4) suggesting that there are a number of points at which 
susceptibility to hyperuricemia due to kidney function may be due to differences in one 
or more of these proteins leading to overly efficient re-absorption of uric acid into the 
blood, or under-efficient re-secretion into the kidney tubules: under-excretion (Hediger 
et al., 2005, Taniguchi and Kamatani, 2008) 
 
1.6 Loss of uricase 
Unlike humans, most other mammals have an additional enzyme for regulating serum 
urate known as uric acid oxidase, or uricase.  Uricase efficiently converts uric acid to the 
more soluble allantoin, which is readily passed out in the urine.  The efficacy of this 
enzyme is highlighted by the fact that mammals with functional uricase do not contract 
gout (Johnson and Rideout, 2004).  The uricase gene still exists within the human 
genome, however, the gene for human uricase is inactive due to a mutation that occurred 
in humans during the Miocene era, around 10 to 22 million years ago (Wu et al., 1989, 
Wu et al., 1992).  This loss of uricase activity explains the large difference in serum uric 
acid levels observed in uricase sufficient mammals, which maintain a low serum urate 
level of less than 1mg/dL (Wu et al., 1992). 
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Figure 1.4. Schematic of urate handling in the kidney.  Approximately 99% of the 
filtered urate (blue arrows) is reabsorbed back into the blood stream by transport 
proteins that line the lumen of the tubule.  Urate is then re-secreted and re-absorbed by 
further transport proteins involved in the exchanging of various ions resulting in a net 
90% retention of urate.  The other 10% is excreted through the urine (black arrow).  
Blue arrows show the movement of urate across tissues.  Adapted from Poor et al. 2003. 
 
Chapter 1: General Introduction 
 
11 
There are other mutations of the uricase gene in other higher primates, independent of 
the human mutation, implying that the lack of uricase and a heightened serum uric 
confers some selective advantage (Wu et al., 1992, Watanabe et al., 2002).  One possible 
benefit of a loss in uricase during that period may have been an advantageous increase 
in blood pressure.  It is thought that during the Miocene era, when the mutations in 
uricase arose, primates would have maintained a largely vegetarian diet, which was low 
in sodium, resulting in low blood pressure.  Low blood pressure is problematic when 
spending a large amount of time “standing” erect, as blood flow to the brain is less 
efficient.  Rat studies have shown that a low sodium diet causes low blood pressure, 
however an increase in uric acid levels by inhibiting rat uricase caused an increased in 
blood pressure to normal levels (Mazzali et al., 2001).  A small human study has also 
shown that therapy aimed at lowering serum uric acid also lowered blood pressure (Feig 
and Johnson, 2007).  It is ironic that this evolutionary advantage may have become 
disadvantageous in the current environment of a modern western diet. 
 
Another possible advantage of a loss in uricase was to harness the function of uric acid 
as an antioxidant.  Uric acid is the most abundant antioxidant present in the body, and as 
such, is likely to play an important role in eliminating errant reactive oxygen species in 
the circulation and tissues (Ames et al., 1981 & Hochstein, 1981, Becker, 1993).  For 
example, it has been hypothesized that this antioxidant effect is important in protection 
from the oxidative damage in the central nervous system (CNS) caused by peroxynitrite.  
The administration of uric acid to mice with experimental allergic encephalomyelitis, a 
disease used to model human multiple sclerosis, has been shown to delay and even 
reverse clinical symptoms of the disease (Hooper et al., 1998).  Meanwhile, patients 
with Parkinson’s disease have demonstrated a lower plasma uric acid level than healthy 
individuals, suggesting that the loss of antioxidant protection is involved with the 
progress of CNS damage (Annanmaki et al., 2007).  The antioxidant effects of uric acid 
may be particularly important in humans, since humans lost the ability to sythesize 
ascorbate, an important antioxidant in most other organisms (Proctor, 1970).  Therefore,  
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it is highly likely that heightened uric acid levels in humans serves as a general 
protective mechanism against the generation of oxidative damage under both 
homeostatic and inflammatory conditions. 
 
1.7 Gout risk factors 
Even though the precipitation of MSU crystals is predicted by hyperuricemia, only 25% 
of hyperuricemic individuals develop gout (Campion et al., 1987).  Some individuals 
can be in a state of asymptomatic hyperuricemia for several years before suffering a 
gout attack, while in the vast majority high uric acid will never precipitate into an attack.  
MSU crystals can also be present within the joint between attacks without elaborating an 
inflammatory response (Pascual et al., 1999).  The reasons for these observed 
phenomena are currently unknown and demonstrates that there are still a number of 
mysteries surrounding the onset of gout that have yet to be unravelled. 
 
1.7.1 Gender 
A prime risk factor in gout is gender.  Gout is the most common form of inflammatory 
arthritis in men over 40 (Roubenoff, 1990).  In fact, gout is heavily a predominantly 
male disease where prevalence in men is typically four-fold that observed in women 
(Hall et al., 1967).  It is currently believed that women are protected from gout due to 
the uricosuric effects of estrogen and consistent with this idea is the observation that it is 
rare for women to suffer gout prior to menopause (Nicholls et al., 1973).  Testosterone is 
also known to increase the expression of URAT1, a key protein in urate reabsorption in 
the kidney, further implicating sex hormones as the cause of gender differences (Li et 
al., 2004). 
 
1.7.2 Diet 
Dietary purine intake is a significant contributor to serum uric acid levels (Griebsch and 
Zollner, 1974, Coe et al., 1976).  The intake of high purine foods is often sufficient to 
induce the onset of a gout attack in hyperuricemic individuals, making diet a major risk 
factor in gout. Purine rich foods include shellfish (mussels, oysters, clams), seafood 
(sardines, anchovy, trout), red meat, offal foods (liver, heart, tongue, kidney, brain), 
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asparagus, mushrooms and beer.  In particular, prospective studies have shown that 
individuals with high meat and/or seafood intake have elevated serum urate levels and 
are at the highest risk of developing gout (Choi et al., 2004b, Choi et al., 2005). 
 
Other foods associated with increased risk, including fructose (Choi and Curhan, 2008, 
Choi et al., 2008) and some alcoholic beverages (Choi et al., 2004a, Choi and Curhan, 
2004), increase serum uric acid indirectly.  For example, fructose, which is a common 
sweetener in soft drinks and fruit juices, is a major contributor to uric acid levels by 
interfering with ATP recycling, causing ATP to be converted to AMP and subsequently 
degraded to uric acid rather than being recycled from ADP back to ATP (Fox and 
Kelley, 1972, Fox et al., 1987).  In addition, this reduction in ATP stores causes the 
body to increase the rate of purine synthesis in the liver to replenish the degraded ATP, 
further raising the pool of purines available for degradation to uric acid (Raivio et al., 
1975).  Alcohol also leads to an increase in purines by increasing ATP turnover during 
the metabolism of ethanol (Faller and Fox, 1982, Puig and Fox, 1984), the increased 
turnover leading to a similar elevated purine breakdown as observed in fructose 
consumption. 
 
1.7.3 Genetic and race-related risk 
As mentioned previously, genetics also play a part in gout risk. Since intrinsic over-
production of purines is rare, increased genetic risks are likely to be due to differences in 
renal excretion.  Recently, genetic studies have identified two genes and their respective 
proteins as having a strong influence on the regulation of serum urate: URAT1 and 
GLUT9.  Both proteins are involved in urate reabsorption following glomerular 
filtration.  Polymorphisms in SLC22A12, the gene that encodes URAT1, have been 
shown to be associated with both hyperuricemia and hypouricemia (Ichida et al., 2004, 
Shima et al., 2006, Vazquez-Mellado et al., 2007), while a particular allele of GLUT9 
has been associated with a reduction in serum urate in Italian, UK, German and Croatian 
populations (Li et al., 2007, Stark et al., 2008).  These genes are a good starting point for 
exploring racial and genetic susceptibilities, and since uric acid handling in the kidney is 
a multi-step process, other genetic susceptibilities are likely to be revealed. 
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The over-representation of gout in certain racial groups implies that there may be 
genetic causes to explain the high prevalence.  As a case example, Maori have more 
than twice the incidence of gout than non-Maori in New Zealand (Klemp et al., 1997).  
It has not yet been ruled out that this high incidence is due to factors other than genetics.  
Gout, for instance, had been notably absent within Maori prior to 1880 (Lennane et al., 
1960).  Yet after the conversion of the Maori diet from a high vegetable and 
carbohydrate diet to a high meat and high fat diet, gout quickly emerged in extreme 
prevalence (Lennane et al., 1960), where now approximately 10% of adult Maori males 
contract gout (Klemp et al., 1997). 
 
1.7.4 An aging population 
The risk of contracting gout increases with age (Wallace et al., 2004).  Increased 
longevity in industrialised nations may therefore account for some of the increase in 
gout prevalence that has been observed (Saag and Choi, 2006). This is influenced by a 
decrease in renal function with advancing age and further complicated by some 
medications commonly used by the elderly that have diuretic side effects that are also 
capable of raising serum urate levels (De Leonardis et al., 2007).  The treatment of gout 
within the elderly is often complicated by renal failure, intolerance to certain treatments 
and the presence of other health conditions that can limit the medications for gout (De 
Leonardis et al., 2007). 
 
1.8 Co-morbid diseases 
If the need for increased blood pressure was indeed a contributing factor in the loss of 
uricase in humans, it is unfortunate that the modern western diet now drives 
hypertension to almost epidemic proportions.  However, it does provide an explanation 
for the existence of hyperuricemia and hypertension as co-morbid diseases (Messerli et 
al., 1980).  In fact, several studies have linked hyperuricemia not only to hypertension, 
but also to other metabolic syndrome-based disorders including cardiovascular disease 
(Puig and Ruilope, 1999), making it an associated risk factor for a wider collection of 
globally increasing diseases. 
Chapter 1: General Introduction 
 
15 
 
1.9 Treatment and management of gout 
There are three main approaches in the management of gout.  The first is based on a 
lifestyle approach, focused on controlling serum uric acid by moderating food intake.  
The second involves the use of drugs aimed to lower serum urate and tends to be a long-
term regimen.  The third uses non-steroidal anti-inflammatory drugs to alleviate the 
symptoms of inflammation associated with a gout attack. 
 
1.9.1 Diet 
There are a number of studies showing that the intake of certain foods are associated 
with heightened serum urate levels.  Limiting the intake of purine-rich foods and uric 
acid promoting substances such as alcohol are recommended to prevent raising uric acid 
levels and precipitating gout attacks (Choi et al., 2004b, Choi et al., 2004a).  
Conversely, there are a number of dietary items associated with small reductions in 
serum uric acid and lower gout risk.  Low fat-dairy (Choi et al., 2004b), cherries (Jacob 
et al., 2003), vitamin C (Huang et al., 2005, Gao et al., 2008) and long term coffee 
drinking (Choi and Curhan, 2007, Choi et al., 2007) are examples, although the cause of 
the urate lowering effects of these treatments are currently unknown.   
 
Research has shown that being overweight increases the risk of gout (Choi et al., 2005).  
A small study has also shown that weight loss can improve gout symptoms.  In this 
research weight loss of as little as 5 to 8kg in obese gout sufferers improved serum urate 
levels by 11% and reduced the average attacks from 2.1 to 0.6 episodes per month 
within the groups of patients observed (Dessein et al., 2000). 
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1.9.2 Anti inflammatory drugs 
Gout attacks are intensely painful.  For this reason, anti-inflammatories are used to 
alleviate the symptoms of gout attacks.  This includes the use of glucocorticoids, but 
more commonly involves the use of non-steroidal anti-inflammatory drugs (NSAIDs) 
including Indomethacin, Naproxen and Ibuprofen (Jordan et al., 2007).  NSAIDs can be 
used as a prophylaxis to disease or to alleviate the symptoms of inflammation during or 
immediately before the onset of an attack.   
 
Colchicine is also used for the treatment of gout.  It is the active component of the plant 
Autumn crocus, which has been used for several centuries as a remedy for gout prior to 
colchicine isolation in 1820 (Ahern et al., 1987). Colchicine can be used to alleviate the 
symptoms of an attack or as a low dose prophylactic regime.  It has a number of known 
therapeutic activities including the inhibition of microtubule polymerisation that 
contributes to the inhibition of neutrophil migration and activation (Sternlicht and 
Ringel, 1979, Chia et al., 2008). In the past, the use of colchicine was often 
controversial due to its reputation as a potent poison.  It has a narrow therapeutic 
window as a number of toxic side effects can be observed during treatment, such as 
diarrhoea, gastrointestinal damage, fever, vomiting and in a few extreme cases, death 
(Bonnel et al., 2002, Sussman et al., 2004).  Since colchicine has the potential for these 
side effects it is not well tolerated in some individuals that are already physiologically 
compromised such as the elderly, or patients with renal failure. 
 
1.9.3 Uric acid lowering drugs 
The lowering of serum uric acid can also be achieved through the use of drugs that work 
by a number of mechanisms to lower serum urate, acting as a prophylaxis to gout 
attacks.  These drugs accomplish their effect by either lowering the production of uric 
acid (uricostatic drugs) or by increasing renal excretion (uricosuric drugs).  Allopurinol 
is a commonly prescribed uricostatic pro drug that is converted in the liver to the active 
metabolite oxypurinol (Becker et al., 2005).  Oxypurinol prevents uric acid from being 
generated by inhibiting xanthine oxidase, the enzyme responsible for the last 
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Figure 1.5. Steps catalysed by xanthine oxidase (XO) in the breakdown of purines 
into uric acid.  The figure shows the steps that are inhibited by oxypurinol.  (Adapted 
from Pacher et al., 2006). 
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step in conversion of purines from hypoxanthine and xanthine to uric acid (Fig. 1.5).  
Febuxostat and Y-700 are additional examples of xanthine oxidase inhibitors 
(Bomalaski and Clark, 2004, Becker et al., 2005).  Uricosuric drugs function by 
preventing reabsorption of uric acid in the kidney so that more uric acid gets excreted.  
Examples of these are probenecid, which inhibits the reabsorption of uric acid by 
competitive inhibition of the OAT urate transporter protein in proximal tubules in the 
kidney (Sweet et al., 2003); and benzbromarone, which inhibits URAT-1 mediated re-
absorption of uric acid in tubules (Enomoto et al., 2002). 
 
1.9.4 Limitations of current therapies 
Despite the usefulness of these therapies, they are not without their limitations.  For 
instance, the use of NSAIDs is often associated with side effects such as gastric ulcers 
(Conaghan and Day, 1994); some individuals with poor renal function cannot tolerate 
some medications (Mikuls et al., 2004); and the need for daily dosing of uricosuric 
drugs often leads to low compliance (Sarawate et al., 2006).  In addition, gout often goes 
misdiagnosed or poorly managed.  Thus, a deeper understanding of gouty disease may 
provide insights into new and more effective ways to identify and treat gout.  It may 
suggest ways in which at risk individuals can be more easily identified and protected 
from gout attack, or it may identify the cell types that must be targeted in order to 
mitigate the inflammatory response or speed resolution.  Indeed, there are many 
questions on the “bare bones” cellular level that may be key in revealing the important 
cellular inflammatory events that can be targeted for an improved clinical benefit. 
 
1.10 Cellular inflammation in acute gout inflammation 
In order for gout to be initiated, cells have to recognise and respond to MSU crystals, 
and induce inflammation.  The nature of that response depends on the cell types 
recognising those crystals, and on the cells subsequently recruited to the site of 
inflammation.  Some of the important cells and cellular mediators in gout have been  
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identified, but much remains to be answered.  This section summarises what is currently 
known about the cellular responses in gout inflammation providing the backdrop for the 
research that was undertaken in this thesis. 
 
1.10.1 Initiation of gout inflammation 
MSU initiates the activation of inflammatory cells in gout.  When MSU forms within a 
joint, the local cells are activated to initiate an inflammatory response.  Mast cells, 
monocytes, and synoviocytes are thought to contribute by producing inflammatory 
molecules including IL-1β, TNFα, IL-8, IL-6 and S100 proteins (Di Giovine et al., 
1987, Guerne et al., 1989, di Giovine et al., 1991, Getting et al., 1997, Ryckman et al., 
2003a).  Proteins already present in the serum are also thought to be involved in 
activating inflammatory cells; for instance, complement proteins are thought to be 
activated at the surface of MSU crystals (Russell et al., 1982).  Collectively these 
inflammatory mediators facilitate the recruitment of leukocytes via the upregulation of 
adhesion molecules on epithelial cells and the cognate adhesion molecules on 
responding leukocytes, enabling the recruitment of blood leukocytes into the joint space.  
Once neutrophils invade the joint, they are able to interact with and phagocytose MSU 
crystals to produce IL-8 and S100 proteins, which further augment leukocyte 
recruitment during the pro-inflammatory stage of the inflammatory response (Ryckman 
et al., 2004).  Contact of neutrophils with MSU has also been shown to trigger the 
production of reactive oxygen species that contribute to the destructive inflammatory 
environment in gout (Abramson et al., 1982). 
 
1.10.2 The necessity of MSU recognition by immune cells as a “danger signal” 
MSU is a non-infectious agent and so induces a sterile inflammatory response.  As it is a 
sterile response it may be difficult to understand why MSU would induce the 
inflammatory response just described.  Recent findings have indicated a potential 
beneficial role of the inflammatory response to MSU crystals.   
 
It has long been understood that in order to induce an acquired immune response, 
stimulation of the immune response by an antigen must occur in the presence of an 
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adjuvant or “danger signal” to amplify immune signalling and avoid tolerance 
(Matzinger, 1994).  Bacterial and yeast cell wall components or viral RNA are known to 
provide the required danger signal through Toll-like receptor (TLR) signalling, which 
recognise the presence of foreign agents and initiate the appropriate immune defence to 
invading organisms (Akira et al., 2001).  Dead cells are also known to provide adjuvant 
effects (Shi et al., 2000, Shi and Rock, 2002).  Through fractionation of the components 
of dead cells, Rock and his colleagues identified that uric acid released from dead cells 
was associated with the observed adjuvant effect (Shi et al., 2003).  The presence of uric 
acid was able to activate dendritic cells and facilitate the expansion of CD8 T-cells.   
This adjuvant effect was only observed when uric acid was present at concentrations 
high enough for crystals to form (7mg/dL).  Not only does this identify the important 
function of uric acid to provide a danger signal around areas of tissue damage, it also 
suggests that the response to MSU in a gout attack may simply occur as a result of an 
overactive adjuvant response that, in the absence of any secondary antigenic stimulus, 
resolves of its own accord. 
 
1.10.3 Innate cell recognition of MSU to induce an inflammatory response. 
In order for inflammation or a “danger signal” to be initiated by innate cells responding 
to MSU, there must be some means of recognition of MSU by innate cells.  In part, 
some of the inflammation can be due to an indirect activation of cells, via the cleaving 
and activation of complement proteins at the surface of MSU crystals (Russell et al., 
1982).  However, in the absence of serum, MSU is still able to activate immune cells to 
produce pro-inflammatory molecules indicating a role for direct recognition of MSU by 
innate cells.  Currently the receptors responsible for crystal recognition are not 
definitively known. TLR2 and TLR4 have been shown to play a role in MSU neutrophil 
recruitment in a murine air pouch model (Liu-Bryan et al., 2005).  Recognition of MSU 
by the same pattern recognition receptors that recognise bacterial endotoxin has been 
strengthened by evidence showing that the endotoxin scavenging receptor and 
TLR2/TLR4 adaptor molecule CD14 can bind directly to MSU (Scott et al., 2006).  The 
absence of CD14 causes a substantial reduction in both neutrophil recruitment and IL-1β 
production (Scott et al., 2006).  In contrary research using a murine peritoneal model of 
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acute gout, TLRs were dispensable in MSU inflammation (Chen et al., 2006).  As a 
result of these data, the exact relevance of TLRs to MSU inflammation remains unclear. 
 
More recently, the production of IL-1β by macrophages has been shown to be dependent 
upon the rupturing of phagosomes within cells that have phagocytosed MSU crystals 
(Hornung et al., 2008).  Clearly, cell activation by MSU must occur through more than 
one pathway and the local site may heavily affect the nature of the incipient response.  
With the identification of the importance of MSU in both inflammation and immunity, 
elucidation of the recognition processes for MSU is likely to be a subject of extensive 
research. 
 
1.10.4 Production of cytokines by MSU-stimulated innate cells 
Innate cells stimulated with MSU crystals will produce a number of inflammatory 
molecules.  Neutrophils and monocytes exposed to MSU produce large amounts of IL-8, 
a principal chemokine in neutrophil recruitment and priming.  Mice, which do not 
produce IL-8, fulfil these functions via other pleiotropic mediators, such as S100 
proteins as well as other IL-8R agonists such as KC and MIP proteins (Lee et al., 1995, 
Ryckman et al., 2003b).  The production of other cytokines including TNFα and IL-1β 
by stimulated monocytes primes neutrophils to produce superoxide and augments their 
recruitment by inducing increased expression of adhesion molecules on endothelial cells 
(Burt and Jackson, 1997, Chapman et al., 1997).  The production of MCP-1 causes the 
further release of monocytes from the bone marrow and their subsequent recruitment to 
the inflammation site (Randolph and Furie, 1995, Serbina and Pamer, 2006).  Hence, 
there are a number of cytokines that contribute to the inflammatory response in gout.  
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1.10.4.1 IL-1β  and the inflammasome 
MSU crystals stimulate the secretion of IL-1β from macrophages (Martinon et al., 
2006).  Recent research has highlighted a key role for IL-1β in gouty inflammation 
whereby the blockade of IL-1β abrogates inflammation (Chen et al., 2006). 
 
The cleaving of preformed stores of proIL-1β into active IL-1β requires the assembly of 
a multi-protein complex called the inflammasome (Martinon et al., 2002).  In 
macrophages, the inflammasome is comprised of the intracellular pattern recognition 
receptor NACHT-LRR-PYD-containing protein-3 (NALP3), the accessory protein ASC, 
and procaspase-1.  Following activation by MSU through a process that is currently 
unknown, NALP3 oligomerises and recruits ASC, which in turn binds procaspase-1 
leading to autocatalytic processing and activation (Mariathasan et al., 2004).  Activated 
caspase-1 cleaves the inactive proIL-1β allowing it to be secreted from the cell in its 
active form (Martinon et al., 2002).   
 
Mice deficient in components of the inflammasome (ASC, caspase-1 and NALP3) or in 
IL-1β receptor (IL-1R) show a reduced neutrophil recruitment (Chen et al., 2006).  
Furthermore, using a combination of mouse knockouts and bone marrow chimeras, 
Myd88 signalling induced by IL-1R engagement on non-hemopoietic cells has been 
shown to be the important functional activity of IL-1β in neutrophil recruitment (Chen 
et al., 2006).  Although it has not yet been established, it is likely that the non-
hemopoietic cells in question were endothelial cells, given that IL-1β has been shown to 
upregulate adhesion molecules on endothelial cells, a process that is crucial for 
neutrophil recruitment (Chapman et al., 1997). 
 
Another study illustrating the importance of IL-1β in gout tested the effectiveness of IL-
1β blockade in acute gout patients.  Anakinra, a recombinant version of IL-1 receptor 
antagonist, was administered to ten patients who had either failed, or could not tolerate 
standard therapies.  All patients responded rapidly to this therapy, with 9/10 patients 
showing complete resolution of signs of arthritis three days following the initiation of 
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the therapy (So et al., 2007).  Collectively, these findings provide a body of evidence for 
the importance of IL-1β in gout. 
 
1.10.5 Resolution in gout 
A characteristic feature of a gout attack is the spontaneous resolution of inflammation.  
The cessation of leukocyte infiltration and the reduction in neutrophil numbers to 
background levels occurs over the space of seven to ten days (Poor and Mituszova, 
2003).  Although the cause of this spontaneous resolution in gout is not conclusively 
known, there are lines of evidence that mononuclear phagocytes mediate resolution in 
gout via Transforming Growth Factor β (TGFβ). 
 
The first line of evidence comes from a study showing that extraneous TGFβ inhibits 
MSU-induced cellular infiltration in a rat model subcutaneous air pouch (Liote et al., 
1996).  However, this study did not identify any endogenous sources of TGFβ in 
relation to the gouty disease. 
 
The second line of evidence comes from experiments by the Haskard group showing 
that monocyte-like primary cells and cell lines produced pro-inflammatory cytokines 
(e.g. IL-6, IL-1β, TNFα) when exposed to MSU in vitro, while mature macrophage-like 
primary cells and cell lines showed reduced levels of these pro-inflammatory cytokines 
and instead produced large amounts of TGFβ (Yagnik et al., 2004).  This led to the 
hypothesis that the differentiation state of the monocyte-macrophage dictates the nature 
of the response of a mononuclear phagocyte to MSU.  When mixed leukocyte 
populations were harvested from human blisters formed by a chemical irritant, this same 
pattern of switching from a “pro” to an “anti” inflammatory response was also observed 
when these cells were stimulated with MSU ex vivo suggesting that monocyte-
macrophages alter their responsiveness to MSU over the course of an inflammatory 
response (Yagnik et al., 2004). 
 
The third line of evidence comes from mice that lack tissue transglutaminase, 
Transglutaminase 2 (TG2).  Along with a host of other activities, TG2 is important in 
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the uptake of apoptotic cells, and as such, macrophages from TG2-/- mice are defective 
in the ability to take up apoptotic cells (Rose et al., 2006).  There appears to be some 
involvement of TGFβ in this system as exogenous active TGFβ restores the phagocytic 
capacity of TG2-/- macrophages to take up apoptotic cells.  Conversely, the depletion of 
TGFβ inhibits apoptotic cell uptake in TG2+/+ macrophages.  In terms of gout, TG2-/- 
mice treated with MSU by intraperitoneal injection exhibited a prolonged and more 
intense neutrophil infiltration implying that macrophages mediate neutrophil uptake via 
TG2 in a system that implicates TGFβ.  Unexpectedly, there were no salient differences 
in the level of soluble TGFβ in the surrounding milieu of TG2-/- and TG2+/+ mice 
measured over the course of the in vivo response, implying that TGFβ may have been 
exerting effects at levels below detection. 
 
The fourth line of evidence for the involvement of mononuclear phagocytes in the 
resolution of acute gout comes from the observation that macrophages that ingest 
apoptotic neutrophils (but not necrotic neutrophils) produce anti-inflammatory 
mediators including TGFβ as well as PGE2 and IL-10, meanwhile downregulating pro-
inflammatory cytokines (such as TNFα) (Fadok et al., 1998).  In a way, this fourth line 
of evidence incorporates all of the phenomena discussed in the above paragraphs, as 
mononuclear cell differentiation is likely to occur concomitantly with the accumulation 
of neutrophils in vivo.  The question as to which of these possibilities actually occurs in 
gout has yet to be demonstrated in vivo. 
 
1.10.6 Key innate cells in gout 
It is proposed that neutrophils, monocytes and macrophages play key roles over the 
course of acute gout inflammation.  Monocytes and macrophages are the source of 
important chemokines and cytokines in acute gout, while neutrophils produce 
inflammatory molecules such as superoxide that augment the inflammatory response 
and cause physiological damage.  As important cells in gout, the activities of these three 
cell types will be investigated in this thesis. 
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1.10.7 Neutrophils 
Neutrophils, also known as polymophonuclear leukocytes (PMN), are the most 
numerous white blood cells in humans comprising 50-70% of circulating white blood 
cells.  Under homeostatic conditions they have a very short lifespan.  Following release 
from the bone barrow, neutrophils will undergo spontaneous apoptosis within 6-10 
hours (Athens et al., 1961, Dancey et al., 1976) and are cleared from the circulation by 
liver and splenic macrophages (Shi et al., 2001). 
  
Neutrophils are an important cell type in host defence and are usually the first cells 
recruited to a site following infection or tissue damage.  Once recruited to a site, they are 
involved in the uptake of infectious and particulate matter, pathogens and damaged 
tissue, and produce hazardous molecules to kill and digest the offending organisms and 
dead tissue (Cassatella, 1995).   
 
1.10.7.1 Neutrophil recruitment 
The recruitment of leukocytes such as neutrophils from the blood into a space such as 
the synovium requires a number of events that broadly fit into four stages: leukocyte 
rolling; leukocyte activation; leukocyte arrest; and transendothelial migration. 
 
The first stage, leukocyte rolling, is dependent on adhesion molecules called selectins.  
Even under non-inflammatory conditions, free flowing neutrophils can undergo contact 
with endothelial cells through the interaction of selectin adhesion molecules P-selectin, 
E-selectin and L-selectin on leukocytes (Kansas, 1996), with P-selectin glycoprotein 
ligand-1 (PSGL-1) and other adhesion molecules expressed on endothelial cells 
(McEver and Cummings, 1997).  In particular, the interaction of L-selectin with PSGL-1 
allows the capture and tethering of neutrophils to the endothelial wall in a manner that is 
strengthened under shear stress caused by blood flow (Marshall et al., 2003).  The 
subsequent rolling of leukocytes along the endothelium is achieved through the 
formation of new selectin-PSGL-1 interactions concomitant with the breaking of old 
ones (Yago et al., 2007 McEver, & Zhu, 2007).  
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The activation of leukocytes at the next stage is connected to the activation of 
endothelial cells. Under inflammatory situations, endothelial cells are stimulated by 
cytokines to express adhesion molecules and present chemoattractants on their luminal 
surface (Campbell et al., 1998, Campbell et al., 1996).  These chemoattractants can be 
produced directly by the endothelial cells or generated at the site of inflammation - for 
instance, by activated mast cells - and transported to endothelial cells as circulating 
microparticles (Huo et al., 2003, von Hundelshausen et al., 2001).  Chemoattractants 
transferred to the luminal endothelium may be found bound to glycosaminoglycans, 
which allow chemoattractants to be presented to rolling leukocytes   (Johnson et al., 
2005 ).   
 
Exposure of leukocytes and the endothelium to chemokines activates both cell types and 
leads to the rapid arrest of leukocyte rolling.  Leukocyte arrect is dependent on integrins, 
including β1-integrin VLA4, and the β2-integrin LFA1 (Constantin et al., 2000, 
Laudanna et al., 2002, Shamri et al., 2005).  Integrins are typically present on leukocytes 
in an inactive conformation, however, chemoattractant stimulation of leukocytes induces 
cellular signals via specific G-protein-coupled receptors that lead to a rapid 
conformational change of integins.  The altered integrin structures exhibit a highly 
increased affinity for their cognate molecules on endothelial cells (Constantin et al., 
2000, Laudanna et al., 2002, Shamri et al., 2005).  Typically, these cognate molecules 
are immunoglobulin super family members such as ICAM1 and VCAM1 (Campbell et 
al., 1998, Campbell et al., 1996).  Interactions between integrins with ICAM1 and 
VCAM1 are strong, and lead to full arrest of leukocytes. 
 
The final stage involves the movement of leukocytes through endothelial cells and the 
basement membrane.  Neutrophils begin to crawl through endothelial cells junctions in a 
manner that is dependent on MAC1 and ICAM1 (Phillipson et al., 2006, Schenkel et al., 
2004).  Signalling through ICAM1 causes the release of intracellular Ca2+, the activation 
of p38 mitogen activated protein kinase (MAPK) and RAS homologue (RHO) GTPase 
which together leads to endothelial contraction facilitating the opening of inter-
endothelial junctions (Greenwood et al., 2003, Huang et al., 1993, Millan and Ridley, 
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2005, Muller, 2003).  This is further aided by the release of inter-endothelial cell 
adhesion, through the diminishment of contact of vascular endothelial cadherin (VE-
cadherin) on neighbouring endothelial cells (Shaw et al., 2001).  Adhesion molecules 
within the junction promote leukocyte-endothelial cell interactions. Transmigration 
through the junction occurs through a number of adhesion molecules, including 
homophilic interactions of platelet/endothelial cell adhesion molecule 1 (PECAM1) 
(Petri and Bixel, 2006), and also CD99, as well as interactions of junction adhesion 
molecules (JAMs) with LFA1, VLA4, MAC1 (Lou et al., 2007, Mamdouh et al., 2003, 
Muller, 2003, Nourshargh et al., 2006 , Schenkel et al., 2002, Vestweber, 2002).  
Finally, movement through the basement membrane occurs at gaps between pericytes 
(cells wrapped around post-capillary venules) and at areas of low protein deposition 
within the extracellular matrix (Sixt et al., 2001, Wang et al., 2006).  Movement of 
neutrophils through the basement membrane and between pericytes appears to involve 
α6β1-integrin (Dangerfield et al., 2002) as well as proteases such as matrix 
metalloproteinases (Adair-Kirk et al., 2003) and neutrophil elastase (Wang et al., 2005) 
expressed on the cell surface. 
 
1.10.7.2 Recruitment of neutrophils in gout 
A neutrophil rich synovial infiltrate is a feature of a gout attack where particular 
cytokines and chemokines have been shown to play a pivotal role in neutrophil 
recruitment.  Animal models of gout have shown an absolute requirement for the IL-8 
receptor (CXCR-2) (Terkeltaub et al., 1998) and of IL-1β (Chen et al., 2006, Martinon 
et al., 2006) in the recruitment of neutrophils, while other molecules such as TNFα, 
GM-CSF (Hachicha et al., 1995) S100A8 and S100A9 (Ryckman et al., 2003a) and 
complement proteins (Tramontini et al., 2004, Russell et al., 1982) are thought to 
augment recruitment.  One of the major roles of these soluble mediators is the 
upregulation of adhesion.  Indeed, TNFα and IL-1β generated by MSU-activated 
monocytes has been shown to upregulate the adhesion molecules E-selectin, ICAM-1 
and VCAM-1 on human endothelial cells allowing the tethering of neutrophils to 
endothelial cells in vitro (Chapman et al., 1997). 
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Several cell types produce the chemokines and cytokines required for neutrophil 
recruitment in gout.  MSU-induced IL-8 is likely to come from a number of sources 
including monocytes, macrophages and neutrophils (Terkeltaub et al., 1991, Hachicha et 
al., 1995).  Macrophages are a potential source of IL-1β in gout (Martinon et al., 2006) 
while mast cells also contribute to neutrophil recruitment in MSU inflammation through 
histamine and PAF release (Getting et al., 1997).  These studies indicate that the 
recruitment of neutrophils is dependent on a number of cell types that collectively 
contribute to the overall neutrophil response in acute gout. 
 
1.10.7.3 Activation and survival of neutrophils in inflammation 
Exposure of neutrophils to cytokines and growth factors (IL-1β, TNFα, IFNγ, G-CSF, 
GM-CSF) at the site of inflammation has been shown to prolong the survival of 
neutrophils from several hours to several days in vitro (Akgul et al., 2001).  The 
implication of this is that neutrophils that would usually be short-lived will persist in the 
inflamed tissue for an extended period of time allowing for the accumulation of sizeable 
numbers of neutrophils at an inflammatory site and therefore a prolonged pro-
inflammatory activity.  
 
The neutrophil receptors that recognise MSU are currently unknown.  In other 
inflammatory conditions, the recognition of foreign particles, bacteria, or other 
inflammatory agents occurs via pattern recognition receptors such as TLRs and NLRs 
(Ozinsky et al., 2000, Martinon and Tschopp, 2005).  Foreign agents may also be 
detected and phagocytosed by first becoming opsonised with antibodies and 
complement factors that allows the particle to be taken up into the neutrophil through 
interactions with Fc and complement receptors respectively (Tjelle et al., 2000). 
 
The result of phagocytic uptake is the containment of the particle within specialised 
structures called phagosomes (Tjelle et al., 2000).  Phagosomes are formed during the 
invagination of the membrane and the remodelling of the neutrophil actin cytoskeleton 
around the foreign particle during internalisation.  Phagosomes are only slightly larger 
than the ingested particle and become the focus site for intracellular inflammatory attack 
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and pathogen neutralisation (Rozenberg-Arska et al., 1985).  Cytoplasmic granules fuse 
with the phagosome to release proteolytic enzymes and bactericidal proteins into the 
phagosome in a process called degranulation (Hirsch and Cohn, 1960).  The respiratory 
burst enzyme, NADPH oxidase, also assembles at the phagosome membrane to produce 
reactive oxygen species (Hampton et al., 1998).  In addition to superoxide production 
within the phagosome, the activation of NADPH oxidase also leads to the production of 
extracellular superoxide from the cell surface that can also inflict biological damage 
upon microbes as well as surrounding tissue (Tan and Berridge, 2000). 
 
The recognition and phagocytosis of inflammatory particles initiates the production and 
release of additional cellular pro-inflammatory cytokines, most commonly IL-8 and 
S100A8/A9, which recruit further neutrophils to amplify the inflammatory response 
(Harada et al., 1994, Ryckman et al., 2003b).  The level of cytokines such as IL-8 is 
commonly used as a measure of neutrophil activation (Harada et al., 1994).   
 
1.10.7.4 Production of superoxide 
A fundamental function of neutrophils in inflammation is the production of superoxide 
in a process called the “respiratory burst.”  Superoxide (O2•-) is a major component of 
host defence and plays a pivotal role in the generation of all the other reactive oxygen 
species (Fig. 1.6) (Segal, 2005).  Superoxide itself is only a mild oxidant.  However, 
spontaneous and enzyme mediated dismutation of superoxide to hydrogen peroxide 
(H2O2) facilitates the production of much more powerful oxidants.  For instance, H2O2 
forms the highly reactive hydroxyl radial (OH•-) in the presence of transition metals 
such as iron; and  H2O2 also forms hypohalous acids such as hypochlorous acid (HOCl) 
after reacting with halide ions in the presence of myeloperoxidase (Fig. 1.7).  In 
addition, superoxide can react with nitric oxide (NO) to produce highly reactive 
peroxynitrite (ONOO•-) (Fig. 1.7).  The primary role of these ROS is as bactericidal and 
fungicidal molecules (Segal, 2005).  The importance of these compounds is illustrated in 
Chronic Granulomatous Disease (CGD), a rare genetic disorder whereby neutrophils are  
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Figure 1.6. The formation of reactive oxygen species is dependent on superoxide.  
This flow chart summarises how superoxide is used to generate the other reactive 
oxygen species. 
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unable to produce a respiratory burst and the subsequent ROS.  As a result, CGD 
individuals frequently suffer from life threatening bacterial and fungal infections (Segal 
et al., 2000). 
 
1.10.7.5 Collateral damage through excessive ROS production 
The down side of ROS production and indeed, of other neutrophil inflammatory 
activities, is the collateral damage caused to the host during defensive ROS generation. 
Classically, NADPH oxidase activation occurs following contact and phagocytosis of 
foreign particles or bacteria and, as this process occurs within the phagosome, a 
significant amount of superoxide production is intracellular (Hampton et al., 1998).  
However, high levels of extracellular superoxide can also be measured following the 
activation of neutrophils.  In addition to this, H2O2 formed by superoxide dismutation is 
cell permeable and can pass into the extracellular space.  Errant ROS are indeed 
problematic, leading to oxidation of host enzymes, proteins and lipids (a process that 
itself induces a chain reaction of further oxidation), and ultimately tissue damage, as 
observed in the joint during inflammatory arthritis (Kroger et al., 1996, Miesel et al., 
1996).  This problem is particularly relevant in chronic inflammation and in situations in 
which the generation of superoxide is physiologically irrelevant, such as in gout, where 
MSU triggers a sterile inflammatory response. 
 
1.10.8 Neutrophil investigation 
Neutrophils are recruited in high numbers in gout and are known to produce large 
amounts of superoxide in addition to pro-inflammatory cytokines following exposure to 
MSU while the intensity of neutrophil infiltration is considered a correlate of the 
severity of gout response in animal models.  Since neutrophils are able to induce 
damage to host tissues, the recruitment of neutrophils and their activation has been a 
subject of interest in gout research.   
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Figure 1.7.  Equations outlining the reactions in the formation of ROS and the 
enzymes involved. 
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A common research approach has been to use purified human blood neutrophils, yet 
neutrophils are never an isolated player during an inflammatory gout response.  
Therefore, a major area for investigation is how this cell fits into the network of cellular 
responses during a gout attack, working in concert and cooperation with other 
inflammatory cells, such as monocytes and macrophages.  
 
1.10.9 The mononuclear phagocyte system 
Monocytes and macrophages are part of a highly diverse group of cells that make up the 
mononuclear phagocyte system (MPS).  The MPS is a set of related cells that includes 
blood monocytes, tissue macrophages, kupffer cells, langerhans cells, dendritic cells, 
osteoclasts, and microglia (Hume et al., 2002).  These cells play a key role in 
inflammation and host defence, mediating a wide number of processes from 
phagocytosis to antigen presentation, production of anti- and pro-inflammatory 
mediators, immunosuppression and tissue repair.  In gouty arthritis, monocytes and 
macrophages appear to play a key role in both pro- and anti-inflammatory responses to 
MSU. 
 
1.10.10 Monocytes 
Monocytes are phagocytic mononuclear cells that comprise approximately 5% of white 
blood cells in circulation.  Although they can respond to inflammatory stimuli such as 
LPS and produce inflammatory mediators (e.g. IL-8, TNFα, IL-6) they are considered to 
be an immature precursor cell (van Furth and Cohn, 1968).  Once monocytes are 
recruited from the circulation into tissues they have the capacity to differentiate into a 
number of cell types depending on factors including tissue type (joint, skin, bone, brain) 
and the chemical mediators present in the local environment.  The developmental 
sensitivity of monocytes to chemical mediators is clearly displayed in vitro where 
monocytes cultured in M-CSF will predominantly differentiate into macrophages 
(Warren and Vogel, 1985), monocytes cultured in GM-CSF and IL-4 will become 
dendritic cells (Zhou and Tedder, 1996), while monocytes cultured with RANKL and 
M-CSF become osteoclasts (Udagawa et al., 1990). 
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Monocytes consist of two populations that are easily distinguished from each other 
using a combination of markers such as Gr-1 and 7/4 in mice, and CD14 and CD16 in 
humans (Geissmann et al., 2003).  Additional markers CX3CR1, CDC62L and CCR2 
can also be used (Table 1.1).  When monocytes first egress the bone marrow they are 
Gr-1+ (mouse) or CD14+ (human).  Large numbers of these monocytes are recruited to 
sites of inflammation and so have been termed “inflammatory” monocytes (Geissmann 
et al., 2003).  Although inflammatory monocytes can differentiate into both 
macrophages and dendritic cells in vitro, they appear to be predisposed to becoming 
dendritic cells following an in vivo insult, such as Listeria monocytogenes (Auffray et 
al., 2007).  This is supported by experiments showing that these monocytes are also 
responsible for replenishing langerhans cells following an inflammatory insult to the 
skin (Ginhoux et al., 2006).   
 
The second population of monocytes are Gr-1- in mouse and CD14lo in humans.  Studies 
depleting circulating monocytes and observing monocyte reconstitution suggest that Gr-
1- monocytes are derived from Gr-1+ monocytes (Sunderkotter et al., 2004).  Adoptive 
transfer studies have shown that Gr-1- monocytes invade most tissues under homeostatic 
conditions and are thus thought to replenish resident macrophage and dendritic cell 
populations under steady state conditions (Geissmann et al., 2003).  Due to this they are 
termed “resident monocytes.”  Resident monocytes have also been shown to patrol the 
vascular wall of blood vessels and respond to inflammatory stimuli such as L. 
monocytogenes in vivo (Auffray et al., 2007).  Resident monocytes can differentiate into 
dendritic cells in vitro with exposure to GM-CSF and IL-4, but gene expression profiles 
show that these monocytes are predisposed to becoming macrophages following an 
inflammatory challenge in vivo (Auffray et al., 2007). 
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Resident Inflammatory
CD14 lo hi
CD16 (FcgRII)  + -
CX3CR1 hi lo
CCR2  -  +
CD62L  -  +
Resident Inflammatory
Ly-6C (Gr-1) - +
 7/4 - +
CX3CR1 hi lo
CCR2  -  +
CD62L  -  +
Human monocytes
Mouse monocytes
 
 
Table 1.1. Expression levels of selected markers on resident and inflammatory 
monocytes expression markers.  Expression of human and mouse monocytes markers 
are shown.  Information taken from Gordon 2005. 
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Although monocytes can respond to inflammatory stimuli, their main contribution is 
likely associated with the cell type into which they differentiate following recruitment.  
For instance, dendritic cells will be efficient at presenting antigen, influencing T-
cellresponses and engaging the adaptive immune response (Banchereau and Steinman, 
1998); whereas macrophages will efficiently phagocytose pathogens and initiate a range 
of responses from inflammatory mediator production, to bactericidal activities, to tissue 
repair (Hume et al., 2002); while osteoclasts will adhere to and resorb bone (Udagawa et 
al., 1990).  The factors that govern the differentiation fate of monocytes in vivo are 
complicated, yet the influence of those factors on monocytes is intimately involved in 
the nature of an inflammatory response.  Therefore, an important aspect to 
understanding an inflammatory disease is to understand monocyte fate and function 
within the context of that disease. 
 
1.10.10.1 Monocytes in gout 
Understanding the role of monocytes in gout has come almost exclusively from in vitro 
experiments with murine cell lines and human blood monocytes. In one study, a number 
of murine monocyte-macrophage cell lines were put in an order of differentiation status 
based on the expression of the F4/80 antigen, then stimulated with MSU (Yagnik et al., 
2000).  Based on this arrangement, cell lines that were more monocyte-like produced 
large amounts of TNFα when exposed to MSU, while the cell lines that were more 
macrophage-like did not.  In a follow up study, freshly isolated CD14+ human blood 
monocytes produced TNFα and IL-β when stimulated with a single dose of MSU.  
However, CD14+ monocytes were allowed to differentiate into macrophages by simple 
cell adhesion and stimulated with MSU crystals subsequently lost the ability to produce 
TNFα and IL-β and began to produce TGFβ, indicating a switch from a pro-
inflammatory to an anti-inflammatory phenotype (Landis et al., 2002, Yagnik et al., 
2004).  This led to the idea that monocytes interacting with MSU drive the inflammatory 
phase in gout, while macrophages are involved in resolution (Fig. 1.8). 
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Figure 1.8 A proposed model for the involvement of monocytes and macrophages 
in acute gout.  The Haskard model of acute gouty inflammation proposes monocytes to 
be key inflammatory cells in the initiation of acute gouty inflammation, producing pro-
inflammatory cytokines in response to MSU crystals; and mature macrophages to be 
important in the resolution of gout through the production of TGFβ following exposure 
to MSU.  Figure adjusted from Dalbeth and Haskard, 2005. 
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In the only in vivo based model used to demonstrate the response of monocytes to MSU, 
skin blisters were induced on human skin using the irritant cantharidin.  During the 
course of the inflammatory response unpurified leukocyte infiltrates were removed from 
the blisters and exposed to MSU (Yagnik et al., 2004).  Restimulation of the 
heterogeneous cell populations with MSU exhibited the generation of TNFα from 16h 
blisters, whereas cells from 48h blisters produced no TNFα and instead produced anti-
inflammatory TGFβ.  Although these cells exhibited a cytokine ‘switching’ following 
stimulation with MSU in vitro, no phenotyping of the cell types was undertaken. 
 
The results from the above in vitro experiments show consistency but have clear 
limitations.  First, the primary criterion used to classify the murine cell lines as 
monocyte- or macrophages-like was a combination of F4/80 and BM8 expression, yet it 
is now known that the BM8 antibody also recognises the F4/80 antigen (Schaller et al., 
2002).  A close examination of the F4/80 expression levels within the study also reveals 
that there was very little difference between most of the cells lines, making F4/80 a poor 
correlate of differentiation between these cells (Yagnik et al., 2000).  In the absence of 
appropriate differentiation or activation markers it is not possible to ascribe functions to 
stages of differentiation.  This lack of appropriate phenotypic markers also applies to 
CD14+ monocytes and cantharidin induced leukocytes, for which there was no 
characterisation of phenotype. 
 
A second limitation is that the in vitro studies cannot account for the phenotypic changes 
that occur during recruitment. Interaction of monocytes with endothelium leads to an 
increase in expression of several genes in monocytes, including MMP-1, MCP-1, TG2 
caveolin-1 and CD4 (Thomas-Ecker et al., 2007).  Infiltrating monocytes are exposed to 
a complex mixture of cytokines, serum exudate, cells and tissues which provide a very 
different condition for differentiation than those provided in vitro, where monocytes are 
routinely differentiated only using M-CSF, GM-CSF or by adherence to plastic plates 
(Fleetwood et al., 2007).   
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Together these factors indicate that cell lines and in vitro differentiated monocytes are 
potentially very different to monocytes recruited in vivo. This hypothesis requires 
examination in a relevant in vivo model.   
 
1.10.11 Macrophages 
The term macrophage refers to a highly diverse cell type that is found in most tissues 
throughout the body that share a common stem cell progenitor.  They include kupffer 
cells of the liver, alveolar macrophages of the lung, serosal macrophages of the 
peritoneum, type A cells in the joint synovium, histiocytes of connective tissue, and 
microglia of the central nervous system (Gordon and Taylor, 2005).  Although they can 
differ greatly in their phenotype and responsiveness depending on their environment, 
they share common cardinal features including phagocytosis, cytokine and chemokine 
production (IL-1β, TNFα, IL-6, IL-12, IL-10, IFNγ, etc) (Leenen and Campbell, 1993).  
They are often identified by the expression of the M-CSF receptor (Sasmono et al., 
2003, Sweet and Hume, 2003). In mice, F4/80 is a marker for macrophage identification 
(Hume et al., 1983). 
 
Macrophages are laid down in tissues during oocytogenesis and are either maintained by 
local progenitor cells or replenished by circulating monocytes during steady state 
conditions (Lichanska and Hume, 2000).  During inflammatory conditions it is believed 
that they are replenished solely by monocytes (Geissmann et al., 2003).  
 
The most characteristic feature of macrophages is a high level of plasticity in terms of 
the range of responses and phenotypes they are able to employ.  Macrophages are very 
sensitive to environmental signals and will adjust their responses according to stimuli 
that are present (Stout and Suttles, 2004).  In this way, the specific response of 
macrophages to a particular stimulus can depend on a complex interplay between the 
stimulus, the extracellular signals in the surrounding milieu, the length of time that the 
macrophage has been exposed to those signals, and the sequential changes in the 
microenvironment, including those initiated by the macrophage itself (Leenen and 
Campbell, 1993).  The complexity of possible responses from macrophages necessitates 
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the investigation of macrophage responses in an environment that faithfully reflects the 
inflammatory condition that is being modelled. 
 
1.10.11.1 Macrophages in gout 
Based on in vitro studies outlined in Section 1.10.10.1, macrophages are thought to be 
involved in the resolution of a gout attack, through the production of the anti-
inflammatory molecule TGFβ and the absence of pro-inflammatory cytokines following 
stimulation with MSU.  However, macrophages have also been reported to produce IL-
1β, TNFα, MCP-1, IL-18, iNOS and upregulate the expression of TREM-1 in response 
to MSU (Jaramillo et al., 2004a, Jaramillo et al., 2004b, Chen et al., 2006, Martinon et 
al., 2006, Murakami et al., 2006).  These responses suggest the potential for 
macrophages to play a pro-inflammatory role in vivo.  These contrasting reports 
highlight that macrophage function in gout is still not clearly understood, and that 
further investigation into this area is needed. 
 
1.10.12 Using research models to investigate gout  
In order to study acute gouty inflammation, it has been essential to develop research 
models.  The first substantiated animal model for gout was developed by Faires and 
McCarty, in which they injected synthetic MSU into dog knees (Faires and McCarty, 
1962). Using this model, they were able to reproduce the same symptoms that they had 
observed when they had self administrated MSU, such as pain and joint swelling and 
cellular infiltration.  Following up on this experiment McCarty used this model to show 
that the intensity of pressure within the inflamed joint correlated to neutrophil 
infiltration and was dependent on the dose of MSU administered (McCarty et al., 1966, 
Phelps and McCarty, 1966).  This not only confirmed MSU as the direct etiological 
agent in gout but also corroborated the use of animal models to study gout.  Since then, 
hamster and rabbit joints have also been used as models of gouty inflammation. 
 
In the last 20 years, mouse and rat models have also been developed to study gout.  The 
size of the murine joint precludes an effective study of gout by intrasynovial injection of 
MSU, and so murine models have been established using alternative tissue sites to 
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mimic the joint synovial space.  In these models, either the peritoneum or the sub-
epidermis is used as an MSU injection site to follow inflammatory responses to MSU. 
 
1.10.12.1 Murine peritoneal model of gout 
The peritoneal model was first used in gout research by Getting and colleagues (Getting 
et al., 1997).  The peritoneum contains cell types that are similar in nature to cells in the 
joint, including macrophages, epithelial cells, mast cells, fibroblasts and lymphocytes. In 
this model, MSU crystals are injected into the peritoneum which induces a strong 
leukocyte infiltration, including neutrophils, as well as the production of cytokines and 
chemokines known to be associated with gout. A limitation of this model is the absence 
of certain cell types that are specific to bone niches including osteoclasts and 
chondrocytes, and tissue such as cartilage and bone.  The relatively large amount of 
space within the peritoneum also prevents the observation of mechanically induced 
algesia due to oedema, a phenomenon that accompanies a gout attack within the 
enclosed space of the joint.  Despite these disadvantages, outcomes of this model have 
been carried through to clinical studies in gout confirming the usefulness and relevance 
of this model.   
 
1.10.12.2 Murine air pouch model 
In the murine air pouch model a sac is formed on the back of rats (or mice) by a 
subcutaneous injection of sterile air several days before MSU challenge.  This faux 
space is formed to mimic the joint synovium.  Injection of MSU into this space induces 
the recruitment of leukocytes.  A description of MSU-induced recruitment in this model 
has been reported by Schiltz and colleagues (Schiltz et al., 2002).   
 
This model has the same limitation as the peritoneal model: an absence of a few cell 
types that would be found in the bone niche.  However, another limitation of this model 
is that the inflammation caused by the formation of the air pouch may set up a 
background inflammatory environment, either in cell number or cell phenotype, which 
may affect subsequent inflammatory challenges.  In this way, it is difficult to compare 
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the quality of MSU induced inflammation in a previously uninflamed environment, as 
would be expected in an acute attack of gout. 
 
In this research, the MSU-peritonitis model has been chosen as the  inflammatory model 
for gout.  This is due to my interest in the onset of acute gout against an unmanipulated 
naïve background of known phenotype.  It induces a cellular infiltration that mimics 
clinical gout, is widely used in the literature and has shown relevancy in clinical follow-
through experiments.  For these reasons I feel confident that the findings from the use of 
this model will be relevant to acute gouty disease. 
 
1.11 Aims of this study 
The research summarised in this chapter implicates neutrophils, monocytes and 
macrophages as key players in acute gout.  It is my intent that this thesis will deepen and 
clarify the roles of these cells in acute gout and address aspects of cellular inflammation 
in gout that require further investigation. 
 
The aims of this study were: 
 
Aim 1 To determine whether inflammatory factors - other than MSU - that are 
present in the inflammatory environment during an acute gout attack 
contribute to the activation of neutrophils. 
 
Aim 2 To assess whether neutrophil activation in MSU-inflammation can be 
inhibited by the novel anti-inflammatory compounds, sesquiterpene 
dialdehydes. 
 
Aim 3 To determine the role of monocytes and macrophages in the initiation of 
MSU-induced inflammation in vivo.  
 
Aim 4 To profile the differentiation pathway of MSU-elicited monocytes during 
the course of acute MSU-induced inflammation in vivo. 
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Chapter 2 
Materials and Methods 
 
2.1 Reagents 
 
Buffer/Media Source 
 
Dulbecco’s Phosphate-Buffered Saline (D-PBS) Invitrogen, NZ 
Hanks’ Balanced Salt Solution (HBSS) Invitrogen, NZ,  
 Sigma-Aldrich, NZ 
Medium 199 (M199) Invitrogen, NZ 
Phosphate Buffered Saline (PBS) Invitrogen, NZ 
RPMI-1640 Invitrogen, NZ 
 
Chemical/Miscellaneous materials Source 
   
0.25% trypsin/EDTA Invitrogen, NZ 
10% neutral buffered formalin Sigma-Aldrich, NZ 
Acetone BDH chemicals NZ Ltd. 
Alexa488 Streptavidin Invitrogen, NZ 
Alexa555 Streptavidin Invitrogen, NZ 
Bovine fibroblast growth factor (bFGF) Invitrogen, NZ 
Bovine serum albumin (Fraction V, IgG free) Invitrogen, NZ 
Calcium chloride BDH chemicals NZ Ltd. 
Clodronate Sigma-Aldrich, NZ 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich, NZ 
Diphenyleneiodonium chloride (DPI) Biolab Scientific, Australia 
DNaseI (Grade II) Roche, NZ 
Epidermal growth factor Roche, NZ 
Ethanol BDH chemicals NZ Ltd. 
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Fetal bovine serum Sigma-Aldrich, NZ,  
 Invitrogen, NZ 
FITC Annexin-V BD Bioscience, NZ 
FITC Streptavidin eBioscience, San Diego, USA 
FluoSpheres fluorescent microspheres Invitrogen, NZ 
    (0.5um; 505/515nm; 2% solids) 
Gelatin Merck, Australia 
Glutamax Invitrogen, NZ 
GolgiStop BD Bioscience, NZ 
Heparin Wellington Hospital, NZ 
HEPES Sigma-Aldrich, NZ 
Hoechst 33342 (bisbenzamide) Sigma-Aldrich, NZ 
Horseradish peroxidase Sigma-Aldrich, NZ 
Hydrochloric acid BDH chemicals NZ Ltd. 
L-a-Phosphatidylcholine Sigma-Aldrich, NZ 
Lipopolysaccharide, E.coli 0111:B4 (LPS) Biolab Scientific, Australia  
Luminol Sigma-Aldrich, NZ 
Macrophage colony stimulating factor (M-CSF) Peprotech, New Jersey, USA 
Methanol BDH chemicals NZ Ltd. 
o-dianisidine Sigma-Aldrich, NZ 
Penicillin-streptomycin Invitrogen, NZ 
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich, NZ 
Polymorphprep Medica Pacifica Ltd. 
Propidium iodide BD Bioscience, NZ 
Puregene RBC lysis buffer ProGENZ, NZ 
R-PE Streptavidin eBioscience, San Diego, USA 
Saponin Sigma-Aldrich, NZ 
Sodium azide Sigma-Aldrich, NZ 
Sodium chloride BDH chemicals NZ Ltd. 
Sodium chloride 5M (Cell culture and endotoxin tested) Sigma-Aldrich, NZ 
Sodium hydroxide BDH chemicals NZ Ltd. 
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Thioglycollate Medium Difco, Detroit, MI, USA 
Uric acid Sigma-Aldrich, NZ 
WST-1 Dojindo, Kumamoto, Japan 
Zinc fixative BD Bioscience, NZ 
 
2.1.1 Sesquiterpene dialdehydes 
The dialdehyde compounds used in this study and shown in Figure 4.1 were kindly 
provided by Nigel Perry of the Plant and Extracts Research Unit (PERU) at Plant and 
Food Research in Otago, New Zealand. 
 
2.2 Antibodies 
All antibodies for use in flow cytometry or immunofluorescent histology were titrated 
before use to determine the ideal concentration for use.  Antibodies of the same isotype 
as the treatment antibody, conjugated to the same fluorophore as the treatment 
antibodies, yet with specificity to an irrelevant, non-present antigen were used as control 
in stainings.  
 
BD Bioscience (NZ) 
 
APC Mouse anti human CD15 
APC Hamster anti mouse CD11c 
APC Rat anti mouse Gr-1 
Mouse IgG2b,k Isotype control 
PerCP-Cy5.5 Rat anti mouse CD11b 
R-PE Armenian hamster IgG1,k Isotoype control 
R-PE Hamster anti mouse MCP-1 
R-PE Mouse anti human IL-8 
R-PE Rat anti mouse IL-6 
R-PE Rat IgG1 Isotype control 
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eBioscience (San Diego, USA) 
 
Anti mouse IL-6 
Armenian hamster anti mouse/rat IL-1β 
Biotin Mouse anti-rat IgG 
Biotin Rabbit anti mouse IL-1β 
Biotin Rat anti mouse IL-6 
Biotin Rat IgG2a Isotype control  
FITC Goat anti armenian hamster IgG 
Rat anti mouse TNFα 
Rat IgG1 Isotype control 
R-PE Rat anti mouse F4/80 
R-PE Rat anti mouse TNFα 
 
Serotec (Oxford,UK) 
 
Alexa488 Rat anti mouse F4/80 
FITC Rat anti mouse CD68 
FITC Rat anti mouse neutrophils (7/4) 
R-PE Rat anti mouse CD206 
 
Other 
 
Anti-mouse FcγRII antibody (24g.2) was kindly provided by Thomas Backstrom from 
the Malaghan Institute of Medical Research. 
 
2.3 Kits Source 
 
Biotin blocking kit Invitrogen, NZ 
Bioplex bead array kits Biorad, NZ 
Cytokine bead array (CBA) kits BD Bioscience, NZ 
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Diff-Quik kit Dade Behring, Newark, USA 
IL-1β ELISA kit R&D Systems, Minneapolis,  
 MN, USA 
Limulus amebocyte lysate kit Associates of Cape Cod, Inc,  
 Falmouth, MA, USA 
Lincoplex bead array kits Abacus ALS, NZ 
PKH26 red fluorescent phagocytic cell linker kit Sigma-Aldrich, NZ 
TNFα and IL-6 OptiEIA ELISA kits BD Bioscience, NZ 
 
2.4 Disposables Source 
 
0.5mL/1.5mL microfuge tubes Axygen, Union City, CA,USA 
15mL polystyrene tubes Falcon (BD Bioscience, NZ) 
50mL polystyrene tubes Falcon (BD Bioscience, NZ) 
75cm2 culture flasks Falcon (BD Bioscience, NZ) 
96- and 24-well low cell binding plates Nunc, Rochester, NY, USA 
96-well plates Falcon (BD Bioscience, NZ) 
Sodium-heparin 10mL vacutainers BD Bioscience, NZ  
 
2.5 Buffers and Media 
 
Annexin-V binding buffer 
The efficient binding of annexin-V to phosphatidylserine on the surface of apoptotic 
cells requires a high calcium-containing buffer.  This binding buffer was composed of 
10mM HEPES, 140mM NaCl and 2.5mM CaCl2 at pH 7.4.  The annexin-V binding 
buffer was filter sterilized and used fresh. 
 
FACS buffer 
FACS buffer, used as the staining media to label cell surface antigens with a 
fluorescently labeled cognate antibody.  This solution contained 0.1% Bovine serum 
albumin and 0.01% sodium azide in PBS (pH 7.4). 
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Hanks’ balanced salt solution, HBSS 
There were two sources of HBSS used: 
 
1.  HBSS powder was purchased from Sigma-Aldrich, and made up to the appropriate 
volume with ddH2O and the pH adjusted to 7.4 according to the manufacturer’s 
instructions, followed by filter sterilisation.  This HBSS was used for procedures that did 
not require HBSS to be endotoxin free. 
 
2.  Endotoxin-tested HBSS was also purchased from Invitrogen in liquid form as 
Dulbecco’s HBSS.  This HBSS was used to wash and prepare cells that were going to be 
used in culture.  (For composition refer to Appendix). 
 
Red Blood Cell (RBC) lysis buffer 
RBC lysis buffer was used to remove contaminating red blood cells from blood samples 
and peritoneal lavage fluids as required.  Briefly, cell suspensions with contaminating 
RBCs were pelletted for 5 minutes at 500 x g and the media carefully removed.  1 to 
3mL of RBC lysis buffer was added to the pellet and the cells gently resuspended by 
mild agitation.  Cells were then incubated for 10 minutes at 37ºC, washed twice in 
HBSS and resuspended in the appropriate liquid medium.  If RBC lysis was incomplete, 
the process was repeated. 
 
Two lysis buffers were used. 
1.  Lysis buffer was prepared in the lab as two solutions:  Solution 1 (0.16M NH4Cl) and 
Solution 2 (0.17M Tris).  These buffers were filter sterilized and maintained under 
sterile conditions.  A working RBC lysis buffer solution was prepared by mixing 
Solution 1 and Solution 2 at a 9:1 ratio immediately before use. 
 
2.  Endotoxin-free Puregene RBC lysis buffer was purchased from ProGENZ and was 
preferentially used instead of the in-house lysis buffer when the cells collected were 
used in further cell culture experiments. 
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RPMI-1640 
Endotoxin-tested RPMI-1640 was purchased in liquid form from Invitrogen. (For 
composition refer to Appendix).  In all cases in which the term “complete RPMI-1640” 
appears, it refers to RPMI-1640 supplemented with 10% FBS, 100U/mL penicillin-
streptomycin and 2mM glutamax. 
 
Phosphate buffered saline, PBS 
There were two sources of PBS used:   
 
1.  PBS powder was purchased from Invitrogen, made up to the appropriate volume in 
ddH2O water and the pH adjusted to 7.4 according to the manufacturer’s instructions, 
followed by filter sterilisation.  This PBS was used for procedures that did not require 
PBS to be endotoxin free, such as for FACS buffer and saponin buffer solutions.  
 
2.  Endotoxin-tested PBS was also purchased from Invitrogen in liquid form as 
Dulbecco’s PBS.  This PBS was used to harvest and wash cells that were going to be 
used in culture.  (For composition refer to Appendix). 
 
Saponin buffer 
Saponin is a detergent that creates pores within cell membranes making cells permeable 
to labeling antibodies and as such was used for staining intracellular cytokines with 
fluorescent antibodies.  Saponin buffer was composed of 0.1% saponin, 0.1% bovine 
serum albumin and 0.01% sodium azide in PBS. 
 
Sodium phosphate buffer (50mM) 
Sodium phosphate buffer (300mL) was prepared by mixing 65.8mL of a 0.2M NaH2PO4 
solution with 9.2mL of a 0.2M Na2HPO4 solution.  The mixture was made up to 300mL 
with ddH20 and the pH adjusted to pH6.  The solution was used immediately. 
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2.6 Preparation of MSU 
Monosodium urate crystals were prepared by crystallization of a supersaturated solution 
of uric acid under mildly basic conditions.  Briefly, 250mg uric acid was added to 45mL 
of ddH2O containing 300µL of 5M NaOH and the solution boiled until the uric acid was 
dissolved.  The solution was passed through a 0.2µM filter and 1mL of 5M NaCl was 
added to the hot solution that was then stored at 26°C to allow crystallisation.  After 7 
days the resulting MSU crystals were washed with ethanol and acetone over a Buchner 
flask and allowed to air dry under sterile conditions.  Crystals showed typical physical 
characteristics of MSU, including a needle-like shape and optical birefringence.  The 
typical crystal length was 5 - 20µm and MSU was confirmed as endotoxin-free by LAL 
assay (< 0.01 EU/10mg). 
 
2.7 Endotoxin levels 
Endotoxin can activate innate immune cells and as such stringent efforts were taken to 
ensure that reagents and glassware used for cell culture were not only sterile but 
endotoxin free.  All culture tubes, flasks, microplates and pipettes were explicitly 
pyrogen (endotoxin) free.  Reagents used were either certified as low endotoxin or 
measured for endotoxin levels by LAL assay. 
 
2.7.1 Limulus amebocyte lysate (LAL) assay tested 
The following were tested for endotoxin levels by LAL assay.  The assay kit was run 
according to manufacturer instructions 
 
MSU crystals         < 0.01 EU/10mg 
MilliQ water (ddH2O)       < 0.01 EU/mL 
Cleaned and autoclaved glassware     < 0.01 EU/mL 
(The inside of a 250mL piece of glassware was rinsed with 10mL of water provided in 
the LAL kit and the 10mL of water was tested) 
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2.7.2 Purchased reagents 
5M NaCl     Sigma-Aldrich, NZ < 0.3 EU/mL 
D-PBS      Invitrogen, NZ < 0.03 EU/mL  
HBSS      Invitrogen, NZ < 0.03 EU/mL 
RPMI-1640     Invitrogen, NZ < 0.03 EU/mL 
M199      Invitrogen, NZ < 0.03 EU/mL 
Puregene RBC lysis buffer   ProGENZ, NZ  < 0.03 EU/mL 
Fetal bovine serum    Invitrogen, NZ < 0.08 EU/mL 
      Sigma-Aldrich, NZ < 0.13 EU/mL 
 
2.8 Isolation of cell types 
 
2.8.1 Human neutrophils 
Neutrophils were purified from the peripheral blood of healthy volunteers by 
sedimentation with Polymorphprep.  Briefly, human blood was collected into 10mL 
Vacutainer tubes (anti-coagulated with heparin) by venous puncture and then diluted 
with an equal volume of HBSS.  10mL of diluted blood was then carefully layered over 
4mL of Polymorphprep in a 15mL tube and centrifuged with no brake at 500 x g for 30 
minutes at 19ºC.  This treatment resulted in two distinct white bands: an upper band, 
containing mononuclear cells; and a lower band which contained polymorphonuclear 
cells.  The polymorphonuclear cells were removed by aspiration and washed twice with 
an equal volume of PBS (pH 7.4), centrifuged at 500 x g for 10 minutes at 19ºC and then 
resuspended in the appropriate experiment buffer or medium.  This procedure yielded 
>90% neutrophils as determined by Diff-Quik staining of cytospin samples.   
 
2.8.2 Human peripheral blood mononuclear cells 
Peripheral blood mononuclear cells (PBMCs) were purified from the peripheral blood of 
healthy volunteers by sedimentation with Polymorphprep.  Briefly, cells were prepared 
in the same way as neutrophils in 2.8.1 except the upper band of white blood cells was 
instead collected.  PBMCs were >95% pure (free of polymorphonucleocytes) by Diff-
Quik staining of cytospin samples.   
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2.8.3 Total human white blood cells 
Blood was collected from volunteers into heparinized Vacutainer tubes.  The blood was 
then centrifuged at 500 x g for 10 minutes after which the layer of white blood cells 
(buffy coat) above the RBC layer was clearly visible and collected by aspiration.  
Contaminating red blood cells were lysed by treatment with RBC lysis buffer (Section 
2.5), washed twice with HBSS and suspended in the appropriate medium for the relevant 
experiment. 
 
2.8.4 Enrichment of naïve mouse peritoneal lymphocytes and macrophages 
Peritoneal cells were harvested from naïve mice by peritoneal lavage as described 
(Section 2.16.3).  Cells were retrieved from the lavage fluid by centrifugation (500 x g, 5 
mins) and washed three times with PBS containing 10% FCS and 10U/mL DNaseI.  The 
cell types were then separated using a modified version of a method that has been 
previously described (DaMatta et al., 1995).  Briefly, peritoneal leukocyte cells were 
resuspended in 70% (v/v) Percoll solution containing DNaseI (10U/mL) to a 
concentration of  2 x 106 cells/mL. The Percoll gradient was then prepared by overlaying 
the 70% Percoll-cell preparation (3mL) with a 51% Percoll solution (10mL), then 
overlaying Medium 199 (2mL) containing DNaseI (10U/mL) as the uppermost layer. 
The gradient preparation was centrifuged with no brake (18 mins, 680 x g, 4°C) and 
macrophages recovered from the 8-15 mL band (purity greater than 90%, viability 
greater than 98%), while lymphocytes were recovered from the 4.5-8mL band (purity 
greater than 80%, viability greater than 90%).  Cells were then washed twice in HBSS 
containing DNaseI (10U/mL) and resuspended in complete RPMI-1640 to give a final 
concentration of 1 x 106 cells/mL. 
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2.8.5 Enrichment of peritoneal mast cells 
Peritoneal cells were harvested from naïve mice by peritoneal lavage as described 
(Section 2.16.3).  Cells were retrieved from the lavage fluid by centrifugation (500 x g, 5 
mins) and washed three times with PBS containing 10% FCS and 10U/mL DNaseI.  The 
cells were then resuspended in 8 mL of 70% Percoll solution (6.3 mL Percoll Plus, 3.7 
mL of 2.5x PBS, pH 7.2) and overlayed with 2 mL of RPMI-1640 (5% FBS). The 
gradient was centrifuged with no brake (15 min, 500 x g, room temperature), the Percoll 
solution was removed and the cell pellet was washed in complete RPMI-1640. The cells 
were re-suspended in complete RPMI-1640 to give a final concentration of 1 x 105 mast 
cells/mL.  Purity was greater than 95% while viability was at least 98% as determined 
by Trypan Blue. 
 
2.8.6 Sorting of murine leukocyte populations 
Antibodies against F4/80 and Gr-1, and the antibody clone 7/4 were used to discriminate 
macrophages, monocytes and neutrophils as previously described (Austyn and Gordon, 
1981, Henderson et al., 2003). Mice were administered with an i.p. injection of MSU 
(3mg, 0.5mL PBS) and at different time points cells were harvested as described 
(Section 2.16.3) and stained with F4/80, Gr-1 and 7/4 antibodies.  Resident macrophages 
were identified from naïve mice as F4/80hi, Gr-1-, 7/4- cells; monocytes were identified 
from mice 4 or 8 hours after MSU treatment as F4/80lo, Gr-1int, 7/4+ cells; neutrophils 
were identified from mice 8 hours after MSU treatment as F4/80-, Gr-1hi, 7/4+ cells; and 
immature macrophages were identified 48 hours after MSU treatment as F4/80lo, Gr-1-, 
7/4- cells.  Cells were sorted using a FACSDiva flow cytometer and determined to be 
>99% pure by flow cytometry and Diff-Quik staining. 
 
2.9 Cell lines and culture 
 
2.9.1 Human umbilical vein endothelial cells (HUVEC) 
HUVEC cells are primary cells harvested from the umbilical cord of newborn human 
babies and are endothelial/epithelial in nature.  HUVECs were harvested and prepared to 
passage three by Dr. Sarah Gunningham at the (Christchurch School of Medicine and 
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Health Science, University of Otago) and sent to the Malaghan Institute of Medical 
Research (Victoria University of Wellington).  HUVECs were re-suspended in Medium 
199 (supplemented with 10% FBS, 1ng/mL bFGF) and cultured in 75cm2 culture flasks 
coated with 0.1% gelatin, seeding the flask with 2 x 105 cells.  Cells were grown at 37°C 
and 5% CO2 until just before confluent.  The HUVEC monolayer was then washed twice 
with HBSS and 10mL of 0.25% trypsin/EDTA was added.  The HUVEC culture was 
then returned to the incubator (37°C, 5% CO2) for 5 minutes, after which HUVEC 
detachment could be observed by microscopic examination.  10mL of FBS was added to 
inactivate the trypsin enzyme activity and then cells were collected into a 50mL Falcon 
tube.  HUVECs were washed twice in HBSS, re-suspended in Medium 199 
(supplemented with 10% FBS, 1ng/mL bFGF) and then split into three separate flasks 
after which cells were allowed to grow to confluence again.  HUVECs were cultured in 
this way to passage 7 and then used experimentally. 
 
2.9.2 RAW 264.7 cells 
Murine macrophage cell line RAW 264.7 were seeded at 2 x 105 cells/75cm2 culture 
flask in complete RPMI-1640.  Cells were grown to confluence at 37°C and 5% CO2 
after which the cell monolayer was washed with HBSS and then harvested using a 
rubber scraper.  Cells were then washed again and resuspended in complete RPMI-1640 
at a cell concentration of 1 x 106 cells/mL and plated out into 96 well plates at 200µL 
per well for the subsequent experiment. 
 
2.9.3 Culture of primary mouse mesothelial cells 
Mouse mesothelial cells were harvested and grown based on previously described 
methods(Bot et al., 2003, Muller and Yoshida, 1995).  C57/BL6 mice were euthanised 
by CO2 and the mice sprayed liberally with 70% ethanol and placed into a sterile safety 
hood.  The skin and fur covering the peritoneum were carefully separated without 
puncturing the peritoneal lining.  This skinning technique allowed clean exposure of the 
peritoneal tissue without puncturing the peritoneal cavity and completely preventing fur 
from coming into contact with the peritoneal tissue.  Peritoneal leukocytes were 
removed by injecting 10mL of PBS into the peritoneal cavity, injecting near the inguinal 
Chapter 2:  Materials and Methods 
 
56 
fat pads to allow the resealing of the injection site.  After gently massaging the inflated 
peritoneum, the PBS (containing the resident leukocytes) was removed, and the whole 
lavage process repeated.  Next, 10mL of 0.25% trypsin/EDTA warmed to 37ºC was 
injected into the peritoneum and allowed to sit for 15 minutes under a heat lamp with 
occasional massaging.  The outside of the peritoneum was kept moist with PBS.  The 
trypsin/EDTA was then harvested and washed twice in complete RPMI-1640.  The 
harvested cells were then resuspended in RPMI-1640 containing 20ng/mL epithelial 
growth factor and 5µM hydrocortisone and cultured in 25cm2 collagen-coated flasks.  
Cells were cultured and split three times before use in experiments and were confirmed 
as mesothelial cells by their squamous cobblestone appearance and positive staining for 
cytokeratin. 
 
2.10 Histology 
 
2.10.1 Morphological stain for differential cell counts 
Diff-Quik staining was used to visualize the morphology of white blood cells harvested 
from blood or peritoneal lavage samples allowing differential counts.  Cells were placed 
onto slides by a cytospin cytocentrifuge and were air-dried, fixed for 5 seconds in Diff-
Quik fixative (1.8mg/L Triarylmethane dye methyl alcohol) stained for 10 seconds in 
Diff-Quik Solution I (1g/L xanthine dye) and then stained for 7 seconds in Diff-Quik 
Solution II (0.625g/L Azure A, 0.625g/L Methylene blue).  Alternatively, cells were 
fixed for 20 minutes in 10% buffered formalin, stained for 10 seconds in Diff-Quik 
Solution I, followed by a 4 second staining with Diff-Quik Solution II.  Excess dye was 
then washed off with water.  For differential cell counts, 200 cells were counted per 
sample. 
 
2.10.2 Hematoxylin and Eosin (H&E) staining of peritoneal tissue 
Mice were administered with an i.p. injection of MSU (3mg; 0.5mL PBS) and 72 hours 
after treatment, peritoneal membrane tissue was excised and placed into 10% neutral 
buffered formalin.  Peritoneal membrane tissue was also taken from naïve mice.  Tissue 
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cross sectioning and H&E staining was then performed at the Department of Pathology 
at the Wellington School of Medicine, NZ. 
 
2.10.3 Visualisation of MSU crystal and cell clumping 
Clumping of MSU crystals with cells was observed in two ways. In the first method, 
clumps of MSU crystals were harvested from the peritonea of MSU-treated mice.  
Clumps were placed into suspension in PBS and then sedimented onto slides using a 
cytocentrifuge.  The mesh of crystals and cells were stained with Diff-Quik after which 
they were examined using an Olympus BX51 microscope under bright field and 
polarized light conditions.  In the second method, peritoneal leukocytes (1 x 106 
cells/mL, 200µL) from naïve mice were cultured in 8-well chamber slides for one hour 
following which 200µg/mL MSU was added to the wells.  After 30 minutes, the slides 
were carefully washed with PBS and the cells fixed with zinc fixative.  After 20 minutes, 
slides were carefully washed three times with PBS after which they were stained with 
Alexa 488-anti-F4/80 and Hoechst 33342 in staining buffer (5% FBS, 0.01% sodium 
azide, PBS; pH 7.4).  Cells were then examined by fluorescent microscopy. 
 
2.10.4 Immunofluorescent histology of resident peritoneal macrophages 
Resident peritoneal cells from naïve mice were suspended in complete RPMI-1640 and 
cultured at 1 x 106 cells/mL in 8-well chamber slides.  After incubation at 37°C for 1 
hour, 1:1500 GolgiStop was added. Cells were stimulated with either 200µg/mL MSU, 
1µg/mL LPS, or PBS and incubated for 4 hours, then treated with zinc fixative for 30 
minutes.  Saponin buffer was used to permeabilise the cells and then endogenous biotin 
blocked using a biotin blocking kit as per manufacturer’s instructions.  Non-specific IgG 
binding sites were then blocked using 5% mouse serum or 5% FBS and incubated 
overnight with either anti-mouse IL-6, TNFα, biotinylated anti-mouse IL-1β, or the 
appropriate isotype control.  Cells treated with anti-mouse IL-6 or TNFα were then 
incubated with a biotinylated mouse-anti-rat IgG antibody. Excess antibody was 
removed by washing with PBS and the samples stained with streptavidin-Alexa555, 
anti-F4/80-FITC and Hoechst 33342, mounted in Vectashield antifade and examined 
using an Olympus BX51 fluorescence microscope. 
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2.10.5 Staining of visceral peritoneal tissue 
Mice were treated with an i.p. injection of 3mg MSU as described above.  After 4 hours 
the skin was removed from the abdomen, the peritoneum was cleared of leukocytes by 
lavage with 3mL PBS and the ventral tissue covering the peritoneal cavity was excised 
and placed into cold (incomplete) RPMI-1640.  The tissue was rinsed in PBS and fixed 
in acetone for 10 minutes at -20°C.  The visceral lining of the peritoneum was harvested 
from the fixed tissue by carefully stripping the lining off as a single piece.  The 
harvested visceral tissue was cleaned of fascia and non-specific IgG binding sites were 
blocked with a solution containing 10% FBS.  Endogenous biotin was blocked using a 
kit.  The tissue was stained for the surface markers 7/4 and F4/80 and mounted onto 
slides with Vectashield antifade.  Slides were analysed by fluorescence microscopy and 
images processed using AnalySIS Life Science extended focal imaging software.  
 
2.11 Measurement of superoxide production 
Measurement of neutrophil superoxide production was performed using using the 
tetrazolium salt, WST-1.  WST-1 is commonly used in the presence of 1-methoxy-5-
methylphenazinium methylsulfate (PMS) to measure cell proliferation.  However, Tan 
and Berridge showed that in the absence of PMS, WST-1 reduction is indicative of 
superoxide production in neutrophils (Tan and Berridge, 2000). 
 
2.11.1 PMA stimulation of neutrophils 
Purified human neutrophils were suspended in the appropriate medium condition (PBS, 
HBSS, phenol red-free RPMI-1640 supplemented 100U/mL penicillin-streptomycin, 
2mM glutamax, ± human serum) and added to a 96 well plates at 1 x 105 neutrophils per 
well with 250µg/mL WST-1 and stimulated with 0.2µg/mL PMA in a final total volume 
of 100µL per well.  Immediately following PMA addition, the plate was loaded into a 
Versamax spectrophotometer preheated and maintained at 37°C and the maximum rate 
of change of absorbance (Vmax) at 450nm measured over 20 minutes.  For experiments 
with the sesquiterpene dialdehyde compounds, the compounds were added 30 minutes 
prior to stimulation with PMA. 
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2.11.2 MSU stimulation of neutrophils 
Purified human neutrophils were suspended in HBSS or the relevant conditioned media 
and placed into 0.5mL microfuge tubes at 1.5 x 105 neutrophils per tube in a total 
volume of 140µL per well.  If neutrophils were being cultured in conditioned media, 
then neutrophils were subsequently incubated for 2 hours at 37°C and 5% CO2 to allow 
the neutrophils to adjust to the media condition.  For neutrophils in HBSS, this 
incubation step was not required.  WST-1 (250µg/mL) and a range of concentrations of 
MSU in either HBSS or phenol red-free RPMI-1640 (depending on whether HBSS or 
RPMI-1640 was the neutrophil culture media) were then added to a final total volume of 
150µL.  Tubes were then capped and placed into an incubator on a shaker (200 rpm, 
15mm radius) at 37°C.  After 1 hour MSU crystals were removed from the supernatant 
by centrifugation and 100µL of the crystal-free supernatant was transferred to a 96 well 
plate.  The plate was then loaded into a Versamax spectrophotometer and the absorbance 
measured at 450nm. 
 
2.11.3 Serum stimulation of neutrophils 
Purified human neutrophils were suspended in various concentrations (0 to 10%) of 
human serum or FBS, suspending in phenol-red free RPMI-1640.  The effect of 
autologous versus the use of non-autologous human serum was tested as part of specific 
experiments and is outlined in chapter 3 (Section 3.2.2); otherwise, non autologous 
human serum was used.  Human and bovine serum that had been heat inactivated at 
56°C for 30 minutes was also tested. 1.5 x 105 neutrophils were added to 0.5mL 
microfuge tubes, following which, WST-1 (250µg/mL) was then added to the tubes to a 
final total volume of 150µL. Tubes were then capped and placed into a shaking 
incubator (200 rpm, 15mm radius) at 37°C.  After 1 hour cells were removed from the 
supernatant by centrifugation and 100µL of the supernatant was transferred to a 96 well 
plate.  The plate was then loaded into a Versamax spectrophotometer and the absorbance 
measured at 450nm 
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2.11.4 Superoxide production by ex vivo murine peritoneal neutrophils 
Mice received an i.p. injection of the sesquiterpene dialdehyde compound in 50µL of 
DMSO or 50µL of DMSO alone (control) to one side of the peritoneum following which 
an i.p. injection of MSU (3mg, 0.5mL PBS) was immediately administered to the 
opposite side of the peritoneum as described (Section 2.16.3).  After four hours, 
peritoneal leukocytes were harvested by peritoneal lavage with 3mL PBS containing 
25U/mL heparin.  Cells were then washed and the concentration adjusted to 1 x 106 
cells/mL in HBSS.  100µL of the cell suspension was added to 96-well plates without 
the addition of any stimulus ex vivo, following which WST-1 added (250µg/mL).  Cells 
from a naïve mouse, which do not contain neutrophils, were also included as a negative 
control.  The plate was then loaded into a Versamax spectrophotometer that had been 
preheated and maintained at 37°C and the maximum rate of change of absorbance at 
450nm measured over 20 minutes.  Cytospin samples of each cell suspension were also 
prepared and differential counts obtained by Diff-Quik staining.  Vmax values obtained 
from the Versamax readings were then adjusted for neutrophil percentages to give a 
Vmax value per 1 x 106 cells.  For mice treated with sesquiterpene dialdehyde 
compounds, the final Vmax value was normalized to the Vmax of cells from mice that 
had been treated with the control carrier solvent. 
 
2.11.5 Luminol chemiluminescence 
The measurement of NADPH oxidase generated ROS from HUVECs was measured 
using peroxidase catalyzed luminol chemiluminescence.  HUVECs suspended in phenol 
red-free Medium 199 containing 0.5% FBS (or higher % FBS for serum studies) were 
plated to a 96-well white plate at 2 x 105 cells/well.  Sesquiterpene dialdehyde 
compounds, DPI, L-NAME or controls were added to the cells and the cells incubated 
for 1 hour at 37°C and 5% CO2.  10U/mL horseradish peroxidase and 10µM luminol 
were added to the cells with a final volume of 200µL/well.  The plate was then placed in 
a BMG fluostar microplate reader that had been pre-warmed to 37ºC.  The total emitting 
light was measured over 1 hour without any emission filter and the resulting Vmax values 
(Units/sec) normalized to the DMSO controls. 
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2.12 Viability stains 
2.12.1 Trypan blue 
Cell membranes are impermeable to the dye trypan blue.  Once cells have died and lost 
cell membrane integrity trypan blue can then be taken up by cells that then become blue 
in colour.  Cells were diluted 1:1 and then enumerated using a hemocytometer.  The cell 
concentration was determined by taking the number of cells in a quadrant and 
multiplying by 2 x 104 to give cells/mL.  Alternatively cells were diluted 1:9 (cell 
suspension:Trypan blue dye) and multiplied by 1 x 105 to give cells/mL. Cells were not 
in trypan blue suspension for more than 5 minutes to reduce the possibility of false 
positives. 
 
2.12.2 Neutrophil trypan blue assay for sesquiterpene dialdehyde compounds 
Purified human neutrophils were suspended in HBSS and cultured in 24 well plates at a 
concentration of 1 x 106 cells/mL and at a volume of 500µL per well.  Sesquiterpene 
dialdehyde compounds or DMSO controls were then added.  After 30 minutes, a sample 
of each well was diluted in an equal volume of trypan blue, then the total live cells (clear 
in appearance) and dead cells (blue in appearance) enumerated using a hemocytometer.  
200 cells were counted. 
 
2.12.3 Annexin-V and propidium iodide (PI) double staining 
Cellular apoptosis is associated with a number of cellular changes, one of which is the 
externalization of phosphatidylserine (PS) from the inner leaflet of the plasma 
membrane to the outer leaflet.  The exposure of PS makes it available for binding to 
annexin-V, a calcium-dependent phospholipids-binding protein that has a high affinity 
for PS.  Because of this, a fluorescently labeled annexin-V protein can be used to 
determine the presence of apoptotic cells in the presence of a high calcium-containing 
buffer (Section 2.5) (Vermes et al., 1995).  However, both necrotic and late stage 
apoptotic cells can appear as annexin-V+ as a loss of cell integrity allows annexin-V to 
penetrate and stain intracellular PS.  To make the distinction of the different modes of 
cell death, PI is also used as a viability stain.  PI binds to DNA but only when a cell 
membrane has lost integrity and become permeable (Nicoletti et al., 1991).  When 
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observed over time, changes in annexin-V and PI staining can be indicative of the 
process of cell death.  Double negatives indicate viable cells, while annexin-V single 
positives indicate early apoptotic cells.  PI single positives are necrotic cells while 
annexin-V/PI double positives are late stage dying and dead cells.  Hence, annexin-V/PI 
staining not only indicates the proportion of cells undergoing each different stage of 
viability/cell death, but also the mode of cell death depending on whether the cells first 
go through an annexin-V single positive stage, or a PI single positive stage. 
 
2.12.4 Measuring the effect of sesquiterpene dialdehyde compounds on neutrophil 
viability by annexin-V/PI staining 
Purified human neutrophils were suspended in complete RPMI-1640 and cultured in 24 
well plates at a concentration of 1 x 106 cells/mL and at a volume of 500µL per well.  
Sesquiterpene dialdehyde compounds (ranging from 0.01 to 10µM in concentration) or 
DMSO controls were then added.  After four hours, neutrophils were collected and 
washed and stained with FITC labeled annexin-V (5µL/100µL cells) and 10µg/mL PI in 
annexin-V binding buffer.  Staining was then determined by flow cytometry and 
viability determined as described in Section 2.12.3. 
 
2.13 Cytokine analyses 
Cytokine levels in harvested lavage fluid, serum and from culture supernatants were 
assayed either by Cytokine Bead Array (CBA) and analysed on a FACSCalibur flow 
cytometer, by Bio-Rad multiplex array systems and analysed on a Bio-Plex flow 
cytometer, or by ELISA.  Each measurement system was used according to 
manufacturer’s instructions. 
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2.14 Human neutrophil, mononuclear cell and white blood cell experiments 
 
2.14.1 Neutrophil and WBC apoptosis and viability assay 
Fresh human neutrophils or WBCs were suspended in complete RPMI-1640 and were 
added to 96 well plates at 2 x 105 cells/well in the presence of MSU (200µg/mL) or PBS 
(10µL) in a final total volume of 200µL.  Neutrophils were then incubated at 37°C and 
5% CO2.  At various times, neutrophils were harvested and stained immediately with 
FITC labeled annexin-V (5µL/100µL cells) in annexin-V binding buffer.  Anti human 
CD15 antibody was also included in the staining mix.  CD15 is a carbohydrate adhesion 
molecule with a high expression on neutrophils, thus anti CD15 can be used to identify 
neutrophils in mixed WBC populations (Kerr and Stocks, 1992).  Five minutes before 
analysis on the flow cytometer, 10µg/mL PI was added and then annexin-V/PI staining 
determined using a FACSCalibur flow cytometer. When testing for the effect of 
sesquiterpene dialdehyde compounds on cell viability, sesquiterpene dialdehyde 
compounds were added at time 0h and the neutrophils and WBCs recovered and stained 
with annexin-V (5µL/100µL cells), 10µg/mL PI and anti-CD15 in annexin-V binding 
buffer, 4 hours and 24 hours after incubation. 
 
2.14.2 Neutrophil and WBC soluble cytokine production 
Fresh human neutrophils or WBCs were suspended in complete RPMI-1640 and were 
added to 96 well plates at 2 x 105 cells/well in the presence of MSU (200µg/mL) or PBS 
(10µL) in a final total volume of 200µL.  Neutrophils were then incubated at 37°C and 
5% CO2 and at various times the supernatants were collected and the cytokines in the 
serum assayed by CBA array multiplex kit. 
 
2.14.3 Preparation of conditioned media 
Purified human PBMCs were suspended at 5 x 105 cells/mL in phenol red free RPMI-
1640 supplemented with 10% autologous human serum, 100U/mL penicillin-
streptomycin and 2mM glutamax.  40mL volumes of the cell suspension were then 
transferred to 75cm2 cell culture flasks.  MSU crystals (200µg/mL) were then added to 
the cell culture flasks to prepare “MSU-conditioned media,” while PBS (500µL) was 
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added to flasks to prepare “conditioned media.”  The cell cultures were then incubated 
for 16 hours at 37ºC, 5% CO2.  A 40mL volume of the same RPMI-1640 media, which 
contained no cells, was also transferred into a 75cm2 cell culture flask and incubated 
with the other cell cultures overnight to serve as a negative control that was termed 
“unconditioned media.”  After incubation, the supernatants were collected and all MSU 
crystals and cells removed by centrifugation.  Supernatants were then stored at -20°C 
until analysis. 
 
2.14.4 Intracellular IL-8 staining of neutrophils 
Human neutrophils were suspended in the various conditioned media in 24 well low cell 
binding plates at a concentration of 1 x 106 cells/mL in a total volume of 500µL.  MSU 
(200µg/mL) or PBS (20µL) was added and neutrophils incubated for 4 hours at 37°C 
and 5% CO2.  Neutrophils were then fixed in 10% buffered formalin for 15 minutes, 
permeabilised with saponin buffer and then stained with fluorescently labeled anti 
human IL-8 or an Isotype control.  Saponin buffer and excess antibody was then washed 
off by washing three times with FACS buffer.  The percentage of IL-8+ neutrophils 
suspended in FACS buffer was then determined by flow cytometry. 
 
2.14.5 Measuring the effect of soluble mediators on neutrophil viability 
Human neutrophils were suspended in the various conditioned media in 24 well low cell 
binding plates at a concentration of 1 x 106 cells/mL in a total volume of 500µL and 
incubated for 24 hours at 37°C and 5% CO2.  Neutrophils were collected and washed 
and stained with fluorescently labeled annexin-V and PI in annexin-V binding buffer.  
Staining was then determined by flow cytometry and viability determined as described 
in Section 2.12.3. 
 
2.14.6 Measuring the effect of soluble mediators on MSU-stimulated superoxide 
production 
This was performed as outlined in Section 2.11.2. 
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2.15 Phagocytosis assays 
2.15.1 Phagocytosis of fluorescent beads 
Peritoneal exudates cells were harvested from MSU treated mice at various times after 
MSU administration as described (Section 2.16.3).  Cells were suspended at 1 x 106/mL 
in RPMI-1640 with 10% FBS and 2mL of the cell suspension placed in 10mL falcon 
tube. Fluorescent beads (fluospheres, 2% solids) were separately diluted in PBS, and 
50µL of diluted beads added to the cells to the give the final dilution factor.  That is, a 
dilution factor of 5 x 10-4 represented that beads in the 2mL cell suspension were 50,000 
times more dilute than in the original purchased beads stock solution (2% solids).  The 
bead and cell suspension was then placed on a shaker in an incubator (200 rpm, 15mm 
radius) at 37ºC for 30 minutes.  Cells were then layered over the top of 1mL of FBS and 
the suspension centrifuged for 5 minutes at 500 x g.  This procedure pelleted the cells 
while unphagocytosed beads remained at the serum-medium interface.  The supernatant 
was then removed and the cells washed twice in FACS buffer, stained for the 
appropriate cell surface markers and analysed by flow cytometry. 
 
2.15.2 Peroxidase staining for phagocytosed neutrophils 
Peritoneal exudate cells were harvested from MSU treated mice at various times after 
MSU administration as described (Section 2.16.3).  Cells were suspended at 1 x 106 
cells/mL in complete RPMI-1640 and split into two groups, the first of which was 
processed immediately following cell harvest. The second group was placed in a shaking 
incubator (160 rpm, 15mm radius) and 37ºC in 50mL Falcon tubes to allow for the 
phagocytosis of apoptotic neutrophils for 4, 18 or 22 hours (depending on the 
experiment), after which the cells were processed in the same way as the previous group.  
Harvested cells were washed and re-suspended in PBS and samples of the cells prepared 
by cytospin.  The cells were then fixed with 10% buffered formalin for 20 minutes at 
37°C and washed twice with PBS.  Cells were then stained with peroxidase stain (1mM 
o-dianisidine, 5mM H2O2, 50mM sodium phosphate buffer, pH 6) for 30 minutes at 
37°C and then washed twice more in PBS followed by a counter stain with Diff-Quik.  
Monocyte-macrophages were then scored for their level of peroxidase staining in the 
cytoplasm based on a three tier scale: Negative, containing no staining; Low, containing 
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a few speckled traces of staining in the cytoplasm; and High, containing easily visible 
phagocytosed cells or extensive staining through the cytoplasm. 
 
2.16 Animal studies 
2.16.1 Ethical approvals 
All experimental procedures were approved by the Victoria University Animal Ethics 
Committee in accordance with their guidelines for the care of animals.  
 
2.16.2 Mice 
C57BL/6 male mice were bred and housed in a conventional animal facility at the 
Malaghan Institute of Medical Research, Wellington, New Zealand. All animals used for 
experiments were aged between 8-10 weeks.  
 
2.16.3 MSU-induced peritonitis 
C57BL/6 mice were administered with an i.p. injection of a 3mg slurry of MSU in 
0.5mL PBS.  At different time points mice were euthanased by CO2 and the blood 
harvested by cardiac puncture.  Mice were then dowsed with 70% ethanol and the fur 
covering the peritoneum carefully removed without puncturing the peritoneal 
membrane. A 3mL volume of PBS containing 25U/mL heparin was then injected into 
the peritoneum, injecting near the inguinal fat pads to allow the injection hole to re-seal 
on extraction of the syringe needle.  The inflated peritoneum was then massaged for 30 
seconds following which the syringe needle was re-introduced into the peritoneum and 
the PBS (containing peritoneal exudate cells) were withdrawn.  The peritoneal lavage 
fluid was expelled into a sterile tube containing 200µL FBS, unless the lavage fluid was 
to be measured for TGFβ in which case FBS was excluded. Serum and lavage fluid was 
retained for cytokine analysis.  Cells were retrieved from the lavage fluid by 
centrifugation (500 x g, 5 mins) and were subsequently washed twice with PBS before 
further culture or before antibody staining for analysis by flow cytometry.  Cytospin 
samples of the cells were prepared by sedimentation using a cytocentrifuge, after which 
they were stained with Diff-Quik.  For differential counts using these samples, 200 cells 
were examined per slide.   
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2.16.4 Thioglycollate-induced peritonitis 
C57BL/6 mice were administered with an intraperitoneal (i.p.) injection of 4% 
thioglycollate (0.5 mL). After six hours the mice were euthanased by CO2 and the 
peritoneal exudate cells harvested as described for MSU crystal-induced peritonitis 
above. 
 
2.16.5 Testing of sesquiterpene dialdehyde compounds in the in vivo gout model 
Mice were treated with a 50µL i.p. injection of the sesquiterpene dialdehyde compound 
or 50µL of DMSO (control) to one side of the peritoneum following which an i.p. 
injection of MSU (3mg, 0.5mL PBS) was immediately administered to the opposite side 
of the peritoneum. Peritoneal leukocyte cells were harvested 4 hours after MSU 
administration by lavage with 3mL of PBS containing 25U/mL heparin and 10% FBS.  
In addition to the required cell number and differential counts, peritoneal leukocytes 
were retained to measure the levels of superoxide being produced by infiltrating 
neutrophils (Section 2.11.4). 
 
2.16.6 PKH26 experiments 
PKH26-PCL is a dye that is selectively taken up phagocytes; principally macrophages, 
and to a lesser extent, monocytes and neutrophils (Bellingan et al., 1996).  PKH26-PCL 
dye was prepared according to manufacturer’s instructions.  Mice received an injection 
of 0.5mL of the PKH26 dye solution i.p. and one day later the mice received an 
injection of MSU i.p. (3mg, 0.5mL PBS).  Mice were sacrificed at various time points 
after MSU treatment and the peritoneal exudates cells harvested by peritoneal lavage as 
described (Section 2.16.3).  Cells were then stained for Gr-1 and F4/80 and analysed by 
flow cytometry. 
 
2.16.7 Preparation of clodronate-loaded liposomes 
Clodronate liposomes were prepared as previously described (van Rooijen et al., 1996).  
Briefly, 86mg phosphatidylcholine and 8mg of cholesterol were dissolved in 10mL of 
chloroform and added to a round-bottom flask.  The flask was placed onto a rotary 
evaporator at high vacuum to form a thin film on the inside of the flask.  10mL of 0.7M 
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clodronate (pH 7.1) was added and then the film gently dispersed by gentle rotation for 
10 minutes.  The flask was then removed from the rotary evaporator, flushed with 
nitrogen and incubated overnight at 4°C (still under nitrogen).  The resulting liposomes 
were then harvested by centrifugation 2000 x g for 40 minutes, washed twice and made 
up to 4mL in PBS.  Liposomes were stored at 4°C and used within three days of 
production. 
 
2.16.8 Clodronate liposome depletion of resident macrophages 
Mice were treated with 200µL i.p. injection of either clodronate liposomes, PBS loaded 
liposomes or PBS.  Three days following the first injection, mice were challenged with 
an i.p. injection of 3mg of MSU following which cells were harvested as described by 
lavage as above (Section 2.16.3). 
 
2.17 Intracellular staining of ex vivo cells 
Total peritoneal exudate cells from mice treated with MSU for 4 hours were harvested 
by peritoneal lavage and quickly suspended at 1 x 106 cells/mL in complete RPMI-1640 
and 1:1500 GolgiStop and transferred into 24 well low cell binding plates.  Positive 
controls were stimulated with 1µg/mL LPS after which all cells were incubated for a 
further 4 hours at 37°C to allow for accumulation of intracellular cytokine levels.  Cells 
were then stained for the surface markers F4/80, Gr-1 and 7/4 and intracellular IL-6. 
Cells were analysed by flow cytometry using a BD FACSCalibur.  Cytospin samples of 
exudate cells were also prepared by Diff-Quik staining to complement differential cell 
counts determined by flow cytometry. 
 
2.18 Restimulation assays 
Harvested peritoneal exudate cells from MSU- or thioglycollate-treated mice and cells 
purified by cell sorting were cultured in complete RPMI-1640 at 1 x 106 cells/mL in 96 
well plates and treated with either PBS, 200µg/mL MSU, or 100ng/mL LPS overnight at 
37°C.  Supernatants were then harvested after 16 hours for cytokine analysis. 
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2.19 Whole peritoneal tissue and peritoneal leukocyte culture 
Naïve mice were euthanased by CO2 and the skin removed from the abdomen under 
sterile conditions.  The naïve peritoneal leukocytes were collected from the mouse by a 
gentle lavage of the cavity with 3mL PBS containing 25U/mL heparin.  Next, the ventral 
tissue covering the peritoneal cavity was excised and placed into cold RPMI-1640.  
Naïve peritoneal leukocytes were then washed twice in PBS and then re-suspended in 
complete RPMI-1640 at a concentration of 1 x 106 cells/mL while the peritoneal tissue 
was placed into complete RPMI-1640 that had been pre-warmed at 37ºC. MSU 
(200µg/mL) or PBS (control) were added to either peritoneal leukocytes, tissue cells or 
a combination of both in a 96 well plate containing 200µL of complete RPMI-1640.  In 
experiments involving the peritoneal tissue, the visceral side of the tissue was placed 
face down over the top of the wells and then the lid of the 96-well plate was placed over 
the top so as to form a seal between the tissue and the well.  The plate was then inverted 
to allow the media, cells and MSU to contact the peritoneal tissue.  In treatments 
involving only leukocytes, cells were prepared in a separate 96-well plate and were not 
inverted.  Cells were then incubated at 37ºC, 5% CO2 for 4 hours following which the 
supernatants were collected and assayed for cytokine levels by ELISA and cytokine 
bead array. 
 
2.20 Cytokine production from macrophages following uptake of neutrophils 
Peritoneal exudate cells from mice treated with MSU in vivo for 8 and 18 hours were 
harvested by lavage as described (Section 2.16.3), suspended to 1 x 106 cells/mL in 
complete RPMI-1640 and then split into three equal aliquots.  The first aliquot of cells 
was used for culturing immediately (0h), while the second and third groups were placed 
in vented 50mL Falcon tubes and then put on a shaker (160 rpm, 15mm radius)  in an 
incubator at 37ºC for 4 and 22 hours respectively to allow for the phagocytosis of 
apoptotic neutrophils; after which the incubated cells were cultured in the same way as 
the first group.  When culturing the groups of cells, cells were washed in complete 
RPMI-1640, the cell concentration adjusted to 1 x 106 cells/mL, and plated into 96 wells 
after which they were stimulated with 200µg/mL MSU, 100ng/mL LPS or 10µL PBS 
(control).  Supernatants were collected at 8 and 24 hours after in vitro stimulation.  
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Cytospin samples of cell cultures prior to in vitro stimulation were prepared and treated 
with Diff-Quik and peroxidase stain as described above. 
 
2.21 Inter-experimental variability 
Experiments measuring the generation of superoxide via WST-1 reduction had optical 
density readings that varied up to as much as 20% between different neutrophil donors 
but nevertheless maintained the same patterns of superoxide activity.  Measurements 
involving the stimulation by MSU conditioned media for an improvement in neutrophil 
viability (Figure 3.9) and of IL-8 production in neutrophils (Figure 3.10) varies up to 
30% between different neutrophil donors but also maintains the same pattern of 
differences between experiments. 
 
2.22 Image analyses and editing 
Microscope images of cells and tissues were acquired and optimized using AnalySIS 
Life Imaging Software.  AnalySIS software was also used to determine width and area 
of cells on cytospin slides.  Photoshop software was used on microscopic images to 
remove debris from the acquired images. 
  
2.23 Statistical analysis 
The Student’s t-test was used to determine statistical significance when there were less 
than three treatment groups within an experiment being compared against each other.  In 
experiments for which there were three or more groups, a one-way ANOVA and Tukey 
multiple comparison test was used.  Statistical significance was determined when P < 
0.05. 
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Chapter 3 
Neutrophil activation in MSU-induced 
inflammation 
 
3.1 Introduction 
Neutrophils were identified as important cells in gout almost 40 years ago when 
Phelps and McCarty performed a key experiment demonstrating the association of 
neutrophils with gout using the canine joint.  Dogs treated with an intrasynovial 
injection of MSU crystals experienced a rich leukocyte infiltrate comprised of 
around 80% neutrophils (Phelps and McCarty, 1966).  In this model, the degree of 
joint swelling was shown to be directly proportional to the amount of neutrophils 
infiltrating into the joint space.  This was most clearly demonstrated when 
circulating neutrophils were selectively depleted in the blood by an intravenous 
treatment with the drug vinblastine: dogs that had been completely depleted of blood 
neutrophils displayed a complete abolishment of an acute gout inflammatory 
response. 
 
Since finding that neutrophils are important in gout, researchers have undertaken to 
unravel the contribution of neutrophils to gout inflammation.  A number of changes 
in neutrophil activity have been noted in in vitro conditions modelling gout 
inflammation.  Under homeostatic conditions, neutrophils have a short lifespan 
undergoing apoptosis after approximately ten hours (Athens et al., 1961, Dancey et 
al., 1976).  However, upon exposure to MSU, neutrophils delay their apoptotic 
program and extend their lifespan by several hours (Akahoshi et al., 1997, Tudan et 
al., 2000).  In addition to a delay in apoptosis, direct contact with MSU crystals 
results in the secretion of a number of inflammatory molecules including IL-8 
(Hachicha et al., 1995), PGE2 (Gilbert et al., 2003) and the release of lysosomal 
enzymes (Weissmann and Rita, 1972).  
 
One of the major inflammatory products resulting from the contact of MSU with 
neutrophils is superoxide (Abramson et al., 1982, Simchowitz et al., 1982).  
Superoxide is a reactive oxygen species (ROS) that is the basis for the production of 
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a host of ROS generated by neutrophils to fight infection (Section 1.10.7.4)(Babior, 
2000).  Since MSU crystals are a non-infectious, non-living solid material, the 
production of ROS is without notable benefit.  The result of ROS production under 
these circumstances is that errant ROS production can inflict damage upon host 
tissue (Sies, 1997). 
 
The enzyme responsible for the ROS production as part of the respiratory burst is the 
phagocytic NADPH oxidase (Phox), a functional enzyme complex that is dependent 
on the co-localisation of both membrane and cytosolic subunits (Nauseef et al., 
1991).  The membrane element, flavocytochrome b558, is composed of a stabilising 
complex of p22phox with the flavin-centred gp91phox.  In the cytosol, there are four 
cytosolic components: p40phox, p47phox, p67phox, which exist in a heterotrimeric 
complex; and the small GTPase, rac. In resting neutrophils, Phox is inactive and in 
an unassembled state (Fig. 3.1A).  Once neutrophils become activated, there are at 
least three signalling pathways that result in the assembly of all of the subunits at the 
membrane to create the enzyme complex (Fig. 3.1B). Phosphorylation of p47phox by 
protein kinases such as protein kinase C and AKT exposes its p22phox-binding 
domain, localising the complex to bind to flavocytochrome b558.  The production of 
lipid mediators by phosphatidylinositol 3-kinase (PI3K) and phospholipase D 
provide lipids that help bind p40phox and p47phox to the membrane.  Rac dissociates 
from the inhibitory protein RhoGDI following guanine nucleotide exchange in the 
cytosol and moves to the membrane, binding to p67phox.  Assembly of all the enzyme 
subunits at the membrane initiates the two-electron transfer from cytosolic NADPH 
to the bound flavin adenine dinucleotide (FAD) (Fig. 3.1C).  Two haem molecules at 
the centre of gp91phox act as electron carriers through the reduction and reoxidation 
of iron at the haem centres.  In the final step, electrons are transferred from haem to 
phagosomal or extracellular oxygen in sequential one-electron transfers (Lambeth, 
2004).  Generation of superoxide can be observed within 30 seconds of neutrophil 
stimulation, demonstrating the speed at which these processes can occur and the 
readiness of neutrophils to respond to inflammatory stimuli. 
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Figure 3.1. The NADPH oxidase enzyme. (A) The inactive enzyme complex consists of a membrane component (gp91phox and p22phox) and a 
number of cytosolic components (p40phox, p47hox, p67phox and the small GTPase rac). (B) Three events occur once neutrophils are stimulated: 
p47phox is phosphorylated by protein kinases such as protein kinase C and AKT, causing p47phox to bind to p22phox at the membrane; 
Phosphatidylinositol 3-kinase and phospholipase D produce phosphorylated phosphatidylinositols (PtdInsP) and phosphatidic acid facilitating 
binding of p40phox and p47phox to the membrane complex; and rac is released from the inhibitory protein RhoGDI by an enzyme mediated 
exchange of GDP for GTP on the rac protein, following which, rac binds to the enzyme complex at the membrane. (C)  Assembly of the 
cytosolic and membrane components form the active enzyme complex.  The enzyme catalyses the two electron transfer from NADPH to FAD 
and through the heme centres by a process catalysed by iron reduction and re-oxidation.  Single electrons are then transferred to oxygen 
molecules resulting in the generation of two superoxide molecules per NADPH into the phagosome or extracellular space.  Figure adapted from 
(Lambeth, 2004). 
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The process by which MSU crystals activate NADPH oxidase is currently unknown.   
One potential pathway of activation by MSU is through the phosphorylation of PKC 
and the activation of phospholipase D that leads to the activation of NADPH oxidase 
(Fig. 3.1B) (Naccache et al., 1993). However, PKC inhibitors cause only a moderate 
reduction in MSU-induced superoxide activity (Naccache et al., 1991) and as such, a 
number of pathways are likely to be involved. 
 
The current model of neutrophil recruitment and activation in gout is outlined in 
Figure 3.2.  Once MSU crystals have formed in the joint, local innate immune cells 
interact with the crystals and produce cytokines and chemokines that recruit 
neutrophils into the joint space (Section 1.10.7).  When neutrophils infiltrate into the 
joint they are exposed to MSU crystals, resulting in the activation and subsequent 
production of neutrophil IL-8, superoxide and a delay in apoptosis.  Together, these 
activities augment the accumulation and activation of neutrophils and induce the 
production of ROS that inflict inflammatory symptoms and physical damage in the 
local joint environment. 
 
The studies leading up to this model have primarily focussed on a single aspect of 
neutrophil activation, that is; either viability (Akahoshi et al., 1997), IL-8 production 
(Hachicha et al., 1995), or superoxide production alone (Simchowitz et al., 1982), 
emphasizing the engagement of those activities via direct contact with MSU.  
However, neutrophils are likely to be exposed to inflammatory mediators prior to 
contact with MSU that may influence neutrophil responses.  This idea has been 
partially explored in a study showing that extraneous TNFα can prime neutrophil 
superoxide production in response to MSU (Burt and Jackson, 1997).  However, 
these authors did not investigate the effect of MSU-generated cytokines on 
neutrophil viability or neutrophil cytokine production.  This chapter explores how 
human neutrophil responses to MSU-induced inflammation are affected by 
inflammatory factors that are present in the environment prior to direct contact with 
MSU. 
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Figure 3.2.  Current model of neutrophil activation in gout.   MSU crystals 
stimulate local cells in the joint to produce a number of pro-inflammatory cytokines 
that recruit neutrophils into the joint space.  Neutrophils then make contact with 
MSU and are activated (yellow) to produce IL-8 and superoxide.  Contact with MSU 
also results in an improvement in neutrophil viability. 
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3.2 Results 
3.2.1 Measuring neutrophil superoxide production 
Activation of neutrophils is associated with the production of superoxide.  Previous 
research has shown that MSU crystals stimulate neutrophils to produce superoxide.  
To confirm this, human neutrophils were cultured in HBSS and exposed to MSU.  
Superoxide production was measured using the dye, WST-1.  Consistent with 
previous research, neutrophils produced superoxide in response to MSU (Fig. 3.3).   
Superoxide was produced in a dose-dependent manner that reached a maximal 
response at 0.5mg/mL. 
 
Next, various culture conditions were tested to optimise the conditions for 
superoxide production.  PBS and RPMI-1640 were explored as alternative assay 
media, with superoxide production compared against neutrophils activated in HBSS.  
In addition, different serum supplementations were tested, including different serum 
concentrations and serum from different species. 
 
First, the effect of different media conditions on the background level of superoxide 
production by unstimulated human neutrophils was compared: In the absence of 
serum, background production of superoxide by neutrophils in RPMI-1640 was 
twice that of neutrophils in PBS and HBSS (Fig. 3.4).  The addition of autologous 
human serum below 10% caused an unexpected increase in background superoxide 
production.  This effect was more pronounced in more complex media, to the extent 
that neutrophils in RPMI-1640/serum produced a greater amount of superoxide than 
in HBSS/serum, which produced more than in PBS/serum (See Appendix for 
formulations of media).  A substantial increase in background superoxide production 
peaked at 0.22% in all media, indicating that very low concentrations of serum 
stimulated superoxide production.  At 10% serum, background levels were closer to 
those observed in neutrophils cultured in the absence of serum.  The stimulatory 
effect of low-level serum appeared to be species specific as the same activity was not 
observed in the presence of FBS.  In fact, even the smallest amount of FBS (0.11%) 
completely inhibited the background production of superoxide.  This revealed that 
the stimulatory effect of low human serum on human neutrophil superoxide 
production is not a universal feature of any type of serum.  
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Figure 3.3.  MSU stimulated production of superoxide by human neutrophils.  
Neutrophils were isolated from peripheral blood and suspended in serum-free HBSS 
(1.5 x 105 cells, 150µL).  Neutrophils were stimulated with 200µg/mL MSU in the 
presence of the dye WST-1 (250µg/mL).  The production of superoxide was 
measured in 100µL of harvested cell- and MSU-free supernatant by WST-1 
reduction at absorbance 450nm (A450) after 1h.  Measurements were performed in 
triplicate.  Values represent mean ± S.E.M.  Results are representative of three 
separate experiments. 
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Figure 3.4.  The effect of different media conditions on background superoxide 
production by human neutrophils.  Neutrophils were isolated from peripheral 
blood and cultured in a number of different media conditions (1.5 x 105 cells, 
150µL) in the absence of stimuli.  Culture conditions included combinations of PBS, 
HBSS or RPMI-1640 (RPMI) with autologous human serum (HuSer) and fetal 
bovine serum (FBS). The production of superoxide was measured by WST-1 
reduction (250µg/mL) at absorbance 450nm (A450) in 100µL of the cell- and MSU-
free supernatant after 1h.  Measurements were performed in triplicate.  Values 
represent mean ± S.E.M. (Vmax).  Results are representative of three separate 
experiments. 
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In summary, the results above suggested that the complexity of the medium and the 
concentration and source of serum were factors that affected superoxide production 
by neutrophils.  In an in vivo setting, neutrophils are likely to have a number of 
nutrients present in the surrounding milieu (modelled by RPMI-1640), and not just a 
few salts (modelled by PBS and HBSS).  Therefore, despite an elevated level of 
background superoxide production, RPMI-1640 was chosen as the most appropriate 
culture medium to measure superoxide activity.   
 
3.2.2 Superoxide production by MSU-stimulated neutrophils is affected by 
human serum concentration. 
As serum concentration had an obvious effect on otherwise unstimulated neutrophils, 
this raised the question of how human serum concentration alters the superoxide 
response by neutrophils stimulated with MSU crystals. 
 
It is already known that serum proteins can affect MSU-induced superoxide 
production.  Most of this previous research is based on the idea that MSU becomes 
coated by serum proteins both in vivo and in vitro, and these proteins (including 
apolipoprotein B) inhibit neutrophil responses to MSU (Terkeltaub et al., 1984, 
Ortiz-Bravo et al., 1993).  It has also been shown that MSU crystals can activate 
complement proteins in plasma, leading to an enhanced superoxide response 
(Boogaerts et al., 1983).  However, it has never been considered that serum alone 
may play a role in neutrophil activation in gout.  The effect of low serum levels has 
so far remained undiscovered because MSU stimulation of human neutrophils has 
typically been performed either in the absence of serum (Burt and Jackson, 1997, 
Barabe et al., 1998) or at 10% human serum (Abramson et al., 1982).  Therefore, the 
level of human serum present in the culture medium may be an important aspect in 
modelling conditions that correctly reflect the in vivo situation. 
 
In the circulation, neutrophils are exposed to very high levels of serum and to low 
level serum in a swollen joint in inflammatory conditions (Schmid and Macnair, 
1956, Kushner and Somerville, 1971).  To incorporate serum effects into MSU 
stimulated superoxide production, purified human neutrophils were cultured in the 
presence of different concentrations of autologous serum and stimulated with MSU.  
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A concentration of 500µg/mL is commonly used to induce a maximal superoxide 
response (Fig. 3.3); however, to avoid missing possible potentiation as well as 
suppression of superoxide by serum, responses were tested at a suboptimal MSU 
concentration of 200µg/mL.  The addition of PBS to the culture medium instead of 
MSU was used to determine the effect of serum alone. 
 
As shown in Figure 3.5, unstimulated neutrophils exhibited the same background 
response to serum concentration that was observed in the previous experiment (Fig. 
3.4).  A low level of human serum caused an increase in the base level production of 
superoxide, and as serum concentration was increased, the base level superoxide 
production decreased, re-affirming that serum itself directly affects superoxide 
production.  Interestingly, when neutrophils were stimulated with MSU they 
produced significantly lower levels of superoxide compared with serum alone up to a 
concentration of 2.5%.  At serum concentrations above 2.5% serum MSU 
stimulation increased the amount of superoxide produced by neutrophils compared 
to serum alone returning to background levels at 10% serum concentration.   
 
To determine whether the serum effect was due to proteins present in the serum, this 
experiment was repeated using human serum that had been heat inactivated at 56°C 
for 30 minutes.  Heat inactivation of serum abrogated the increase in base level 
superoxide observed at low serum concentrations, indicating the presence of 
stimulating proteins in the serum that were sensitive to heat treatment (Fig. 3.5).  
Neutrophils cultured in heat inactivated serum displayed a similar pattern of 
responsiveness to MSU as neutrophils cultured in normal serum; that is: in low 
serum concentrations, MSU reduced background superoxide production, while in 
higher serum concentrations MSU increased superoxide production (Fig. 3.5).  To 
determine if the complex effects of serum and MSU on neutrophil superoxide 
production were dependent on autologous serum, neutrophils from a single donor 
were exposed to serums from four different individuals and then stimulated with 
MSU.  Neutrophils showed the same pattern and degree of both background and 
MSU-stimulated superoxide production as neutrophils cultured in autologous serum 
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Figure 3.5.  The effect of serum on the production of superoxide by human 
neutrophils. Neutrophils were isolated from peripheral blood and cultured (1.5 x 105 
cells, 150µL RPMI) in normal autologous serum or heat inactivated autologous 
serum (H.I.) and were unstimulated (10 µL PBS) or stimulated with 200µg/mL MSU 
crystals. The production of superoxide was measured by WST-1 reduction 
(250µg/mL) in 100µL of cell- and MSU-free supernatant after 1h at absorbance 
450nm (A450). Values represent mean ± S.E.M. where n = 10 readings per datapoint. 
Results are representative of three separate experiments. 
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Figure 3.6.  The effect of non-autologous serum on the production of superoxide 
by human neutrophils. Neutrophils were isolated from peripheral blood and 
cultured (1.5 x 105 cells, 150µL RPMI) in normal and heat inactivated (H.I) serum 
from four separate donors.  Serum 1 represents the results from neutrophils in the 
presence of autologous serum, while Serums 2 – 4 represent responses from 
neutrophils incubated with serums from heterologous donors. Neutrophils were 
unstimulated (10 µL PBS) or stimulated with 200µg/mL MSU crystals. The 
production of superoxide was measured by WST-1 reduction (250µg/mL) in 100µL 
of cell- and MSU-free supernatant after 1h at absorbance 450nm (A450). 
Measurements were performed in triplicate.  Values represent mean + S.E.M.  
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(Fig. 3.6).  This indicated that the effect of human serum on human neutrophil 
production of superoxide was not dependent on the autologous donor serum. 
 
The data presented in the previous section indicate that stimulation of neutrophils by 
MSU in vitro can cause conflicting results depending on the chosen culture 
conditions, ranging from inhibitory (low serum conditions) to stimulatory (high 
serum conditions).  The implications of this will be discussed later (Section 3.3).  
Since neutrophils are exposed to different concentrations of serum in vivo depending 
on their location (peripheral blood, joints, etc.), the most appropriate conclusion 
from these results is that although neutrophils are clearly stimulated by MSU to 
produce superoxide, the magnitude of the response is influenced by presence of 
serum and other proteins. 
 
3.2.3 The effect of MSU on neutrophil viability and IL-8 production 
Neutrophil superoxide production is only one measurement of neutrophil activation 
by MSU.  Neutrophil activation can also be observed as a delay in neutrophil 
apoptosis – as measured by an improvement in neutrophil viability – in combination 
with an increase in the production of pro-inflammatory cytokines, such as IL-8.  
Hence, the effect of MSU on neutrophil survival and cytokine production was 
determined.  To do this, purified human neutrophils were cultured with or without 
MSU over 24 hours, and the effect on neutrophil viability and cytokine production 
quantified.  As soluble cytokines were being measured, cells were cultured in 10% 
FBS rather than human serum, eliminating the likely complication of high 
background levels of human cytokines present in human donor serum. 
 
Neutrophil viability was measured by flow cytometry using propidium iodide (PI), 
and fluorescently labelled Annexin-V.  The combination of these stains clearly 
delineated viable from apoptotic cells (Fig. 3.7A).  Viable cells were Annexin-V-/PI-; 
whereas apoptotic cells were Annexin-V+/PI-; necrotic cells were Annexin-V-/PI+; 
and late stage dead cells from both apoptosis and necrosis were Annexin-V+/PI+. 
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Figure 3.7.  The effect of MSU on neutrophil viability and cytokine production.  Human neutrophils (2 x 105 cells; 200µL) purified from 
peripheral blood were cultured with or without 200µg/mL MSU.  The effect of MSU on neutrophil viability was measured by flow cytometry. A. 
Gating strategy for determining neutrophils that are viable (double negative), apoptotic (Annexin-V+, PI-) and dead (PI+).  B. Viability profile of 
unstimulated neutrophils cultured over 24h.  C. Viability profile of MSU stimulated neutrophils over 24h. D. Cytokines produced by 
unstimulated neutrophils.  E. Cytokines produced by MSU stimulated neutrophils. Cytokine production from neutrophils was measured by 
cytokine bead array.  Measurements were performed in triplicate.  Values represent mean ± S.E.M. Results are representative of three separate 
experiments. 
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In unstimulated neutrophil cultures the number of apoptotic neutrophils began to 
increase after 2 hours; and after 10 hours, 50% of neutrophils were apoptotic (Fig. 
3.7B).  In neutrophils that were cultured with MSU, neutrophil apoptosis was 
delayed such that 50% of cells were still viable at 20 hours (Fig. 3.7C).  This 
indicated that exposure to MSU approximately doubled the half-life of neutrophils in 
culture.  In addition, after 24 hours survival was twice as high in MSU-stimulated 
neutrophils than in unstimulated neutrophils (Fig. 3.7B-C).  The increase in survival 
time following exposure to MSU was consistent with reports from other researchers 
(Akahoshi et al., 1997). 
 
To determine the effect of MSU on neutrophil cytokine production, supernatants 
from the neutrophil viability experiments above were assayed for the production of a 
number of classical inflammatory cytokines.  Of the cytokines assayed (TNFα, IL-
1β, IL-6 and IL-8), only IL-8 was detectable in the culture supernatant of neutrophils 
(Fig. 3.7D and E).  Unstimulated neutrophils produced a low background level of IL-
8, whereas neutrophils produced a large amount of IL-8 in response to MSU (Fig. 
3.7D and E). 
 
Together, these results show that direct exposure to MSU crystals activates 
neutrophils resulting in an increase in cell survival and the production of the pro-
inflammatory cytokine IL-8. 
 
3.2.4 The effect of mixed cell populations on MSU-induced neutrophil activation  
In gout, neutrophils are not the sole leukocytes present in the joint during an acute 
inflammatory attack; several other cell types are present including monocytes, 
macrophages and lymphocytes, that may contribute to the inflammatory response 
and affect neutrophil activation and function.  To mimic the effect of other cell types 
on neutrophil activation, total human white blood cells (WBCs) were used to model 
the mixture of inflammatory cells found in the joint over the course of an 
inflammatory response.  Human blood WBCs are composed of 50-70% neutrophils 
and contain a mixture of cells including monocytes and lymphocytes.  One drawback 
is that WBCs do not contain macrophages, and so the predominant mononuclear 
phagocyte in the blood is the monocyte.  Nevertheless, WBCs are the closest model 
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of the mixture of inflammatory cells found in the human joint without 
implementation of complex mixtures of immortalised cell lines. 
 
The effect of mixed cell populations on neutrophil viability, was measured by 
Annexin-V and PI staining.  Identification of human neutrophils was performed by 
flow cytometry using anti-CD15 (Fig. 3.8A).  As shown in Figure 3.8B, neutrophils 
survived longer in the presence of unstimulated WBCs than neutrophils alone (50% 
survival after 20h and 10h respectively) (Figs. 3.7B and 3.8B).  In fact, neutrophil 
survival in unstimulated WBCs was similar to the survival of MSU-stimulated 
purified neutrophils, with both sets of neutrophils displaying 50% viability at 20 
hours (Figs. 3.7C and 3.8B).  When mixed WBCs were stimulated with MSU, there 
was a dramatic improvement in neutrophil survival.  After 24 hours, 80% of 
neutrophils in MSU-stimulated WBCs were still viable (Fig. 3.8C).  These results 
indicate that the presence of other leukocytes significantly enhances neutrophil 
survival in both the presence and absence of MSU. 
 
Improved neutrophil survival is often associated with the presence of inflammatory 
cytokines.  Therefore, the production of pro-inflammatory cytokines in the WBC 
cultures was measured.  With respect to WBCs alone, only background levels of IL-
8 were observed (Fig. 3.8D).  However, stimulation of WBCs with MSU produced 
greater than three fold higher levels of IL-8 than observed in MSU-stimulated 
neutrophils alone, as well as high levels of additional cytokines including IL-6, IL-
1β and TNFα (Fig. 3.8E).  As WBCs were a mixed cell population, cell supernatants 
did not allow the identification of the cellular source of these cytokines.  However, I 
had previously shown that isolated neutrophils only produced IL-8 (Fig. 3.7E) 
indicating that cells other that neutrophils were likely to be the major producers of 
IL-6, TNFα and IL-1β and may even be additional producers of IL-8 because the 
contribution of neutrophil IL-8 cannot be determined directly.  Despite this 
limitation, these results show that neutrophil survival was greatly increased in mixed 
cell populations and increased even further following stimulation with MSU, and 
that this increase is associated with the production of high levels of cytokines. 
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Figure 3.8.  The effect of other leukocytes on MSU-stimulated neutrophil viability.  Total white blood cells (WBCs) (2 x 105 cells; 200µL) 
were purified from peripheral blood and cultured with or without 200µL MSU.  The effect of MSU on neutrophil viability in the mixed cell 
population was determined by flow cytometry, using CD15 to identify neutrophils.  A. CD15 gating of neutrophils.  B. Viability profile of 
neutrophils in unstimulated WBCs over 24h. C. Viability profile of neutrophils in MSU-stimulated WBCs over 24h.  D. Cytokines produced by 
unstimulated WBCs.  E. Cytokines produced by MSU stimulated WBCs.  Cytokine production from WBCs was measured by cytokine bead 
array.  Measurements were performed in triplicate.  Values represent mean ± S.E.M. Results are representative of three separate experiments. 
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 3.2.5 The effect of soluble mediators on neutrophil activation and function 
A number of human studies have shown the potential of peripheral blood 
mononuclear cells (PBMCs), in particular of human monocytes, to produce pro-
inflammatory cytokines following exposure to MSU (Guerne et al., 1989, di Giovine 
et al., 1991).  Elevated production of cytokines by MSU-stimulated WBCs 
implicated PBMCs as the source of these cytokines. Enhanced neutrophil survival 
was associated with increased cytokine levels; however, neutrophil survival was 
enhanced even in the absence of MSU stimulation.  Therefore, the effect of PBMCs 
on neutrophil survival may have either been due to the increased levels of 
inflammatory mediators, by cell-to-cell contact between neutrophils and PBMCs, or 
both.   
 
In the process of neutrophil recruitment under MSU-stimulated conditions, 
circulating neutrophils are likely to encounter soluble signals released into the 
circulation by MSU-stimulated resident cells in the joint.  This would occur prior to 
contact with activated cells in the joint, or with MSU.  For this reason, MSU-induced 
soluble mediators seem likely candidates for the viability-enhancing effects of MSU 
on neutrophils in mixed cell populations.  In addition to improved viability, MSU-
induced soluble mediators may affect other aspects of neutrophil activation such as 
the production of IL-8 and superoxide. 
 
To assess whether the observed increase in neutrophil survival required cell-cell 
contact or was orchestrated by soluble mediators, PBMCs were isolated from human 
blood and used to generate three types of media for experiments:  
 
• Unconditioned media; a control media (RPMI-1640; 10% human serum) that 
had not been exposed to cells nor MSU 
• Conditioned media; media (RPMI-1640; 10% human serum) that had been 
incubated with PBMCs in the absence of any stimulus but contained PBS as 
a control for MSU 
• MSU-conditioned media; media (RPMI-1640; 10% human serum) that had 
been derived from PBMCs that had been stimulated with 200µg/mL MSU. 
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3.2.5.1 Neutrophil survival is improved by MSU-induced soluble mediators and 
does not require cell-cell contact 
To determine the effect of soluble mediators on neutrophil survival, neutrophils were 
exposed to the three different media described above.  Approximately 50% of human 
neutrophils cultured with unconditioned media were still viable after 24 hours 
compared to 68% of neutrophils cultured in conditioned media (Fig. 3.9, top left and 
top middle).  This increased to 85% viability in neutrophils exposed to MSU-
conditioned media (Fig. 3.9, top right), indicating that the improvement in neutrophil 
survival observed in stimulated mixed cell populations was caused by soluble 
mediators, and did not require cell-to-cell contact. As in the earlier neutrophil 
experiment, viability of neutrophils in unconditioned media increased to 73% 
following MSU treatment (Fig. 3.7B and Fig. 3.9, bottom left).  In contrast, 
neutrophils that were cultured in MSU-stimulated conditioned media showed no 
further improvement in viability when MSU was added to the culture (Fig. 3.9, 
bottom right).  These results demonstrate that soluble mediator stimulation of 
neutrophils has an equal if not greater influence on neutrophil viability compared 
with direct interaction of neutrophils with MSU. 
 
3.2.5.2 Neutrophil IL-8 production is activated by MSU-induced soluble 
mediators 
Soluble mediators from MSU-stimulated PBMCs had such a profound effect on 
neutrophil viability that the effect of these mediators on neutrophil IL-8 production 
was next examined.  Since soluble IL-8 may have been derived either from the 
prepared conditioned media or from newly stimulated neutrophils, intracellular 
cytokine staining was used to focus on neutrophil IL-8 production.   
 
As shown in Figure 3.10, approximately 14% of neutrophils cultured in conditioned 
and unconditioned media were IL-8+ compared to almost 60% IL-8+ neutrophils in 
MSU-conditioned media (Fig. 3.10, upper panels). This suggests that soluble 
mediators from MSU-stimulated cells have the capacity to activate neutrophils to 
produce IL-8, without neutrophils being in direct contact with MSU.  When 
neutrophils in conditioned and unconditioned media were stimulated directly with 
MSU, only 26% of cells were IL-8+ compared with 59.8% of neutrophils cultured 
with MSU-conditioned media alone (Fig. 3.10, bottom left and middle, top right). 
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Figure 3.9.  The effect of soluble mediators derived from MSU-stimulation on neutrophil viability. Human neutrophils were purified from 
peripheral blood and cultured for 24h (5 x 105 cells, 500µL) in the presence of untreated media (Unconditioned, left hand panels), media 
conditioned by unstimulated mononuclear cells (Conditioned, middle panels), or media conditioned by MSU-stimulated mononuclear cells 
(MSU-conditioned, right hand panels).  Neutrophil cultures were also cultured in the presence of 200µg/mL MSU (lower panels).  Neutrophil 
viability was determined by Annexin-V/PI staining.  Results are representative of three separate experiments. 
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Figure 3.10.  The effect of soluble mediators derived from MSU-stimulation on neutrophil IL-8 production. Human neutrophils were 
purified from peripheral blood and cultured (5 x 105 cells, 500µL) for 4h in the presence of untreated media (Unconditioned, second column 
panels), media conditioned by unstimulated mononuclear cells (Conditioned, third column panels), or media conditioned by MSU-stimulated 
mononuclear cells (right hand panels).  Neutrophil cultures were also cultured in the presence of 200µg/mL MSU (MSU treated, lower panels).  
Neutrophil IL-8 production was then determined by intracellular staining.  Results are representative of three separate experiments. 
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Neutrophils stimulated with MSU-conditioned media alone also produced a much 
higher level of IL-8 per cell than those stimulated with MSU alone, as shown by the 
difference in the mean fluorescence intensity (MFI) (Fig. 3.11).  Neutrophils 
receiving both soluble mediators and direct MSU stimulation were difficult to 
recover but still showed a high proportion of IL-8+ cells (49%) (Fig. 3.10, lower 
right).  Stimulation with MSU provided no additional response in terms of IL-8 
production compared to stimulation with soluble mediators alone (Fig. 3.10, top and 
bottom right).  
 
In summary, soluble mediators from MSU-stimulated cells (represented by MSU-
conditioned media) exerted a much more potent effect on neutrophil IL-8 production 
than direct stimulation with MSU. 
 
3.2.5.3 MSU-induced soluble mediators prime human neutrophils to produce 
superoxide 
The effect of the conditioned media on neutrophil superoxide production was 
examined next.  Neutrophils exposed to MSU-conditioned media alone induced a 
modest, statistically insignificant increase in superoxide production compared with 
neutrophils cultured in conditioned and unconditioned media (Fig. 3.12, 0mg/mL 
MSU).  Although the maximum response to MSU was the same for all culture 
media, neutrophils stimulated with MSU in the presence of MSU-conditioned media 
were sensitised to low concentrations of MSU such that neutrophils produced more 
superoxide at significantly lower concentrations of MSU than neutrophils cultured in 
the other media (Fig. 3.12).  Hence, in the case of superoxide activity, extracellular 
signals from MSU stimulated cells appear to play a significant role in neutrophil 
priming but have no stimulatory effect alone. 
 
3.2.6 Neutrophil activation and viability in vivo 
The outcomes of the in vitro experiments indicate that if neutrophils are exposed to 
high levels of pro-inflammatory cytokines prior to contact with MSU crystals, they 
may infiltrate the site of inflammation in a primed state.  Indeed, in a mouse model 
of MSU-induced peritonitis, the administration of MSU into the peritoneum is 
associated with the production of pro-inflammatory cytokines both locally, and in 
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Figure 3.11.  Histogram comparing the effect of soluble mediators and MSU on 
neutrophil IL-8 production.  H uman neutrophils were purified from peripheral 
blood and cultured for 4h (5 x 105 cells, 500µL) with either MSU-conditioned 
media, or 200µg/mL MSU (in unconditioned media).  The production of IL-8 by 
neutrophils was detected by intracellular staining.  Results are representative of three 
separate experiments. 
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Figure 3.12.  The effect of MSU-stimulated soluble mediators on neutrophil 
superoxide production. Human neutrophils were purified from peripheral blood 
and cultured for 4h in the presence of untreated media (Unconditioned), media 
conditioned by unstimulated mononuclear cells (Conditioned), or media conditioned 
by MSU-stimulated mononuclear cells (MSU-conditioned).  Neutrophils were then 
cultured (1.5 x 105 cells, 150µL) with various concentrations of MSU in the presence 
of WST-1 (200µg/mL).  After 1h, superoxide production was measured by WST-1 
dye reduction at absorbance 450nm (A450).  Measurements were performed in 
triplicate.  Values represent mean ± S.E.M. * = P < 0.05 and *** = P < 0.001 as 
determined by Student’s t-test against the Unconditioned control at the relevant 
MSU concentration.  Results are representative of three separate experiments.  
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the serum (Figs. 5.3 and 5.16), which provides two points of exposure to neutrophil-
stimulating soluble mediators prior to direct contact with MSU.  If neutrophils are 
exposed to these mediators, then they should already show signs of activation once 
they have infiltrated into the peritoneum. 
 
To test whether neutrophils infiltrating into the peritoneum in response to MSU are 
activated and produce superoxide, mice were administered with MSU i.p. and four 
hours later, infiltrating neutrophils were tested for superoxide activity.  As a control, 
a group of mice that had been pre-treated with a subcutaneous injection of colchicine 
were included (Chia et al., 2008).  As a known inhibitor of neutrophil inflammation 
and a drug used in the treatment of gout, any reduction in neutrophil inflammation 
observed in colchicine-treated mice would represent a suppression of MSU-induced 
activation. 
 
MSU crystals induced the recruitment of neutrophils, which was greatly inhibited by 
colchicine as has been demonstrated previously (Fig. 3.13A) (Chia et al., 2008).  
More importantly, neutrophils recruited by MSU stimulation produced superoxide in 
vitro without additional ex vivo stimulation, which was inhibited by colchicine 
treatment in mice (Fig. 3.13B).  These data indicate that neutrophils recruited by 
MSU are in an activated state while in the peritoneum. 
 
In order to answer the question of whether neutrophils showed improved viability in 
the peritoneum, the viability of neutrophils over the course of an MSU response in 
vivo was tested.  The rate of neutrophil apoptosis remained steady at around 20% 
over the whole duration of the inflammatory response (Fig. 3.14).  This was 
unexpected, as high levels of cytokines in the peritoneum within the first 8h and very 
low cytokines from 8h onwards (Fig. 5.3) would have suggested a higher viability in 
the early stages of recruitment.  In addition to this, it would also be anticipated that 
contact with MSU crystals in the peritoneum would also improve neutrophil viability 
in the early stages of recruitment.  The most likely reason for the stable rate of 
apoptosis (or viability) observed, is that neutrophils were fully activated by the time 
they had infiltrated the peritoneum, and as such, 80% viability may represent the 
upper limit of neutrophil viability in gout inflammation in vivo. 
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Figure 3.13.  Production of superoxide by MSU recruited neutrophils.  Mice 
were treated with an i.p. injection of MSU (3mg, 0.5mL PBS) and 4h later, the cells 
were harvested from the peritoneum by lavage (3mL PBS).  A control group of mice 
that received a subcutaneous injection of colchicine (2mg/kg) prior to MSU 
administration were also included.  (A) Total neutrophils in the peritoneum after 4h.  
(B) The rate of superoxide production was measured by WST-1 dye reduction 
(200µg/mL) at absorbance A450 over 20mins with the rate adjusted to per 105 
neutrophils.  Data represented by three mice per group.  Values represent mean ± 
S.E.M.  * = P < 0.05 as determined by Student’s t-test. Results are representative of 
three separate experiments. 
Chapter 3: Neutrophil activation in MSU-induced inflammation 
 
103 
 
 
 
 
 
 
 
 
Figure 3.14.  Neutrophil viability over the course of the acute gout response.  
Mice were treated with an i.p. injection of MSU (3mg, 0.5mL PBS) and at various 
times over the course of the response the cells were harvested from the peritoneum 
by lavage (3mL PBS).  Neutrophil numbers (grey bars) were determined by cell 
count and Diff-Quik staining of cytospin slides.  Neutrophil apoptosis (black line) 
was determined by annexin-V/PI staining of Gr-1+, F4/80- cells.  n = 3 mice per 
group.  Values represent mean + S.E.M. 
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These in vivo results suggest that MSU-recruited neutrophils are in an activated state 
in the peritoneum, producing superoxide and are potentially at their limit of viability 
in vivo. 
 
3.3 Discussion 
As an important cell in the pathophysiology of gout, neutrophils have been the focus 
of many prior investigations that have described some of the responses of 
neutrophils to MSU including IL-8 production, the generation of ROS and an 
improvement in neutrophil viability.  My results elaborate on these prior studies by 
demonstrating that the induction of these activities can occur independently of MSU 
contact via interaction with the cellular mediators generated by MSU-induced 
inflammation. 
 
Cellular mediators were able to cause a delay in apoptosis and induce IL-8 
production in neutrophils in the absence of direct contact with MSU crystals, and the 
level of activation was greater in magnitude than that observed after direct contact 
with MSU crystals. The results of this study contradict other MSU studies that have 
assumed that these activities require direct MSU contact. In fact, the presence of 
both soluble mediators and MSU crystals together provided no further improvement 
in neutrophil viability or IL-8 production over that achieved by soluble mediator 
activation alone.  This suggests that soluble mediators play a more significant role in 
neutrophil viability and IL-8 production in gout inflammation than direct MSU 
contact.  Neutrophil viability remained steady at 80% during an MSU challenge in 
vivo (Fig. 3.14).  This appears to correlate well with the maximum viability of 
stimulated neutrophils in vitro, which was also 80% (Fig. 3.8C). 
 
Physical contact with MSU was required for the generation of superoxide by 
neutrophils.  This makes sense at a physiological level, as the premature generation 
of superoxide would cause unnecessary collateral damage to healthy body tissues if 
produced while neutrophils are in transit.  The requirement of MSU contact would 
therefore restrict the production of damaging ROS to the site of inflammatory insult.  
Nevertheless, the requirement of MSU contact for inducing superoxide production 
did not exclude a role for soluble mediators in superoxide production.  Exposure of 
neutrophils to soluble mediators had a priming effect, causing neutrophils to become 
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sensitised to MSU.  Although the maximal level of superoxide production of 
neutrophils did not change, a much lower concentration of MSU was required to 
reach the maximal level of superoxide production.  Hence, soluble mediators affect 
the intensity of the inflammatory response in the presence of small amounts of MSU. 
 
The priming of neutrophils to MSU-induced superoxide production has been 
explored in vitro previously, but that study used only purified TNFα and GM-CSF as 
priming cytokines.  The research discussed in this chapter uses inflammatory 
mediators generated directly from MSU-stimulated mononuclear cells, making the 
soluble mediators directly relevant to MSU inflammation.  I used PBMCs to model 
the production of soluble mediators by inflammatory cells.  In an in vivo response, 
the source of these cytokines is likely to be MSU-stimulated resident cells.  In fact, 
the generation of cytokines to an in vivo MSU response is explored in a later chapter 
of this thesis (Chapter 5).  Nevertheless, PBMC-generated cytokines are known to be 
associated with gout inflammation (IL-8, IL-6, TNFα, IL-1β).  Further work is still 
required to dissect the contribution of each cytokine to neutrophil priming as well as 
IL-8 production and neutrophil viability. 
 
The studies described here further revealed a previously unreported effect of human 
serum on MSU-induced superoxide production.  In the absence of serum, there was 
little background production of superoxide by neutrophils; however, the addition of 
very small levels of human serum alone (<2%) significantly increased superoxide 
production.  Background superoxide production returned to that observed in the 
absence of serum when serum levels were increased to 10%.  The effect on 
superoxide did not require autologous serum, suggesting these to be general effects 
of human serum but not FBS on neutrophil activation.  In fact, FBS inhibited 
background levels of superoxide at all concentrations of serum tested.  This suggests 
that the stimulatory effect of human serum is not a universal feature of all sera.  The 
observed changes in serum-induced superoxide production were partially mediated 
by proteins that were heat labile (56°C, 30mins), which may include complement 
proteins that are known to be inactivated by this treatment.   It is possible that the 
response of neutrophils to low serum is a sensing mechanism to indicate movement 
from the high serum transit environment of the blood to the low serum environment 
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of the inflammatory site such as the peritoneum or joint.  In this way, a low serum 
environment may be a non-specific activating trigger for neutrophils to produce 
superoxide. 
 
There may be two ways to stimulate the production of superoxide from human 
neutrophils: exposure to a low serum environment; and direct stimulation with MSU.  
It seems that physiologically this system has “covered its bases” whereby the 
production of neutrophil superoxide is certain following recruitment to an inflamed 
tissue.  Ultimately, the observed effect is high superoxide output regardless of 
whether it is serum or MSU mediated. 
 
The effects of serum on MSU-induced neutrophil superoxide imply that the 
contribution of serum components to neutrophil activation is a novel finding.  
Previous studies investigating the effects of serum on MSU inflammation used very 
different approaches.  For instance, a previous study by Terkeltaub et al. showed that 
MSU crystals that had been pre-coated with serum proteins elicited a diminished 
superoxide response in neutrophils compared with uncoated MSU.  This reduced 
response was due to apolipoprotein B coating the surface of crystals (Terkeltaub et 
al., 1984).  Indeed, this area is not well studied, and as such, further investigations 
into the effects of serum on neutrophil function to MSU in vivo are required to 
understand the true mechanisms at play during gouty disease. 
 
The alterations to neutrophil responsiveness by soluble mediators serve as a caveat 
to studying responses from neutrophils purified from individuals not undergoing an 
inflammatory response.  Neutrophils from healthy individuals have received no 
priming or activating signals prior to exposure to MSU in vitro whereas neutrophils 
that have been recruited to a site of inflammation such as a joint will have received 
inflammatory signals that alter the responsiveness of those neutrophils when they 
finally make contact with MSU.  Hence, neutrophils during gouty attacks and 
neutrophils under homeostatic conditions represent different starting points as far as 
a subsequent MSU challenge is concerned.  As the use of human peripheral blood 
neutrophils is a routine practice, it is important to recognise these limitations. 
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Figure 3.15.  Proposed model of neutrophil activation in gout.   MSU crystals 
stimulate local cells in the joint to produce a number of pro-inflammatory cytokines 
that stimulate the recruitment of neutrophils to produce IL-8 (augmenting further 
neutrophil recruitment).  Exposure to cytokines in the joint also leads to a delay in 
neutrophil apoptosis and to neutrophils being primed to produce superoxide (green).  
Neutrophils infiltrating the joint space receive at least two additional stimuli to 
produce superoxide: sensitised neutrophils produce superoxide on contact with MSU 
(yellow), and/or they are stimulated to produce superoxide as a result of moving to a 
potentially low serum environment (yellow). 
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The results presented in this chapter suggest an alternative model of neutrophil 
activation in gout that incorporates the effects of serum and soluble mediators as 
depicted in Figure 3.15.  After the formation of MSU crystals, resident cells produce 
cytokines and chemokines that stimulate neutrophils and cause them to delay 
apoptosis, produce IL-8 and become primed to produce superoxide, all before 
making contact with MSU.  These factors work together to amplify neutrophil 
numbers through recruitment (e.g. through IL-8 related activites) and allow their 
accumulation (due to an extended lifespan).  Neutrophils recruited to the joint 
produce large amounts of superoxide, either on contact with small quantities of 
MSU, and/or producing superoxide spontaneously as a result of movement from the 
high serum environment of the blood to the potentially low serum environment of 
the joint.  Together these events allow for the neutrophil rich inflammatory 
environment observed during an MSU inflammatory attack. 
 
In summary, these results indicate that activation of neutrophils in gout is not simply 
initiated by contact of neutrophils with MSU crystals: activation begins prior to 
MSU contact through soluble mediators and low serum effects.  Soluble mediators 
stimulate IL-8 production and cause a delay in neutrophil apoptosis.  While they do 
not stimulate the release of superoxide, they heavily affect the magnitude of the 
response by exerting a priming effect.  Low human serum conditions are able to 
stimulate the production of large amounts of superoxide even in the absence of MSU 
crystals.  These findings highlight previously unreported pathways of neutrophil 
activation in gout that do not require contact with MSU and are likely to play a 
significant role in gout inflammation. 
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Chapter 4 
Inhibiting neutrophil inflammation 
using sesquiterpene dialdehydes 
 
4.1 Introduction 
Polygodial is a sesquiterpene dialdehyde that is an active component in Horopito 
(Pseudowintera colorata), a native medicinal plant in New Zealand; and in Winter’s 
Bark (Drymis winteri), a medicinal plant used in South America (Morton, 1981, 
McCallion et al., 1982).  These plants have been used traditionally to treat a number 
of symptoms including stomach pain, allergy, bronchitis and inflammation. 
 
A number of studies have explored the antifeedant (Kubo and Ganjian, 1981), 
antifungal (Kubo et al., 2001 ), and antinociceptive properties of polygodial (Mendes 
et al., 2000); however, only one study has extensively explored polygodial as an 
anti-inflammatory.  In this study, polygodial inhibited both swelling and leukocyte 
infiltration in mouse models of oedema and pleurisy using a number of pro-
inflammatory stimuli (da Cunha et al., 2001). The broad range of anti-inflammatory 
activities highlighted polygodial as a promising compound for further investigation 
and potential development as an anti-inflammatory drug with broad applicability.  
To date the effect of polygodial on cellular function in the context of inflammation 
or acute gouty inflammation has not been investigated. 
 
4.1.1 Neutrophil infiltration and superoxide production in gouty inflammation 
Neutrophil recruitment is a key feature of gouty inflammation (Phelps and McCarty, 
1966).  Once recruited, neutrophils become activated and produce superoxide that is 
converted to other more destructive ROS (Section 1.10.7.4).  Therefore, I 
investigated the potential of polygodial to block MSU-induced superoxide 
production by neutrophils as a novel therapeutic approach for treating gout, with 
possible application to other neutrophil-driven inflammatory conditions. To gain 
insight into the structural features required for inhibition, the anti-inflammatory 
activity of polygodial was compared against a group of structurally-related 
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Figure 4.1 Sesquiterpene compound structures
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compounds, shown in Figure 4.1. The outcomes of this study provide basic 
information on the structure-function relationship of these compounds with a view to 
develop a more potent compound that can be used in neutrophil-based inflammatory 
diseases such as gout. 
 
4.2 Results 
4.2.1 Inhibition of neutrophil superoxide production by sesquiterpene 
dialdehydes 
Neutrophils can be activated to produce superoxide by a variety of different 
inflammatory stimuli.  To determine the ability of the sesquiterpenes to inhibit 
neutrophil superoxide production, the compounds were tested in human neutrophil 
cultures treated with either phorbol myristate acetate (PMA) or the gout-causing 
inflammatory stimulus MSU. 
 
PMA activates superoxide production by directly activating intracellular protein 
kinase C, thus representing a non-specific induction of superoxide production 
(Blumberg, 1988).  PMA stimulation therefore provides information on the anti-
inflammatory capacity of the compounds in general.  MSU activation of neutrophils, 
although not clearly understood, is known to be associated with microtubule 
stabilisation (Chia et al., 2008) and was used to provide a more physiologically 
relevant measure of superoxide production and inhibition. 
 
4.2.2 Structure-activity related inhibition of PMA-induced superoxide 
production 
As shown in Table 4.1, Polygodial (Compound 1) exhibited a concentration-
dependent inhibition of superoxide production by neutrophils stimulated with PMA 
with an IC50 value of 0.16µM. The introduction of methyl and alcohol functionalties 
to ring A of the polygodial structure and exchanging the dimethyl in ring A for an 
ethylene group (Compound 2) caused only a minor decrease in anti-inflammatory 
activity. Notably, the presence of a large cinnamate ester group (Compound 3) 
resulted in a 27-fold decrease in the anti-inflammatory activity compared to 
Compound 2.  This suggested that steric hindrance from the large ester group around 
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Table 4.1 IC50 values of sesquiterpene compounds based on PMA- and MSU-
stimulated superoxide production by neutrophils.  Human neutrophils were 
purified from peripheral blood, suspended in HBSS (105 neutrophils/well; 100µL 
HBSS) and incubated in the presence of the sesquiterpene compounds.  Neutrophils 
were stimulated with 0.2µg/mL PMA for 30 minutes or with 200µg/mL MSU for 1h 
and the production of superoxide measured by WST-1 dye reduction.  IC50 values 
were calculated from the dose response curves.  Results are a combination of IC50 
values from three separate experiments, where PMA IC50 values are a combination 
of 2 experiments from E. Chia and one from the W. Martin; and MSU IC50 values 
were by experiments from the W. Martin alone.  Values represent mean ± SEM. 
Compound PMA MSU
1 0.16 ± 0.13 0.78 ± 0.53
2 0.39 ± 0.07 0.82 ± 0.24
3 4.37 ± 1.39 2.00 ± 0.58
4 0.50 ± 0.22 1.07 ± 0.04
5 3.53 ± 2.56 7.49 ± 2.31
6 3.68 ± 1.21 5.84 ± 1.72
7 406 ± 23.7 n.d.
 IC50 values (!M) for O
-
2 production
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the dialdehyde functionalities may have been the cause for loss of activity.  
Surprisingly, loss of inhibition observed for Compound 3 was ‘rescued’ by the 
introduction of an alcohol group to ring B (Compound 4) suggesting that the addition 
of the alcohol group overcomes the steric hindrance of the cinnamate group possibly 
by providing an alternative/additional active site or altering the conformation of the 
cinnamate group to free up the reactive aldehyde groups. 
 
The importance of dialdehyde functionalities for activity was tested by using paxidal 
dimethyl acetal (Compound 7). Loss of the dialdehyde functionalities resulted in a 
93-fold decrease in anti-inflammatory activity compared to Compound 3 confirming 
that the majority of the inhibitory activity of the compounds was associated with the 
dialdehyde groups. 
 
The presence of the ring dilaldehydes alone was shown to be sufficient to inhibit 
neutrophil superoxide production. The absence of ring A from (Compound 5) 
resulted in a 22 fold loss of anti-inflammatory activity compared to polygodial and 
10 fold loss compared to Compound 2.  A similar loss in activity was also observed 
for the aromatic dialdehyde (Compound 6). Together these data indicated that both 
the dialdehyde and the A ring contribute to the inhibitory effect of this group of 
compounds.   
 
4.2.3 Structure-activity related inhibition of MSU-induced superoxide 
production 
After confirming that dialdehyde-containing compounds suppressed superoxide 
production by neutrophils stimulated with PMA, I sought to determine if these 
compounds could also inhibit neutrophil superoxide production induced by MSU 
crystals. As shown in Table 4.1 polygodial was less effective at inhibiting MSU-
induced compared with PMA-induced superoxide production.  In general all of the 
compounds tested were only slightly weaker inhibitors of MSU-induced superoxide 
production compared to PMA, the one exception being Compound 3, which 
exhibited slightly better inhibition of MSU-induced inflammation.  The comparable 
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pattern of inhibitory activity observed for PMA and MSU-induced superoxide 
production indicated that the compounds were likely blocking superoxide production 
via the same, as yet unknown, pathway. 
 
4.2.4 Cytotoxic activity of sesquiterpene dialdehydes 
To exclude the possibility that the anti-inflammatory effect exhibited by the 
compounds was not simply the result of cell death, the active compounds were 
tested for possible cytotoxic effects on neutrophils.  Isolated human neutrophils 
were treated with the compounds for 30 minutes, and cell viability determined by 
trypan blue exclusion. With the exception of Compound 3, none of the compounds 
tested were cytotoxic at the concentrations required for anti-inflammatory activity 
indicating that the inhibitory activity observed was not due to cytotoxicity (Fig. 4.2). 
 
Although no cell death occurred at concentrations required for anti-inflammatory 
activity, some cell death was observed at higher concentrations.  To determine which 
pathway was being activated, apoptosis or necrosis, the highest compound dose was 
used from the above 30 minute assay to induce cell death in neutrophils, with an 
extended length of exposure to four hours to allow for the expression of markers to 
indicate the mode of cell death.  Cells were then stained with annexin-V/PI.   As 
shown in Figure 4.3, exposure to 10µM of each compound caused an increase in the 
annexin-V+/PI- cells, showing that the compounds induced apoptosis, rather than 
necrosis, in neutrophils. 
 
After four hours, all of the compounds triggered concentration-dependent apoptosis 
of neutrophils with the concentrations required to observe 50% cell death (Toxic 
concentration 50%, TC50) are shown with IC50 values in Table 4.2.  Interestingly, 
lower anti-inflammatory activity  was associated with high cell toxicity (Compounds 
3, 5 and 6), whereas compounds with high anti-inflammatory activity displayed 
significantly lower toxicity (Compounds 1, 2 and 4).  This is illustrated when IC50 
values are shown as a ratio of TC50 values in which high ratios indicated high anti-
inflammatory activity (Table 4.2).  These results indicate that the structural 
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Figure 4.2 The effect of sesquiterpene compounds on neutrophil viability after 
30 minutes.  Human neutrophils were isolated from peripheral blood and cultured in 
HBSS (5 x 105 cells, 500µL) in the presence of various concentrations (0.1 to 20µM) 
of the sesquiterpene compounds.  After 30 mins neutrophil viability was determined 
by trypan blue exclusion.  Values were determined from duplicates.  Results 
represent mean ± S.E.M.  Results are representative of three separate experiments. 
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Figure 4.3 The effect of sesquiterpene compounds on neutrophil apoptosis.  Human neutrophils were isolated from peripheral blood and 
cultured in RPMI-1640 (10% human serum)(5 x 105 cells, 500µL) in the presence of sesquiterpene compounds (10µM).  After 4h neutrophil 
viability was determined by Annexin-V/PI staining.  Results are representative of three separate experiments. 
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IC50  [PMA]
!M
1 0.16 >20 >125
2 0.39 17.5 45
3 4.37 10 2
4 0.5 >20 >40
5 3.53 14 4
6 3.68 14.5 4
IC50 [MSU]
!M
1 0.78 >20 >26
2 0.82 17.5 21
3 2 10 5
4 1.07 >20 >19
5 7.49 14 2
6 5.84 14.5 2
Compound
Compound
TC50 [TC50/IC50]
TC50 [TC50/IC50]
 
 
 
Table 4.2 A comparison of sesquiterpene IC50 values for neutrophil superoxide 
production with sesquiterpene TC50 values.  [TC50/IC50] values represent a ratio 
between the TC50 (50% Toxicity Concentration) and IC50 (50% Inhibition 
Concentration) values, with high values representing high anti-inflammatory activity 
and low toxicity.  The values shown in blue represent the minimum value that could 
be calculated from the TC50 values available. 
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components that improve anti-inflammatory activity may also abrogate cytotoxic 
effects.  
 
In summary, the data presented here confirm that the sesquiterpene dialdehyde 
compounds inhibit superoxide production rather than induce cell death. In addition, 
the presence of the dimethyl functionality on Polygodial on ring A, and the presence 
of an alcohol group on either ring A (Compound 2) or ring B (Compound 4) appears 
not only to increase anti-inflammatory activity, but lower cytotoxicity as well. 
 
4.2.5 Inhibition of neutrophil superoxide production in vivo 
Acute gouty arthritis is characterised by the recruitment and activation of 
neutrophils, and the production of superoxide, in response to the known 
inflammatory stimulus MSU.  A peritoneal model of gouty arthritis was used to 
determine whether the in vitro anti-inflammatory activity of the compounds 
translated into an inhibitory effect in vivo.  Compounds polygodial, Compound 2 and 
Compound 4 were selected for in vivo testing on the basis of their high anti-
inflammatory activity and low cytotoxic activity in vitro (Table 4.2).  These 
compounds were tested in vivo in a peritoneal model of gouty inflammation and 
assessed for their efficacy at inhibiting both neutrophil recruitment and neutrophil 
superoxide production by infiltrating neutrophils. 
 
Polygodial has been shown previously by others in our lab to inhibit both neutrophil 
infiltration and superoxide production in vivo at a dose of 25.6µmol/kg.  Therefore, 
polygodial was used as a positive control to compare the activity of Compound 2 
and Compound 4. Compound 4 exhibited dose-dependent inhibition of both 
neutrophil infiltration (Fig. 4.4A) and superoxide production (Fig. 4.4C) in vivo. 
Despite a clear trend, Compound 2 did not significantly inhibit neutrophil infiltration 
(Fig. 4.4B), however, Compound 2 exhibited significant inhibition of superoxide 
production (Fig. 4.4D).  
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Figure 4.4 The effect of sesquiterpene compounds on neutrophil inflammation 
in vivo.  Mice were treated with an i.p. injection of the sesquiterpene compounds, 
25.6µmol/kg of polygodial, or with 50µL of DMSO (control) and then administered 
with an i.p. injection of MSU (3mg, 0.5mL).  4h later the peritoneal exudate cells 
were collected by lavage (3mL PBS, heparin).  Cell counts and cytospin differentials 
were used to determine neutrophil infiltration of mice treated with (A) Compound 4 
and (B) Compound 2.  WST-1 dye reduction was followed over 20 mins at 
absorbance 450nm as a measure of superoxide production by neutrophils from mice 
treated with (C) Compound 4 and (D) Compound 2.  Mice that received no 
compound nor MSU (naïve) were included as negative controls.  Measurements are 
the result of five mice per group.  Values represent mean + S.E.M. * = P < 0.05 and 
*** = P < 0.001 compared with the control group as determined by Tukey multiple 
comparisons test. Results are representative of at least two separate experiments.  
Experiments carried out by E. Chia and figure produced by the W. Martin. 
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These in vivo studies showed that  Compound 2 and Compound 4 had comparable 
or greater anti-inflammatory activity than polygodial in vivo and of the three 
compounds tested, Compound 4 had the greatest effect on neutrophil infiltration 
(Fig. 4.4B), while polygodial and Compound 2 had similarly high inhibitory activity 
on superoxide production at doses near 20µmol/kg (Fig. 4.4C). 
 
4.2.6 Additional anti-inflammatory activities of sesquiterpene dialadehyde 
compounds 
One of the interesting findings from the in vivo experiments was the ability of the 
anti-inflammatory compounds to block MSU-induced neutrophil recruitment. 
Although polygodial has previously been shown to inhibit leukoctye recruitment in 
pleurisy models there has been no work undertaken to determine the mechanism for 
this inhibitory effect. Therefore, I sought to explore whether the compounds were 
able to affect the function of other cells known to be involved in neutrophil 
recruitment in MSU-induced inflammation. 
 
4.2.6.1 Sesquiterpene dialdehydes compounds inhibit superoxide production 
by endothelial cells 
Superoxide can be produced by a variety of cells that utilise different isoforms of 
NADPH oxidase (Nox 1-4) depending on the cell and tissue type and the size of the 
response required. For example the neutrophil isoform of NADPH oxidase, 
otherwise known as Nox2, is responsible for the production of high levels of 
superoxide required for host defense (Section 3.1).  However, other isoforms of 
NADPH oxidase are known to produce much lower levels of superoxide.  Vascular 
endothelial cells express the NADPH oxidase isofoms Nox4, which, instead of 
producing superoxide as an anti-microbial molecule, produce superoxide that 
functions as an intracellular signal (Ago et al., 2004).  Inhibition of NADPH oxidase 
on vascular endothelial cells has been shown to inhibit the adherence of leukocytes to 
endothelial cells in culture, thereby blocking the recruitment of leukocytes in vivo. 
MSU crystals have been shown to stimulate the production of superoxide from 
endothelial cells (Falasca et al., 1993), therefore, the inhibition of vascular isoforms 
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of NADPH oxidase during an inflammatory response could be contributing to the 
inhibition of neutrophil recruitment by the compounds in vivo. 
 
To determine if the compounds were able to inhibit superoxide production by 
epithelial cells, luminol chemiluminescence was used to measure NADPH oxidase 
activity in human vascular endothelial cell (HUVEC) cultures. Superoxide production 
was stimulated in HUVECs by reducing the amount of serum in the culture medium 
to 0.5%.  This led to the production of large amounts superoxide compared with the 
normal culture conditions of 10% serum (Fig. 4.5A). To confirm that the production 
of superoxide was dependent on NADPH oxidase, HUVECs in 0.5% serum were 
cultured with the inhibitor diphenyleneiodonium sulfate (DPI).  DPI is an inhibitor 
of flavin-containing enzymes such as NADPH oxidase, but does not inhibit the 
activity of non-flavin containing enzymes capable of ROS generation, such as 
xanthine oxidase (Cross and Jones, 1986).  DPI inhibited superoxide production in a 
concentration-dependent manner confirming that the production of superoxide by 
HUVECs was likely due to NADPH oxidase activity, rather than other ROS sources 
(Fig. 4.5B). 
 
All of the compounds inhibited the production of superoxide from HUVEC cells 
with IC50 values ranging from 2.5 to 8.4µM (Fig. 4.6).  Similar to the inhibition of 
neutrophil NADPH oxidase, Compounds 2 and 4 showed the highest inhibitory 
activity. This result indicated that the inhibition of superoxide production by 
vascular cells may be a possible mechanism for the inhibition of neutrophil 
infiltration in vivo.  However, a higher specificity for neutrophil NADPH oxidase is 
indicated when the IC50 values of HUVECs are compared with those of neutrophils, 
the high ratio showing that a higher concentration of compound is required to inhibit 
the HUVEC oxidase (Table 4.3) 
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Figure 4.5 The effect of serum on superoxide production from HUVECs.  A. 
HUVECs were cultured in the presence of various concentrations of fetal calf serum 
and the production of superoxide measured by luminol enhanced 
chemiluminescence.  B. HUVECs were cultured in the presence of 0.5% serum in 
the presence of the NADPH oxidase inhibitor DPI.  Measurements were performed 
in triplicate.  Values represent mean + S.E.M.  Results are representative of three 
separate experiments. 
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Figure 4.6 The effect of sesquiterpene compounds on superoxide production by 
HUVECs.  HUVECs were cultured in 0.5% serum in the presence of sesquiterpene 
compounds and the production of superoxide measured by luminol enhanced 
chemiluminescence. Measurements were performed in triplicate.  Values represent 
mean + S.E.M.  Results are representative of two separate experiments. 
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Table 4.3 Comparison of IC50 values of the sesquiterpene compounds from 
HUVEC superoxide production, with IC50 values from PMA- and MSU-
stimulated neutrophil production. 
HUVEC 
    IC50    IC50/IC50 PMA IC50/IC50 MSU
1 6.5 41.9 8.3
2 2.5 6.4 3.1
3 8.4 1.9 4.2
4 4.1 8.2 3.8
5 5.2 1.5 0.7
6 7.5 2.0 1.3
HUVEC IC50/Neutrophil IC50
Compound
(µM)
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4.2.6.2 Sesquiterpene dialdehyde compounds inhibit proinflammatory 
cytokine production in MSU-stimulated macrophages 
Macrophages are important inflammatory cells that produce large amounts of 
cytokines and chemokines in response to inflammatory stimuli (Section 1.10.11).  As 
discussed in Chapter 3, inflammatory mediators play a key role in the recruitment 
and activation of neutrophils in MSU-induced inflammation.  Therefore, I asked 
whether these compounds could inhibit MSU-induced macrophage activation that 
could contribute to the inhibition of neutrophil infiltration in vivo. To determine if 
the compounds were able to inhibit macrophages stimulated with MSU, RAW 264.7 
macrophage cells were exposed to MSU in the presence of the compounds, and the 
cytokines TNFα and IL-6 used as measurements of inflammation. 
 
Due to poor aqueous solubility the compounds had to be dissolved in the organic 
solvent dimethyl sulfoxide (DMSO).  Possible non-specific effects of DMSO upon 
RAW 264.7 cells were determined by activating RAW 264.7 cells with MSU in the 
presence of different concentrations of DMSO.   Concentrations of DMSO above 
0.0125% inhibited MSU-induced TNFα production, whereas IL-6 production was 
unaffected by concentrations up to 0.05% (Fig. 4.7).  To avoid complications with 
higher DMSO levels, compounds were dissolved in 0.01% DMSO which, due to low 
compound solubilities, restricted the compound concentrations in the assay to 1µM. 
 
As shown in Figure 4.8A, only Compound 3 and Compound 6 inhibited TNFα 
production by RAW 264.7 cells in vitro, whereas all the compounds, except 
Compound 6, inhibited IL-6 production to some extent, with Compound 2 exhibiting 
the greatest inhibitory effect (Fig. 4.8B).  Although these compounds appear to alter 
the response of macrophages to MSU there was no obvious dose-dependent pattern 
of inhibition. As a result it is impossible to conclude whether or not the inhibition of 
MSU-induced neutrophil infiltration in vivo by polygodial and Compounds 2 and 4 
(Fig. 4.4) might be linked to the inhibition of MSU-induced activation of 
macrophages.  
Chapter 4:  Inhibiting neutrophil inflammation using sesquiterpene dialdehydes 
 
127 
 
4.3 Summary and Conclusion 
Polygodial has been shown to exert an inflammatory effect in a number of models of 
inflammation although a cellular basis for the anti-inflammatory activity was not 
explored in these models.  The results presented in this chapter show that neutrophils 
are a target of polygodial anti-inflammatory activity and that this activity is also 
observed in additional sesquiterpene dialdehydes in this study.  The sesquiterpene 
dialdehydes inhibit both PMA and MSU induced superoxide production in vitro.  
This inhibitory activity was largely dependent on the dialdehyde groups but was 
further enhanced with the presence of ring hydroxyl groups.  Interestingly, removal 
of ring hydroxyl groups caused an increase in cytotoxicity suggesting that the 
hydroxyl groups have a dual effect of increasing inhibitory activity while preventing 
cytotoxicity.  
 
The inhibitory activity observed in vitro was also observed in vivo with selected 
sesquiterpenes inhibiting neutrophil superoxide production.  These compounds also 
had the unexpected effect of inhibiting neutrophil infiltration.  Although it is 
unknown why the inhibition of neutrophil superoxide production may also affect 
neutrophil infiltration, the compounds were also shown to inhibit superoxide 
production on vascular cells: a process that is involved in neutrophil recruitment.  
Hence it is possible that inhibition of superoxide production by vascular cells may 
play a role in the inhibition of neutrophil infiltration. 
 
It is also possible that the sesquiterpenes may be having an effect on neutrophil 
recruitment through influencing macrophage activation.  Although a clear pattern 
relating chemical structure to the effects on RAW 264.7 cytokine production could 
not be established, nevertheless the compounds were able to affect the production of 
IL-6 and TNFα from MSU-stimulated RAW 264.7 cells further indicating that there 
are secondary effects of polygodial and the sesquiterpene dialadehydes on cells other 
than neutrophils. 
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Figure 4.7 The effect of DMSO on MSU-stimulated cytokine production.  RAW 
264.7 cells were cultured with 200µg/mL MSU in vitro for 24h in the presence of 
different concentrations of DMSO.  The production of TNFα and IL-6 were 
measured in the supernatants by ELISA.  Measurements were performed in triplicate 
and values represent mean + S.E.M.  Results are representative of three separate 
experiments. 
Chapter 4:  Inhibiting neutrophil inflammation using sesquiterpene dialdehydes 
 
129 
 
 
Figure 4.8 The effect of sesquiterpene compounds on MSU-stimulated cytokine 
production.  RAW 264.7 cells were cultured with 200µg/mL MSU in vitro for 24h 
in the presence of different concentrations of sesquiterpene compounds.  The 
production of (A) TNFα and (B) IL-6 were measured in the supernatants by ELISA.  
Values within each experiment were normalised to the concentration of TNFα or IL-
6 produced in the presence of MSU and no sesquiterpene compound.  Values for 
three separate experiments were combined to give the above results.  Measurement 
in each experiment were performed in triplicate and values above represent mean ± 
S.E.M.
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The anti-inflammatory effect of sesquiterpene dialdehydes on both neutrophil 
infiltration and neutrophil activation identifies the clear potential for further study of 
these compounds as promising candidates for development as anti-inflammatory 
drugs for the treatment neutrophil-driven disease.  Indeed, these results clearly 
indicate that these compounds are able to inhibit MSU-induced neutrophilia, 
immediately identifying acute gout as a possible disease target for the therapeutic 
development of these compounds. 
 
The wide range of inflammatory effects of sesquiterpene dialdehydes leads to the 
question of how these compounds may be exerting their effect on a molecular level.  
Unfortunately, there is little information in the literature to give a clear indication of 
the mode of action of these compounds as anti-inflammatories.  However, there does 
appear to be an indication that dialdehydes such as polygodial bind to thiol groups 
on proteins (Jansen and de Groot, 2004).  If this is the case, then it is entirely 
possible that sesquiterpene dialdehydes accomplish a wide range of activities by 
reacting with more than one thiol-containing protein or enzyme.  Whether proteins 
other than NADPH oxidase are additional targets for these compounds is a subject 
for future research. 
 
In summary, polygodial and the other sesquiterpene dialdehyde compounds showed 
a number of anti-inflammatory activities including the inhibition of neutrophil 
superoxide production that translated into an in vivo model of gout.  The activity of 
polygodial could be improved as shown by Compounds 2 and 4, making them 
favourable candidates for drug development for use in gout and other neutrophil 
based inflammatory diseases. 
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Chapter 5 
Macrophages in the initiation of acute 
gout 
  
5.1 Introduction 
Early inflammation in acute gout is associated with the production of pro-
inflammatory cytokines (IL-6, TNFα, IL-1β) and a neutrophil-rich cellular 
infiltration (Di Giovine et al., 1987, Guerne et al., 1989, di Giovine et al., 1991, 
Schiltz et al., 2002). A number of cell types have been proposed to be orchestrators 
in the inflammatory events that surround gouty attacks; including monocytes, mast 
cells, and epithelial cells.   
 
Previous in vitro and ex vivo studies have implicated monocytes as key cells 
involved in the inflammatory phase of gouty inflammation, whilst claiming 
macrophages as raising anti-inflammatory responses to MSU stimulation.  The 
results of these studies were based on immortalised cell lines expressing monocyte-
like and macrophage-like phenotypes that were exposed to MSU in vitro.  
Monocytes were shown to produce pro-inflammatory cytokines such as TNFα, IL-6 
in response to MSU crystals whereas macrophage cultures failed to produce TNFα 
and IL-6, indicating a possible non-inflammatory response to MSU that could be 
associated with resolution of inflammation (Yagnik et al., 2000). 
  
A similar pattern of monocyte pro-inflammatory responses and macrophage anti-
inflammatory responses has also been reported in studies using human CD14+ 
monocytes that had been purified from peripheral blood and then differentiated into 
macrophages in vitro.  Freshly isolated monocytes produced TNFα and IL-1β in 
response to MSU stimulation in vitro; whilst monocytes that had been differentiated 
into macrophages and then exposed to MSU ‘switched’ from producing TNFα and 
IL-1β, to producing TGFβ, an ‘anti-inflammatory’ cytokine commonly linked to 
resolution of inflammation (Yagnik et al., 2004).  Isolated cellular infiltrates from 
catharidin-induced blisters in humans have also shown a switch to TGFβ production 
Chapter 5: Macrophages in the initiation of acute gouty inflammation 
 
133 
following restimulation of 16 hour and 48 hour infiltrates with MSU ex vivo (Yagnik 
et al., 2004).  
 
Together, these results have led to the hypothesis that, in an acute gout attack, 
monocytes drive the inflammatory phase of the response while differentiated 
macrophages mediate its resolution. However there are limitations associated with 
these studies due to the artificial nature of the in vitro models used. In addition, 
despite indications of switching to TGFβ production in human inflammation the 
source of cytokine production was not identified and the monocyte/macrophage 
phenotypes were not characterised.  Therefore, more thorough studies are required to 
establish which monocyte/macrophage phenotypes are specifically responsible for 
cytokine production in the context of MSU-induced inflammation in vivo. 
 
In addition to the limitations associated with the studies described above, more 
recent literature now indicates a possible pro-inflammatory role for macrophages in 
gouty inflammation. Macrophages treated with MSU have been reported to induce 
pro-inflammatory cytokines such as IL-1β where signalling through the IL-1 
receptor is required to activate non-hemopoietic cells to induce neutrophil infiltration 
(Chen et al., 2006, Martinon et al., 2006), a key component in gouty inflammation 
(Phelps and McCarty, 1966).  Other pro-inflammatory activities such as the increase 
of TNFα, MCP-1, IL-18, iNOS and the upregulation of TREM-1 on macrophages 
points to a potential involvement of this cell type in gout (Jaramillo et al., 2004b, 
Jaramillo et al., 2004a, Chen et al., 2006, Martinon et al., 2006, Murakami et al., 
2006). This would be consistent with other acute inflammatory conditions that rely 
heavily on macrophages in the onset of inflammation (Knudsen et al., 2002, Cailhier 
et al., 2005). 
 
Although both macrophages and monocytes appear to produce pro-inflammatory 
cytokines (IL-1β, IL-6, TNFα) following in vitro stimulation with MSU, these 
activities have not been confirmed in an in vivo model of gout.  This would be an 
important step towards understanding the behaviour of these cells in vivo as the local 
inflammatory environment heavily influences the functional phenotype of 
monocytes and macrophages (Stout and Suttles, 2004).  Hence, the in vitro 
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experiments based on the stimulation of murine cell lines and differentiating CD14+ 
human monocytes may not adequately simulate the complex in vivo conditions that 
are likely to influence both the development and the response of these cells during a 
gouty inflammatory response.  In addition, blister exudates recruited in response to 
an irritant that is physiologically irrelevant to gout may represent inflammation and 
cell profiles that have very little to do with those induced by MSU crystals.   
 
These considerations identify a requirement for further investigation into the role of 
mononuclear phagocytes in initiation and progression of gouty inflammation in vivo.  
In vivo studies using MSU as the inducing factor, and distinguishing between the 
different cell types and various phenotypes of mononuclear phagocyte populations 
over the course of the inflammatory response would provide a more accurate 
depiction of the function of these cells in the context of gouty arthritis. 
 
This chapter therefore addresses these issues using a murine peritoneal model of 
acute gout.  Using this model I sought to identify the responses of monocytes and 
macrophages during an inflammatory response to MSU, specifically the contribution 
these cells make to the early phase of gouty inflammation.  
 
5.2 Results 
 
5.2.1 Characterising the murine peritoneal model of acute gout. 
Since no study had previously examined the role of monocytes and macrophages in 
gout in vivo, a combination of surface markers was sought to clearly distinguish 
monocytes from macrophages during MSU-induced inflammation.   
 
To identify different cell populations, peritoneal leukocytes were harvested from 
mice that had been treated with MSU for four hours and were stained for the 
macrophage differentiation marker F4/80 and the myeloid differentiation antigens 
Gr-1 and clone 7/4 antigen (Fig. 5.2).  Monocytes and neutrophils both expressed 
Gr-1 and 7/4, but were distinguishable by their different levels of expression.  
Neutrophils were identified as 7/4+,Gr-1hi (Fig. 5.1A, gate R1) and monocytes as 
7/4+,Gr-1int (Fig. 5.1A, gate R2) expressing low levels of F4/80 (Fig. 5.1B, gate R3). 
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Figure 5.1 Identification of cell types involved in the MSU crystal response in 
vivo.   Mice were treated with MSU crystals i.p. (3mg, 0.5mL PBS). After 4 hours 
peritoneal cells were harvested by lavage (3mL, PBS) and the cell types identified by 
flow cytometry. (A) Neutrophils were identified as Gr-1hi, 7/4+ (Gate R1) while 
monocytes were Gr-1int, 7/4+ (A)(Gate R2) and F4/80lo (Gate R3)(B). (C) F4/80hi 
resident macrophages (Gate R4) were identified in untreated mice.  Results are 
representative of three separate experiments. 
Gr-1
7
/4
 Gr-1
F
4
/8
0
 Gr-1
F
4
/8
0
 
A B C 
R4 
R3 
R2 
R1 
Chapter 5: Macrophages in the initiation of acute gouty inflammation 
 
136 
Given that the mouse peritoneum in C57/BL6 mice is known to consist of 50-80% 
resident peritoneal macrophages, peritoneal cells were harvested from naïve mice 
and stained with the same markers to distinguish macrophages in this model.  
Resident macrophages had quite a distinctive staining, expressing much higher levels 
of F4/80 than monocytes while lacking expression of both Gr-1 and 7/4 (Fig. 5.1C, 
gate R4). 
 
To establish conclusively that the staining protocol was identifying the correct cell 
types, the above populations were sorted and the different cell types observed 
morphologically. Cells that were 7/4+,Gr-1hi were confirmed as neutrophils, having 
nuclei with a “string” like appearance typical of polymorphonuclear cells (Fig. 
5.2A); while 7/4+/Gr-1int  cells were monocytes, containing a more “bean” shaped 
nucleus (Fig. 5.2B).  Interestingly, monocytes isolated during the early response 
were quite morphologically distinct from the sorted F4/80hi resident macrophages, 
which had a larger cytoplasm and more rounded nuclei (Fig. 5.2C).  These 
morphological observations confirmed the correct identification of the appropriate 
cell types of interest using expression of F4/80, Gr-1 and 7/4. 
 
Using this method of distinguishing the cell types of interest, leukocyte infiltration 
and the production of pro-inflammatory cytokines (IL-1β, IL-6, MCP-1 and TNFα) 
was followed over 72 hours in order to establish the acute inflammatory profile of 
peritoneal inflammation in response to MSU.  MSU induced a large cellular 
infiltration that peaked at 16h after MSU administration (Fig. 5.3A).  Cellular 
infiltrate was largely comprised of monocytes and neutrophils, both of which peaked 
at 16 hours after MSU administration (Fig. 5.3B).  Neutrophil infiltration was 
notably faster and larger in number than that of monocytes.  Cytokine analysis of the 
PBS lavage fluid revealed that IL-6, IL-1β and TNFα levels were elevated in the 
peritoneum of MSU-treated mice within 2 hours of MSU administration, peaking at 
four hours for all four cytokines (Fig. 5.3C).  The inflammatory response was self-
limiting with leukocyte cell numbers and cytokine levels returning to normal within 
48 hours.  (For a more comprehensive breakdown of cell types in the peritoneum 
during the response to MSU, see Table 5.1). 
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Figure 5.2 Morphology of cells expressing the myeloid antigens 7/4 and Gr-1. 
Mice were treated with MSU crystals i.p. and after 8 hours peritoneal cells were 
harvested by lavage.  Cells were then surface stained for Gr-1 and 7/4 and sorted 
based on levels of expression. (A) Gr-1hi, 7/4+ cells were neutrophils while (B) Gr-
1int, 7/4+ cells had the morphology of monocytes.  (C) F4/80hi,Gr-1-, 7/4- resident 
macrophages were identified in untreated mice. Original magnification 100x.  Scale 
bar represents 20µm.  Results are representative of three separate experiments.
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Figure 5.3 MSU induces cellular infiltration and cytokine production in vivo.  
Mice were treated with MSU i.p. (3mg; 0.5mL PBS) and at various timepoints mice 
were sacrificed. Cells in the peritoneal cavity were harvested by lavage (3mL PBS). 
(A) Monocytes and neutrophils were identified by FACS using Gr-1 and 7/4.  (B) 
Monocyte and neutrophil numbers were determined by FACS over 72 hours.  (C) 
Supernatants from the peritoneal lavages were analysed for cytokines using CBA.  
Values represent mean ± S.E.M. (n = 3 mice per group).  Results are representative 
of three separate experiments. 
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Table 5.1 Cell composition of the peritoneum during an inflammatory response 
to MSU crystals.  Mice were treated with MSU i.p. (3mg; 0.5mL PBS) as in Fig. 
5.3, and at various timepoints mice were sacrificed. Cells in the peritoneal cavity 
were harvested by lavage (3mL PBS). A.  The percentage composition of the cells in 
the peritoneum at various times after MSU treatment.  B.  The absolute numbers of 
cells in the peritoneum at various times after MSU treatment.  Values represent a 
combination of three separate experiments and show mean ± S.E.M. 
 
Macrophage/ 
Monocytes
Neutrophils Lymphocytes Mast cells
Naïve 83.9 ± 1.4 0.0 ± 0.0 14.1 ± 1.2 2.7 ± 0.7
4h 23.8 ± 1.3 67.4 ± 5.2 8.4 ± 3.9 0.0 ± 0.0
8h 30.4 ± 2.4 67.7 ± 2.2 1.2 ± 0.3 0.0 ± 0.0
16h 40.5 ± 4.1 56.4 ± 3.0 1.6 ± 0.1 0.2 ± 0.2
24h 85.9 ± 3.3 8.3 ± 1.7 3.1 ± 1.0 0.0 ± 0.0
72h 88.3 ± 0.9 3.6 ± 0.9 5.8 ± 1.7 0.2 ± 0.1
Macrophage/ 
Monocytes  (x10
6
)
Neutrophils     
(x10
6
)
Lymphocytes    
(x10
5
)
Mast cells
Naïve 1.7 ± 0.4 0.0 ± 0.0 4.3 ± 0.8 < 6 x 10
5
4h 0.7 ± 0.3 2.4 ± 0.7 2.3 ± 0.6
8h 2.7 ± 0.6 8.9 ± 1.9 1.6 ± 0.7
16h 4.6 ± 1.4 8.6 ± 1.1 2.4 ± 0.3
24h 4.9 ± 1.5 2.0 ± 1.4 2.7 ± 0.9
72h 3.3 ± 1.2 0.2 ± 0.1 2.6 ± 0.5
A
B
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Based on peak cytokine production combined with early leukocyte infiltration I 
chose to focus on the first 4 to 8 hours to determine which cell types, monocytes or 
macrophages, were driving the early inflammatory response to MSU. 
 
5.2.2 Production of pro-inflammatory cytokines by cells stimulated with MSU 
crystals 
Monocytes have been reported to play a pivotal role in the inflammatory response to 
MSU. To investigate the contribution of infiltrating monocytes to early inflammation 
following MSU exposure, peritoneal exudate cells were collected from mice four 
hours after treatment with MSU and examined for the production of the pro-
inflammatory cytokines IL-6 and TNFα by infiltrating 7/4+/Gr-1int monocytes.  
Despite high levels of IL-6 being present in the peritoneum at 4 to 8h, the infiltrating 
monocyte population was not producing IL-6 although they were still able to 
produce IL-6 in response to LPS stimulation in vitro (Fig. 5.4, upper panels).  In fact, 
none of the harvested cells appeared to be producing large amounts of IL-6 (Fig. 5.4, 
middle and lower panels).  This indicated that although monocytes had the potential 
to produce IL-6 in vitro, they were not producing IL-6 when entering the peritoneum 
in vivo.   
 
Although monocytes did not appear to be producing IL-6, they did, however, stain 
positively for TNFα with 11% of monocytes being TNFα+ (Fig. 5.5, upper panel).  
Although this implicated monocytes as a source of TNFα, positive staining was not a 
feature unique to monocytes, but was also present in a small percentage (< 4%) of 
neutrophils and the remaining cells in the peritoneal wash.  It is possible that this 
general TNFα staining of cells was the result of the anti-TNFα antibodies binding to 
intracellular stores of TNFα rather than MSU-induced TNFα per se.  In order to 
determine whether this positive staining represented inducible TNFα, these cells 
were exposed to MSU ex vivo and the levels of cytokines actually released from the 
recruited cells assayed.  As a comparison, cells from the peritonea of naïve mice 
were also tested.  Cells from naïve peritonea contain mainly macrophages, in 
contrast to cells from MSU-treated peritonea which contain monocytes and 
neutrophils.   
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Figure 5.4 IL-6 production by cells infiltrating the peritoneum in response to 
MSU.  Mice were treated with MSU i.p. (3mg; 0.5mL PBS) and after 4 hours the 
cells in the peritoneal cavity were harvested by lavage (3mL PBS). Peritoneal cells 
were analysed by FACS to identify IL-6 production by monocytes, neutrophils or the 
remaining leukocytes in the lavage. Results are representative of three separate 
experiments. 
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Figure 5.5 TNFα  production by cells infiltrating the peritoneum in response to 
MSU.  Mice were treated with MSU i.p. (3mg; 0.5mL PBS) and after 4 hours the 
cells in the peritoneal cavity were harvested by lavage (3mL PBS). Peritoneal cells 
were analysed by FACS to identify TNFα production by monocytes, neutrophils or 
the remaining leukocytes in the lavage.  Results are representative of three separate 
experiments. 
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Cells from MSU-treated mice could not be stimulated to release TNFα following 
exposure to MSU; nor did they produce IL-1β, IL-6 or MCP-1 (Fig. 5.6).  Although 
these cells produced background levels of each of these cytokines, these levels were 
no greater than the background levels observed from cells of naïve mice, which had 
received no inflammatory stimulation in vivo (Fig. 5.6).  In contrast to recruited 
monocytes (and recruited cells in general at 4h) resident cells from naïve mice 
responded to MSU exposure, producing high levels of cytokines following exposure 
and revealing macrophages to be more pro-inflammatory than recruited monocytes.   
 
These results revealed two unexpected features of monocytes newly recruited by 
MSU: they do not secrete the cytokines IL-6, TNFα, IL-6 and MCP-1, and more 
surprisingly, they cannot be stimulated by MSU to produce these cytokines (Fig. 
5.6).  This led me to ask the question of whether this phenomenon was distinct to 
monocytes recruited by MSU or whether this was a general feature of inflammatory 
monocytes.  To determine this, an alternative inflammatory stimulus was used to 
induce leukocyte recruitment to the peritoneum.   
 
An i.p. injection of 4% thioglycollate broth induced the recruitment of both 
monocytes and neutrophils as soon as 4h after administration (Fig. 5.7A).  Similar to 
MSU-recruited exudate cells, thioglycollate-recruited cells were not responsive to 
MSU in vitro (Fig. 5.7B).  These results indicated that non-responsiveness of newly 
recruited monocytes to MSU is likely to be a general characteristic of elicited 
monocytes regardless of the stimulus used to induce recruitment.  
 
5.2.2.1 Investigating cytokine responses of purified monocytes and neutrophils 
to MSU stimulation 
To confirm that monocytes were unable to produce cytokines (IL-1β, TNFα, IL-6, 
MCP-1) in response to MSU, monocytes were isolated from mice 8h after MSU 
treatment by FACS and restimulated with MSU ex vivo.  The sorting procedure 
caused a high non-specific background cytokine production from monocytes; 
nevertheless, purified monocytes showed no additional response to MSU indicating 
that monocytes were once again an unlikely in vivo source of these cytokines (Fig. 
5.8A).
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Figure 5.6 Infiltrating leukocytes are unresponsive to MSU.  Peritoneal cells 
were isolated from mice 4 hours after administration of MSU i.p. or naïve mice and 
were restimulated with 200µg/mL MSU ex vivo for 16h.  Supernatants from cell 
cultures were analysed for IL-6, TNFα, IL-1β and MCP-1 using ELISA and CBA.  
Dark bars represent cells restimulated with MSU crystals, while light bars represent 
PBS controls.  Measurements were performed in quadruplicate.  Values represent 
mean ± S.E.M.  ** = P < 0.01 and *** = P < 0.001 as determined by Student’s t-test 
against the indicated control.  Results are representative of three separate 
experiments. 
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Figure 5.7 Leukocytes infiltrating in response to thioglycollate are unresponsive 
to MSU.  Mice were treated with an i.p. injection of thioglycollate (4%, 0.5mL) and 
after six hours peritoneal cells were isolated from mice by peritoneal lavage (3mL 
PBS).  A, Peritoneal exudates cells contained both monocytes (R1) and neutrophils 
(R2). B, Harvested peritoneal leukocytes were restimulated with 200µg/mL MSU ex 
vivo and after 16h the supernatants from cell cultures were analysed for cytokines 
using ELISA and CBA.  Dark bars represent MSU-treated cells while light bars 
represent PBS controls.  Measurements were performed in triplicate.  Values 
represent mean ± S.E.M.  The experiment in Figure 5.7B was performed by M. 
Walton. 
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Because neutrophils were also present in high numbers in the mixed cellular exudate, 
purified recruited neutrophils were exposed to MSU in vitro and tested as a possible 
source of IL-1β, TNFα, IL-6, or MCP-1.  Despite a high non-specific background 
production of MCP-1, neutrophils did not produce pro-inflammatory cytokines in 
response to MSU, ruling them out as a potential source of the cytokines observed in 
vivo (Fig. 5.8B).   
 
Collectively these data provided strong evidence for the idea that neither monocytes 
nor neutrophils are significant contributors to the generation of the pro-inflammatory 
cytokines (TNFα, IL-1β, IL-6 or MCP-1) in MSU-induced inflammation. 
 
5.2.2.2 Identifying cells that produce pro-inflammatory cytokines after 
exposure to MSU crystals 
The discovery that monocytes were not capable of producing TNFα, IL-1β, IL-6 and 
MCP-1 during the inflammatory phase of gout in vivo led to the question of whether 
cells present locally at the time that inflammation was initiated would be involved in 
driving inflammation.  I had previously noted that peritoneal leukocyte cells from 
naïve mice produced significant amounts of inflammatory cytokines following 
exposure to MSU ex vivo, implicating macrophages as a possible source of pro-
inflammatory cytokines in vivo (Fig. 5.6).   
 
Resident peritoneal leukocytes are a mixture of cells primarily composed of 
macrophages, and therefore it seemed reasonable to assume that macrophages were 
the source of IL-6, IL-1β and TNFα observed in stimulated peritoneal leukocyte 
cultures above.  To confirm that macrophages were they key source of these 
cytokines in the peritoneal leukocytes from naïve mice, different resident cell 
populations were separated into macrophages, lymphocytes and mast cells and then 
exposed to MSU in vitro for 8h.  Although lymphocyte and mast cell populations 
were able to produce low levels of IL-6, IL-1β and TNFα, macrophages produced a 
much higher level of all three cytokines following MSU exposure (Fig. 5.9).  The 
results identified macrophages as the primary source of IL-6, IL-1β and TNFα in 
response to MSU in the peritoneal leukocyte population. 
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Figure 5.8 MSU-elicited monocytes and neutrophils are unresponsive to MSU.  
Mice were treated with an i.p. injection of MSU (3mg, 0.5mL PBS) and eight hours 
later peritoneal cells were isolated by lavage (3mL PBS).  F4/80lo, Gr-1int, 7/4+ 
monocytes and neutrophils F4/80-, Gr-1-, 7/4+ were purified by FACS and 
restimulated with 200µg/mL MSU ex vivo.  After 24h, supernatants were analysed 
for cytokines by ELISA and CBA.  A.  Cytokine production from purified 
monocytes.  B. Cytokine production from purified neutrophils.  Dark bars represent 
MSU treated monocytes while light bars represent PBS controls.  Measurements 
were performed in triplicate.  Values represent mean ± S.E.M. Results are 
representative of three separate experiments. 
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Figure 5.9 Macrophages are the major producers of MSU-induced pro-
inflammatory cytokines in lavaged cells of naïve mice.  Peritoneal leukocytes 
were harvested from naïve mice by peritoneal lavage (3mL) and separated into 
subtypes by density gradient.  Macrophages (2 x 105 cells, 200µL), lymphocytes (2 x 
105 cells, 200µL) and mast cells (2 x 104 cells, 200µL) were exposed to MSU 
(200µg/mL) and the cytokines measured by ELISA and BioPlex Array.  
Measurements performed in triplicate.  Values represent mean + S.E.M.  Results are 
representative of three separate experiments.  Experiments were performed by E. 
Chia. 
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5.2.3 Investigating activation of macrophages following exposure to MSU. 
Although the results described above indicated that resident macrophages were a 
potential source of IL-1β, TNFα, and IL-6 in vivo, these cells were notably absent 
from the peritoneal lavage after MSU administration.  The absence of cytokine-
producing macrophages from the peritoneal lavage of MSU-treated mice led me to 
look at changes in macrophage numbers during the course of the inflammatory 
response to MSU.  Flow cytometric analysis of the F4/80hi, Gr-1-, 7/4- resident 
macrophage population showed complete disappearance of this population from the 
peritoneal lavage 2 hours after MSU exposure (Fig. 5.10). 
 
One possible reason for the lack of macrophage retrieval is the adherence of 
macrophages directly to MSU crystals.  And indeed, after MSU treatment in vivo 
MSU became associated in clumps that appeared as a mesh-like glob of cells and 
crystals (Fig. 5.11A).  Crystals could be visualised within the clumps using polarised 
light microscopy (Fig. 5.11B).  However the density of these clumps made it 
difficult to identify different cell types within the clump using immunofluorescent 
markers.  To determine the likelihood of resident macrophages adhering to MSU 
crystals resident leukocytes from the peritoneum of naïve mice were exposed to 
MSU in vitro and then stained for macrophages using F4/80.  Resident peritoneal 
cells bound to MSU crystals, as indicated by Hoechst staining, and formed clumps of 
crystals and cells in vitro (Fig. 5.12).   Cells within the mesh of crystals stained 
positively for F4/80 showing that the majority of the cells within the mesh were 
macrophages (Fig. 5.12).  The results clearly showed that macrophages adhere to 
MSU following exposure to crystals and form clumps with crystals mimicking the 
clumping observed in vivo (Fig. 5.12; enlarged inset). 
 
In addition to adhesion to crystals, adhesion to surrounding tissues is a common 
feature of macrophage activation and the absence of macrophages shortly after 
administration of inflammatory stimuli has been reported as the ‘macrophage 
disappearance reaction’ in other acute inflammatory models (Nelson and Boyden, 
1963, Haskill and Becker, 1985, Melnicoff et al., 1989).  This phenomenon may also 
have contributed to the reduction of retrievable macrophages from the peritoneum 
following MSU administration. 
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Figure 5.10 Resident macrophages disappear from the peritoneal lavage 
following MSU administration.  Mice were treated with MSU i.p. (3mg; 0.5mL 
PBS) and at various timepoints mice were sacrificed. Cells in the peritoneal cavity 
were harvested by lavage (3mL PBS). Harvested peritoneal cells were analysed for 
the presence of F4/80hi resident macrophages by FACS. Values represent mean + 
S.E.M. (n = 3 mice per group). *** = P < 0.001 as determined by Student’s t-test 
against the naïve time point. Results are representative of three separate experiments. 
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Figure 5.11 MSU crystals become associated with cells as clumps in vivo.  
Clumps found in the peritoneal wash of MSU-treated mice were sedimented by 
cytocentrifuge and stained with Diff-Quick.  A, shows a clump of crystals under 
bright field.  B, shows the same clump under polarized light.  Original magnification 
40x.  Scale bar represents 100µm.   
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Figure 5.12 Resident macrophages associate with MSU crystals in vitro.  
Resident peritoneal leukocytes were harvested from naïve mice by lavage (3mL 
PBS) following which they were exposed to MSU in vitro.  Cells were then stained 
for F4/80 (green) and the nuclear dye Hoechst 33342 (blue).  The MSU/cell mesh 
within the red square is shown enlarged.  MSU crystals within the MSU/cell mesh 
are also shown by differential interference contrast (DIC).  Original magnification 
40x.  Scale bar represents 100µm. Results are representative of three separate 
experiments. 
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To confirm that macrophage adherence was occurring in vivo following MSU 
administration, visceral peritoneal membranes were isolated from mice four hours 
after MSU administration and stained for the presence of F4/80hi,7/4- resident 
macrophages using immunofluorescence. Following MSU treatment, adherent 
resident macrophages were observed on the peritoneal membrane (Fig. 5.13).  No 
adherent macrophages were present on tissue from untreated mice, indicating that 
macrophage activation and adherence had occurred in response to treatment with 
MSU.  As confirmation that adherent F4/80hi cells could produce cytokines to MSU, 
resident peritoneal macrophages were adhered to slides and then exposed to MSU.  
In vitro cultures of the naïve peritoneal cell population identified the F4/80+ resident 
macrophages as producing not only IL-6 but also TNFα and IL-1β in response to 
MSU exposure (Fig. 5.14) indicating that resident macrophages were a source of 
inflammatory cytokines following MSU treatment in vivo. 
 
5.2.3.1 Effect of macrophage depletion in vivo 
Next, I sought to confirm the importance of MSU-induced activation of resident 
macrophages to the inflammatory response in vivo by depleting the resident 
macrophage population in the peritoneum prior to MSU administration. Resident 
peritoneal macrophages were depleted using clodronate-loaded liposomes where 
liposome pre-treatment caused a complete reduction of F4/80hi resident 
macrophages, with an overall 80 percent depletion of all F4/80+ cells.  The small 
proportion of remaining F4/80lo cells observed represented a small number of 
infiltrating monocytes (Fig. 5.15A and 5.15C, 0h).  Following MSU treatment, all 
F4/80+ cells were F4/80lo monocytes, and the infiltration of these monocytes was 
unaffected in macrophage-depleted mice compared with non-depleted mice (Fig. 
5.15C).  As shown in Figures 5.15B and 5.15D, macrophage depletion was 
associated with a significant reduction in total cell numbers and neutrophil 
infiltration following MSU administration.  Reductions in IL-6, IL-1β and MCP-1 
production were also observed, while the level of TNFα was not affected (Fig. 
5.16A).  Cytokine levels also dropped in the serum, with a reduction in IL-6 and 
MCP-1 levels observed (Fig. 5.16B).  These results confirmed that resident 
macrophages play an essential role in the inflammatory phase of gouty
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Figure 5.13 Resident macrophages adhere to the epithelial membrane in 
response to MSU.  Mice received an i.p. injection of MSU (3mg; 0.5mL PBS)  and 
after four hours the visceral epithelial lining of the peritoneum was harvested, fixed 
and then stained wrth anti-F4/80 and 7/4.  Resident peritoneal cells appear as F4/80+, 
7/4- cells.  Original magnification 40x.  Scale bar represents 100µm.  Results are 
representative of three separate experiments. 
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Figure 5.14 Resident macrophages are a source of pro-inflammatory cytokines 
in response to MSU. Resident peritoneal cells were harvested from naïve mice by 
lavage and exposed to 200µg/mL MSU in the presence of GolgiStop for 4 hours.  
Production of the cytokines (red) IL-1β, TNFα and IL-6 by resident macrophages 
(anti F4/80; green) were then determined by fluorescent antibody staining.  Original 
magnification 40x.  Scale bar represents 100µm.  Results representative of three 
separate experiments. 
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Figure 5.15 Depletion of resident macrophages inhibits MSU-induced neutrophil infiltration.  Mice were pre-treated with clodronate 
liposomes three days before being challenged with an i.p. injection of MSU (3mg; 0.5mL PBS).  Cells in the peritoneal cavity were harvested by 
lavage (3mL PBS).  A, The effect of the liposome depletion on resident macrophages was determined by FACS before an MSU challenge.  4h 
and 8h following MSU administration, the number of B, total cells, C, monocyte-macrophages and D, neutrophils were determined in liposome 
treated and non-liposome treated mice. Light bars represent clodronate liposome-treated mice while dark bars represent undepleted control mice.  
Values represent mean ± S.E.M. (n = 5 mice per group). * = P < 0.05, ** = P < 0.01 and *** = P < 0.001 as determined by Student’s t-test 
against the relevant indicated timepoint.  Results are representative of three separate experiments. 
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Figure 5.16 Depletion of resident macrophages inhibits MSU-induced cytokine 
production.  Mice were pre-treated with clodronate liposomes three days before 
being challenged with an i.p. injection of MSU (3mg; 0.5mL PBS).  The peritoneal 
cavity was washed by lavage (3mL PBS).  A.  Cytokine levels in the peritoneal 
lavage fluid.  B.  Cytokine levels in the circulating blood. Light bars represent 
clodronate liposome-treated mice while dark bars represent undepleted control mice.  
Values represent mean ± S.E.M. (n = 5 mice per group). * = P < 0.05, ** = P < 0.01 
and *** = P < 0.001 as determined by Student’s t-test against the relevant indicated 
control.  Results are representative of three separate experiments. 
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inflammation, producing key pro-inflammatory cytokines and recruiting of 
neutrophils. 
 
5.2.4 Differential cytokine production by peritoneal leukocytes and peritoneal 
epithelial cells  
The macrophage depletion studies above showed that although macrophages were 
responsible for recruiting neutrophils in MSU-induced inflammation they were not 
responsible for monocyte recruitment, which was unaffected by macrophage 
depletion (Fig. 5.15C and 5.15D).  This indicated that monocyte recruitment in gout 
is controlled by a mechanism independent of macrophage activation.   
 
Epithelial cells have been reported to respond to MSU crystals opening the 
possibility that non-hemopoietic cells may also be involved in the inflammatory 
response to MSU (Falasca et al., 1993).  It is possible that epithelial cells may have 
contributed to the MSU-induced cytokines responsible for monocyte recruitment in 
vivo.  However, the contribution of epithelial cells in the peritoneal gout model could 
not be determined in the previous experimental setup as epithelial cells are not 
retrievable by lavage.  Therefore, to determine the contribution of both resident 
peritoneal epithelial cells and peritoneal leukocytes to MSU-induced cytokine 
production, whole peritoneal tissue and peritoneal leukocyte cells, harvested from 
naïve mice, were exposed to MSU both separately and together.  The length of 
culture was limited to eight hours to coincide with the period at which maximum 
cytokine production was observed in vivo. 
 
A differential expression of cytokine production was observed between peritoneal 
leukocytes and epithelial cells.  Leukocytes produced TNFα, IL-1β and IL-6 in 
response to MSU, but only showed a modest increase in MCP-1; while epithelial 
tissue exposed to MSU did not produce TNFα, IL-1β and IL-6 but produced MCP-1 
(Fig. 5.17).  Cytokine production was not increased when both cell types were co-
cultured and then exposed to MSU, which meant that there was no overlap or 
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Figure 5.17 Differential production of pro-inflammatory cytokines by 
peritoneal leukocytes and membrane following MSU exposure.  Peritoneal 
leukocytes were harvested from naïve mice by peritoneal lavage (3mL PBS) and the 
peritoneal membrane excised.  Peritoneal leukocytes and peritoneal membrane were 
cultured together or separately in the presence (+) or absence (-) of MSU 
(200µg/mL) for 8h following which the levels of A, IL-6 B, TNFα, C, IL-1β and D, 
MCP-1 were determined by ELISA and BioPlex Array.  Measurements performed in 
triplicate. Values represent mean ± S.E.M. * = P < 0.05, ** = P < 0.01 and *** = P 
< 0.001 as determined by Student’s t-test against the relevant indicated control.  
Results are representative of three separate experiments. 
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synergy in cytokine production by leukocytes versus epithelial cells.  In some 
instances the cytokine response in combined leukocytes and epithelial cell cultures 
was reduced.  However, examination of plates that had been inverted to allow the 
contact of leukocytes with tissue during culture revealed that a number of leukocytes 
had adhered to the bottom of the wells before plate inversion.  Hence, when the 
plates were inverted these cells were excluded from the culture, resulting in 
diminished cytokine levels. 
 
These results indicate that both leukocytes and epithelial cells in the peritoneum are 
involved in the production of pro-inflammatory cytokines in the initial phase of the 
inflammatory response, but produce different sets of cytokines.  Resident peritoneal 
leukocytes produce IL-6, IL-1β and TNFα in response to MSU, while epithelial cells 
produce MCP-1. 
 
The epithelial cell type present on peritoneal tissue is the mesothelial cell.  To 
confirm that mesothelial cells were a source of MCP-1 following MSU stimulation, 
mesothelial cells were harvested from the peritoneum and cultured in vitro.  
Mesothelial cells were large and had a cobbled appearance consistent with 
previously reported literature (Herrick and Mutsaers, 2004)(Fig. 5.18A).  As has 
been reported previously with cultured peritoneal tissue (Riese et al., 1999), 
culturing of mesothelial cells produced a background level of MCP-1 (Fig 5.18B).  
Following exposure to MSU crystals, mesothelial cells increased MCP-1 production, 
further implicating these cells as a source of MCP-1 in the MSU-stimulated 
peritoneum (Fig. 5.18B). 
 
5.3 Discussion 
The results presented in this chapter show that resident tissue macrophages play a 
significant role in the onset of acute gout. Resident macrophages are a key source of 
pro-inflammatory cytokines, including IL-1β, in acute gout attacks.  The key 
indication of the importance of resident macrophages was demonstrated when 
macrophages were selectively depleted.  Not only did this lead to a reduction in 
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Figure 5.18 Mesothelial cells produce MCP-1 in response to MSU.  Peritoneal 
mesothelial cells were harvested from naïve mice by in vivo trypsinization and 
cultured in vitro.  A.  Phase contrast picture of peritoneal monolayers in culture.  
Original magnification 40x.  Scale bar represents 100µm.  B. MCP-1 production of 
mesothelial cells following exposure to 500µg/mL MSU in vitro.  Measurements 
performed in triplicate.  Values represent mean ± S.E.M.  Results are representative 
of three separate experiments.  Figure 5.18A was prepared by W. Martin while the 
experiments for 5.18B were performed by T. Liu. 
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IL-1β and IL-6 but also to a significant reduction in neutrophil infiltration, 
demonstrating that macrophages do not only mediate cytokine responses in gout, 
they play a major role in orchestrating the neutrophil response. 
 
Previous studies investigating the activation of monocytes in vitro have indicated 
that monocytes induce a pro-inflammatory response to MSU. It has therefore been 
hypothesised that monocytes aid in driving the inflammatory phase of gout.  
Contrary to expectations, the monocyte population recruited by MSU did not 
contribute to the early pro-inflammatory response in vivo nor were these monocytes 
responsive to MSU restimulation ex vivo.  Since MSU crystals in the peritoneum 
form a mesh of cells and crystals, it could be argued that infiltrating monocytes may 
not make sufficient contact with crystals in vivo and, as a result, remain unactivated.  
However, this does not explain why the monocytes from MSU-treated peritoneal 
cavity were unresponsive to MSU ex vivo, despite being responsive to other 
inflammatory stimuli such as LPS.  In fact, the lack of monocyte responsiveness to 
MSU may be a general feature of recruited monocytes, as monocytes recruited by 
thioglycollate stimulation showed a similar lack of responsiveness.  The general 
absence of a pro-inflammatory response by infiltrating monocytes to MSU provides 
strong evidence that the infiltrating monocytes are not driving the early 
inflammatory phase in MSU-induced inflammation during the period of high pro-
inflammatory cytokine production and neutrophil infiltration. 
  
These findings were surprising in light of data showing that early leukocyte 
infiltrates from cantharidin-induced blisters produced pro-inflammatory cytokines 
following MSU-restimulation ex vivo (Yagnik et al., 2004). However, in addition to 
recruiting cells with an alternative inflammatory stimulus, the cantharidin study 
looked at later stage cellular infiltrates (16h compared to 4-8h) that likely differ in 
cellular composition and phenotype compared with the initiation phase of MSU-
induced inflammation.  Since the phenotype of the cells was not determined, it is not 
possible to determine whether these cells were representative of an early recruited 
phenotype.  The use of the peritoneal model allowed extensive profiling of the rising 
and then resolving response, enabling cells from the appropriate stage of the 
inflammatory response to be studied.  In addition, unlike the cantharidin study, cells  
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recruited in the in vivo gout model were clearly identified by the phenotypic markers 
Gr-1, 7/4 and F4/80, allowing the contribution of discrete cell populations to be 
determined.  Therefore, phenotypic differences between in vivo MSU-recruited 
monocytes and the monocytes derived by various other means in previous studies 
likely explain why the results presented in this thesis differ from earlier in vitro data.  
 
Like monocytes, neutrophils did not produce IL-1β, TNFα, IL-6 or MCP-1 in 
response to MSU crystals.  This does not exclude an inflammatory role for 
neutrophils in gout, as neutrophils produce superoxide in vivo when recruited in 
response to MSU (Chapter 3).  The lack of classical pro-inflammatory cytokine 
production indicates that their primary function may not be the secretion of these 
cytokines towards driving inflammation in gout.  However, other inflammatory 
mediators not measured within this study may also be involved, such as S100 
proteins.  Studying the involvement of mediators other than cytokines is a subject for 
further investigation. 
 
The difference in responses of infiltrating monocytes to MSU and LPS in vitro 
suggests that monocyte recognition of MSU, unlike LPS, does not occur via TLR4.  
This is consistent with earlier work showing that knocking out the gene encoding 
TLR-4 does not ablate the inflammatory response to MSU (Chen et al., 2006).  
Further investigation into the differences in receptor expression between monocytes 
and macrophages may reveal new candidates for MSU recognition by mononuclear 
phagocytes. 
 
The results in this chapter pinpoint the resident macrophage population as a primary 
source of pro-inflammatory cytokines in the early response to MSU exposure. This 
finding is consistent with a key involvement of resident macrophages in the initiation 
of other forms of acute inflammation (Richards et al., 1999, Knudsen et al., 2002, 
Cailhier et al., 2005).  Previous gout research has mostly ignored the potential of this 
cell type to induce inflammation in favour of a possible anti-inflammatory effector 
function.   
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Earlier in vitro studies have indicated that differentiated macrophages produce anti-
inflammatory cytokines such as TGFβ following MSU exposure (Yagnik et al., 
2004).  More recent literature has shown that MSU can activate differentiated 
macrophages, leading to the activation of the NALP3 inflammasome, the production 
of IL-1β, the upregulation of TREM-1 and the production of the neutrophil 
chemokine KC (CXCL1) (Jaramillo et al., 2004a, Jaramillo et al., 2004b, Chen et al., 
2006, Martinon et al., 2006, Murakami et al., 2006). These data are consistent with 
the in vivo findings described in this chapter whereby the resident macrophage 
population initiates inflammation in response to MSU. In the peritoneal model it 
appears that MSU-activated resident macrophages adhere to MSU crystals and to the 
surrounding tissues, produce pro-inflammatory cytokines and facilitate recruitment 
of neutrophils from the blood during the early inflammatory response. Because 
adherent resident macrophages are not readily recovered from lavage fluids, any 
contribution to disease activation and progression may well have gone unnoticed in 
favour of the contribution of more readily recoverable monocytes.  
 
Depletion of macrophages had no effect on the recruitment of monocytes.  This 
indicates that neither macrophages nor neutrophils are required for monocyte 
recruitment and that monocytes and neutrophils can be recruited via independent 
pathways, as has been observed in other inflammatory systems (Henderson et al., 
2003).  Differential cytokine production by peritoneal epithelium and leukocytes was 
characterised by epithelial cells producing MCP-1, and resident leukocytes 
producing IL-1β, TNFα and IL-6.  Given that MCP-1 is an important molecule in 
the recruitment of monocytes (Lu et al., 1998) and IL-1β is key in neutrophil 
recruitment in gout, the prospect that epithelial cells and resident leukocytes may 
respectively control monocyte and neutrophil recruitment is a plausible interpretation 
of these data and warrants further investigation.  There are clearly other pathways 
involved, as the macrophage depletion also led to a reduction in serum levels of both 
MCP-1 and IL-6 following MSU administration that cannot yet be explained.  
Nevertheless, these observations make important headway into dissecting the various 
pathways of activation involved in gout. 
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Although resident leukocyte cells stimulated with MSU-crystals were also able to 
produce MCP-1 when cultured for 16h, this increase was not as significant when 
incubation time was limited to eight hours, a time period that reflected acute 
activation in vivo.  In contrast, epithelial tissues produced large amounts of MCP-1 
over the same length of time.  This observation serves as a more technical caveat, 
emphasizing the importance of selecting appropriate culture times in vitro that reflect 
what is occurring in vivo in order to draw the most physiologically relevant 
conclusions. 
 
A characteristic of acute gout attacks is the spontaneous resolution of inflammation 
even in the absence of clinical intervention.  It is important to note that the pro-
inflammatory response of the resident macrophage population to MSU observed in 
this study does not exclude differentiated macrophages from playing a role in the 
resolution of inflammation at a later point in time. The plasticity of the macrophage 
phenotype is well known and macrophage switching from a ‘pro’ to an ‘anti’ 
inflammatory phenotype over time remains a viable mechanism of action for 
resolution of acute inflammation.  Although previous in vitro data implies that this 
may occur, functional switching in macrophages derived from resident macrophages 
or recruited monocytes has not been demonstrated in gout in vivo. 
 
Mononuclear phagocytes are highly diverse in phenotype and function and these 
aspects often make it difficult to model their activities faithfully in vitro.  The results 
presented here highlight the advantages of in vivo modelling in understanding the 
role of monocytes and macrophages in inducing gout. The use of in vivo derived 
phenotypes has clear advantages over using in vitro derived cell types as the true 
effector phenotype can be described in the direct context of the disease, and this 
approach has shown that infiltrating monocytes elicited by MSU in vivo behave 
contrary to monocytes derived by other methods.  The observation of contrasting 
monocyte/macrophage responses also indicates that any clinical study investigating 
the function of monocytes or macrophages in gout will need to be select the correct 
cell type for study in order to yield any useful data. 
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In summary, the results presented in this chapter identify resident macrophages - not 
infiltrating monocytes - as key cells initiating and driving inflammation in gout, 
suggesting the need to revisit the current model of acute gout induction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results of this chapter have been accepted for publication in Arthritis and 
Rheumatism.  A draft of this paper has been inserted in the Appendix: 
Resident macrophages: Initiating and driving early inflammation in an MSU-induced 
model of acute gout.  W.Martin, M. Walton, J. Harper.  Arthritis and Rheumatism.  
In press 2008.  
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Chapter 6 
Profiling monocyte differentiation in 
acute MSU-induced inflammation 
 
6.1 Introduction 
The previous chapter revealed the unexpected phenomenon that monocytes do not 
produce pro-inflammatory cytokines (IL-1β, TNFα, IL-6) in response to MSU 
during the early inflammatory phase of gout inflammation in vivo.   The discovery of 
this lack of responsiveness of recruited monocytes is evidence that the use of blood 
monocytes to study gouty inflammation in vitro has led to a limited understanding of 
the role of monocytes in gout.  Therefore, profiling of monocyte function and 
differentiation during an MSU response in vivo is required in order to understand the 
role of monocytes in gout more fully.   
 
Monocytes in the blood consist of two principal subtypes that are broadly referred to 
as “inflammatory” monocytes and “resident” monocytes (Section 1.10.10).  In 
humans, inflammatory monocytes are distinguished as CD14hiCD16- while resident 
monocytes are CD14loCD16hi (Passlick et al., 1989, Geissmann et al., 2003).  There 
are a number of markers that identify the corresponding subtypes in mice, however 
in general they are distinguished by the expression of Gr-1 (Ly-6C), for which 
inflammatory monocytes are Gr-1+ and resident monocytes are Gr-1- (Geissmann et 
al., 2003).  
 
The importance of this distinction is that both monocyte groups have different 
functions.  Inflammatory monocytes are so called due to their recruitment during 
inflammation (Geissmann et al., 2003).  The high expression of chemokine receptors 
(e.g. CCR2 and 7 and CXCR1 and 2) provides further evidence that this subtype is 
poised to respond to inflammatory signals following an insult and that they are 
functionally distinct from resident monocytes (Lu et al., 1998, Weber et al., 2000, 
Grage-Griebenow et al., 2001).  Infiltration of resident monocytes appears to occur 
independent of inflammatory stimuli and is dependent on high expression of the 
fractalkine receptor CX3CR1 (Auffray et al., 2007).  In connection with this, a newly 
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described “patrolling” function has been observed in resident monocytes in the 
vasculature that is not dependent on inflammation (Auffray et al., 2007).  Although 
resident monocytes can also make a contribution to an inflammatory response, the 
ability of these cells to be recruited in the absence of inflammation has led to the 
idea that these cells may be responsible for the replenishment of monocyte-derived 
resident cells under steady state conditions (Geissmann et al., 2003).  
 
It is as yet unclear whether resident and inflammatory monocytes are the source of 
separate cell populations following differentiation.  Both subtypes are able to 
differentiate into DCs or macrophages in vitro depending on the growth factors and 
cytokines present (Sallusto and Lanzavecchia, 1994, Sanchez-Torres et al., 2001, 
Sunderkotter et al., 2004).  However, in vitro systems are artificial by nature and it is 
likely that other complex factors come into play in vivo, such as the combined effect 
of local soluble factors, and the influence of local tissue antigens (Leenen and 
Campbell, 1993).  As the study of monocyte subtypes is a relatively new area of 
research, there are few in vivo studies that have been undertaken to explore 
monocyte differentiation potential.  Research papers using L. monocytogenes and 
UV irradiation as inflammatory stimuli in mice have shown that inflammatory 
monocytes have a tendency to engage a DC differentiation program while resident 
monocytes engage a macrophage differentiation program (Geissmann et al., 2003, 
Ginhoux et al., 2006, Auffray et al., 2007). 
 
In Chapter 5, I have shown that monocytes recruited during MSU-induced 
inflammation are Gr-1+ (inflammatory) monocytes.  In fact, a study following the 
differentiation fate of monocytes in gout in vivo has never been undertaken; rather it 
has been assumed that infiltrating monocytes become anti-inflammatory 
macrophages (Yagnik et al., 2004).  Although research into the subtypes of 
monocytes is still an emerging field, there are ample tools now available to follow 
the changes in the phenotype of monocytes through a combinatory approach using 
surface marker expression, histology, and functional assays. 
 
Since monocytes infiltrate following an MSU insult in vivo and do not appear to be 
involved in the onset of inflammation, I asked the question as to whether monocytes 
instead play a role during the resolution phase of the inflammatory response.  
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Clearance of apoptotic neutrophils by monocyte/macrophages is a phenomenon 
associated with the resolution of inflammation in general.  Phagocytosis of apoptotic 
cells during resolution does not lead to the production of pro-inflammatory 
cytokines, in fact, cells which have taken up apoptotic neutrophils in vitro have been 
shown to actively inhibit the production of pro-inflammatory cytokines via a process 
that has been shown to rely, in part, on the production of TGFβ (Fadok et al., 1998).  
TGFβ production has been widely reported in association with the resolution phase 
of MSU-induced inflammation (Liote et al., 1996, Yagnik et al., 2004).  Although in 
vitro studies have implicated macrophages as the source of TGFβ leading to 
resolution in gout, this has not been confirmed in vivo. 
 
Taking all of these factors into account, the purpose of this chapter was to profile the 
differentiation of monocytes recruited in response to MSU.  This research was 
designed to provide a description of the changing marker expression, morphology 
and function of differentiating monocytes and confirm whether recruited monocytes 
differentiated into macrophages.  Further this study sought to determine whether 
differentiating monocytes play a role in the resolution of inflammation in gout. 
 
6.2 Results 
6.2.1 Monocytes differentiation in vivo 
In order to provide a clear profile of monocytes over the course of a response, 
monocytes were stained for the myeloid differentiation markers 7/4, Gr-1, the 
monocyte-macrophage lineage marker F4/80 and the costimulatory activation 
molecule CD80.  As in Chapter 5, newly recruited monocytes were identified as 
F4/80lo, 7/4hi and Gr-1int. 
 
Monocytes showed a progressive downregulation of both 7/4 and Gr-1 that was 
completely lost by 48h (Fig. 6.1A and B).  During this period, monocytes maintained 
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Figure 6.1 Marker expression on monocytes over the course of an MSU-induced 
acute inflammatory response. 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and over 
the course of the response peritoneal exudate cells were harvested by lavage (3mL 
PBS).  Harvested cells were prepared and stained for a number of monocytes 
markers.  Monocytes were initially identified as F4/80+ cells, after which the 
expression levels of the myeloid differentiation antigens A. Gr-1 and B. 7/4 were 
determined over the course of the response.  The expression level of C. F4/80 and 
the activation marker D. CD80 were also determined.  Measurements were 
performed in triplicate.  Values represent mean ± S.E.M.  Results are representative 
of three separate experiments. 
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a constant low-level expression of F4/80 (Fig. 6.1C).  After 72h, the expression of 
the activation marker CD80 on F4/80lo cells was significantly upregulated indicating 
that monocytes were differentiating towards a more pro-inflammatory phenotype. 
 
6.2.1.1 Mononuclear phagocyte morphology 
In order to view how infiltrating monocytes changed in morphology over time, 7/4, 
Gr-1 and F4/80 were used to identify and sort monocyte and macrophage 
populations over the course of the in vivo response.  Resident peritoneal 
macrophages (F4/80hi) were sorted from naïve mice; infiltrating monocytes (F4/80lo, 
Gr-1int, 7/4hi) were sorted from mice 8h after an MSU injection; and immature 
macrophages (F4/80lo, Gr-1-, 7/4-) were sorted from mice 48h after MSU treatment. 
 
Naïve resident macrophages were large cells, averaging 22µm in diameter on a 
cytospin slide, with rounded nuclei and a large cytoplasm (Fig. 6.2, left panel and 
Fig. 6.3).  In contrast, infiltrating monocytes at 8h were small in size averaging 
13µm in diameter, contained only a small amount of cytoplasm and had more “bean” 
shaped nuclei (Fig. 6.2, center panel and Fig. 6.3).  At 48h after MSU treatment, 
macrophages were at an intermediate size between monocytes and resident 
macrophages averaging 17µm in diameter (Fig. 6.2; right panel and Fig. 6.3).  These 
cells exhibited the classical appearance of macrophages, including a rounded nucleus 
and a large cytoplasm.  However, the size difference between resident and 48h 
macrophages combined with their low F4/80 expression indicated that they were not 
identical resident macrophages and represented an intermediate phenotype between 
monocytes and resident macrophages.   
 
Therefore it appeared that these three cell types represented three different stages of 
differentiation, which, for this study, I have termed as: mature macrophages, 
characterised by a large cell size and a high expression of F4/80; monocytes, 
characterised by the expression of the myeloid antigens Gr-1 and 7/4; and immature 
macrophages, characterised by a low expression of F4/80 without the expression of 
myeloid antigens, and with a cell size that is intermediate to monocytes and mature 
macrophages. 
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Figure 6.2 Morphology of mononuclear phagocytes over the course of the MSU-induced acute inflammatory response. 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and at various times cells were harvested from the peritoneum by 
lavage (3mL PBS). Monocyte-macrophages were then stained for the markers F4/80, Gr-1 and 7/4 and isolated by fluorescence activated cell 
sorting.  Resident peritoneal macrophages (F4/80hi, Gr-1-, 7/4- cells) were isolated from naïve mice; monocytes (F4/80lo, Gr-1int, 7/4+) were 
isolated from mice 8h after MSU administration; and immature macrophages (F4/80lo, Gr-1-, 7/4-) were isolated from mice 48h after MSU 
administration.  Sorted cells were transferred onto slides by cytospin and stained with Diff-Quik for visualisation.  Original magnification 100x. 
Scale bar represents 20µm. 
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Figure 6.3 Cell width of mononuclear phagocytes over the course of the MSU-
induced acute inflammatory response 
The diameter of cells from Figure 6.2 were measured on cytospin slides using 
Olympus AnalySIS software.  Results represent mean ± S.E.M.  50 cells were 
measured for each variable.  Results are representative of two separate experiments. 
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6.2.1.2 Expression of the dendritic cell marker CD11c 
The expression of F4/80 on immature macrophages indicated that these cells were 
most likely precursors for mature macrophages.  However, it could not be ruled out 
that these monocytes may have been dendritic cell precursors that had not yet lost 
the expression of F4/80.  To test this, I examined the expression of the common 
dendritic cell marker CD11c (Shortman and Liu, 2002) on cells over the course of 
the in vivo response. Very few cells in the peritoneum expressed CD11c (< 6%), 
with the vast majority of cells (78%) expressing low F4/80 and no CD11c as far out 
as 48h (Fig. 6.4).  This observation provided evidence that these recruited monocytes 
were not becoming dendritic cells when recruited to gout inflammation. 
 
6.2.1.3 Tracking monocyte differentiation through cell labelling 
Next, I sought to confirm whether inflammatory monocytes were indeed the source 
of macrophage precursors by labelling the infiltrating inflammatory monocyte 
population and following their differentiation in vivo.  To devise a way to label 
infiltrating monocytes, I took advantage of an observation previously noted in our 
lab.  When the peritoneum was pre-treated with the dye PKH26 (which is selectively 
taken up by phagocytes) naïve resident macrophages were selectively stained with 
the dye (Fig. 6.5A).  However, following MSU administration, these labelled 
resident macrophages were not retrievable and instead, a small proportion of 
infiltrating cells became labelled with dye as they entered the peritoneum in response 
to MSU (Fig. 6.5B).  The level of dye uptake was much lower than in naïve resident 
macrophages (Fig. 6.5A and B) and these PKH26lo cells expressed Gr-1 and the 7/4 
antigen indicating that inflammatory monocytes rather than neutrophils had taken up 
the dye (Fig. 6.5B).    This staining approach allowed the Gr-1+ monocytes to be 
followed over the course of their differentiation to confirm the cell type or types they 
became.  
 
Using this labelling technique, PKH26-labelled cells were all F4/80lo one day after 
MSU treatment, corresponding to monocytes (Fig. 6.6).  These monocytes still 
expressed Gr-1, yet most of the monocytes were in the process of downregulating 
Gr-1 expression (Fig. 6.6; Day 1).  There were no labelled cells that were F4/80+ and 
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Figure 6.4 Expression of the dendritic cell marker CD11c over the course of an 
MSU-induced acute inflammatory response. 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and over 
the course of the response peritoneal exudate cells were harvested by lavage (3mL 
PBS).  Harvested cells were prepared and stained for CD11c and F4/80+ and 
analysed by flow cytometry.  Results are representative of three separate 
experiments. 
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Figure 6.5 PKH26 labelling of mononuclear phagocytes. 
Mice received an i.p. injection of the phagocyte dye PKH26 and one day later 
received an i.p. injection of MSU (3mg MSU, 0.5mL).  Peritoneal exudate cells were 
harvested by peritoneal lavage 8h after MSU treatment, stained for the surface 
markers and analysed by flow cytometry.   A. PKH26 staining in cells of mice that 
had received the dye but were not injected with MSU.  B. Shows staining in 
peritoneal cells from mice 8h after MSU treatment.  Results are representative of 
three separate experiments. 
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Figure 6.6 Marker expression on PKH26+ monocytes over the course of an MSU-induced acute inflammatory response 
Mice received an i.p. injection of the phagocyte dye PKH26 and one day later received an i.p. injection of MSU (3mg MSU, 0.5mL).  Peritoneal 
exudate cells were harvested by peritoneal lavage at various times after MSU treatment, stained for surface markers and analysed by flow 
cytometry.  Results are representative of three separate experiments. 
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Figure 6.7 F4/80 expression on differentiating monocytes over the course of an 
MSU-induced inflammatory response 
Histogram of F/80 expression based on the monocyte-macrophages in Figure 6.6.  
Results representative of three separate experiments. 
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Gr-1- showing that all monocytes were of the “inflammatory” rather than “resident” 
subtype.  By day two, virtually all labelled cells were still F4/80lo but had lost the 
expression of Gr-1 (Fig. 6.6; Day 2).  Interestingly, from day three after MSU 
treatment, labelled cells began to upregulate the expression of F4/80 (Figs. 6.6 and 
6.7).  After seven days there were two populations of PKH26 labelled cells: an 
F4/80lo population; and an F4/80hi population comparable in expression level to 
resident macrophages (Fig. 6.6; Day 7 and Naive).  These two populations indicated 
a differentiating, immature macrophage and a resident macrophage phenotype 
respectively.   
 
These results demonstrated that in the gout model, inflammatory monocytes 
differentiated into macrophages, and were the primary source of macrophage 
precursors following a gout attack.  The differentiation of macrophage precursors 
progressed through at least two detectable stages of differentiation.  The first stage 
was from monocyte to immature macrophage, observed through the loss of the 
markers Gr-1 and 7/4.  The second stage was from immature to mature macrophage 
observed through the change from F4/80lo to F4/80hi expression. 
 
6.2.2 Functional changes in differentiating monocytes 
Following evidence of monocyte differentiation to macrophages I next asked the 
question of whether there was a corresponding change in function in association with 
the observed changes in morphology and marker expression over the course of 
differentiation. Two classical functions of mononuclear phagocytes were chosen for 
investigation: the ability to produce chemical mediators in response to inflammatory 
stimuli and the capacity for phagocytosis. 
 
6.2.2.1 Production of pro-inflammatory cytokines in response to MSU 
In chapter 5, I demonstrated that monocytes (Gr-1+, 7/4+, F4/80lo) isolated during the 
first 4-8h following MSU administration did not produce pro-inflammatory 
cytokines (IL-1β, TNFα, IL-6) following restimulation with MSU in vitro.  Since 
these cells, with time, differentiated into macrophages, I wondered whether this 
corresponded to an altered response to MSU.   
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To determine if this was indeed the case, total peritoneal cells were stimulated ex 
vivo from mice following in vivo MSU treatment. Although not all increases were 
statistically significant, total peritoneal cells from naïve mice showed a trend to 
increase pro-inflammatory cytokine production following stimulation with MSU 
(Fig. 6.8; 0h).  Total peritoneal cells from mice treated with MSU for 4-16h did not 
exhibit an increase in cytokine production when re-stimulated with MSU ex vivo.   
 
However, total peritoneal cells began to exhibit pro-inflammatory responses to MSU 
from mice treated with MSU for 24h.  By 72h, the total peritoneal cells produced 
similar levels of pro-inflammatory cytokines to cells from naïve mice.  This showed 
that the late stages of differentiation of recruited monocytes into macrophages were 
associated with increased responsiveness to MSU stimulation. Immature 
macrophages present in the peritoneum 24 to 72h after MSU treatment exhibited 
pro-inflammatory responses to MSU that were similar to those of resident 
macrophages from naïve mice.  To confirm that the newly differentiated 
macrophages were a source of the cytokine and chemokine production, F4/80-
expressing cells were purified from naïve mice and from mice 48h after MSU 
treatment, and re-stimulated with MSU.  The sorting procedure resulted in a high 
background cytokine production which may have prevented observing greater 
differences from MSU stimulation, nevertheless, both cell populations produced pro-
inflammatory cytokines following restimulation with MSU ex vivo and exhibited a 
similar pattern of cytokine production to resident naïve macrophages, thus providing 
functional evidence that monocytes were differentiating into a pro-inflammatory 
macrophage phenotype (Fig. 6.9). 
 
To confirm that these macrophages were pro-inflammatory in vivo, mice that had 
received an initial challenge with MSU were exposed to a second dose of MSU two 
days later.  The inflammatory profile following in vivo restimulation was then 
compared to the profile of mice that had received a single dose of MSU.   
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Figure 6.8 Responsiveness of peritoneal exudate cells to MSU restimulation 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and over 
the course of the response peritoneal exudate cells were harvested by lavage (3mL 
PBS).  Peritoneal exudate cells from each time point were suspended in culture 
medium (1 x 106 cells/mL) and were treated with PBS (light bars) or with 200µg/mL 
MSU (dark bars) to show the capacity of the cells present at each time point to 
produce pro-inflammatory cytokines in response to MSU.  After 16h, supernatants 
were collected and cytokines analysed by ELISA or multiplex bead array.  
Measurements were performed in triplicate.  Values represent mean ± S.E.M. * = P 
< 0.05 and *** = P < 0.001 as determined by Student’s t-test against the relevant 
indicated control.  Results are representative of three separate experiments. 
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Figure 6.9 Stimulation of sorted macrophage populations ex vivo. 
Macrophage populations were sorted by fluorescence activated cell sorting, and 
cultured for 16h in the presence of PBS or MSU (200µg/mL).  Cytokine levels were 
then measured by ELISA and multiplex bead array.  Left, Cytokine production from 
F4/80hi naïve resident macrophages.  Right,  Cytokine production from F4/80lo 
immature macrophages harvested from mice 48h after in vivo MSU treatment.  
Measurements were performed in duplicate and values represent mean ± S.E.M. * = 
P < 0.05 and P < 0.01 as determined by Student’s t-test against the relevant indicated 
control. Results are representative of three separate experiments. 
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Table 6.1 Differential cell counts in peritoneal cells from naïve mice and from 
mice treated with MSU i.p. for 48h. 
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Figure 6.10 In vivo restimulation with a second injection of MSU 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS).  Two days later, mice received a second injection of MSU i.p. and 
over the course of the response peritoneal exudate cells were harvested by lavage (3mL PBS).  (A) Total cells in mice receiving a single 
treatment (light grey bars) or two treatments of MSU (dark grey bars) were determined, as well as (B) monocyte-macrophages (C) and 
neutrophils.  Lavage fluid was analysed for TNFα IL-6 and MCP-1 (D) by cytometric bead array.  Measurements were performed in triplicate.  
Values represent mean ± S.E.M. 
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Two days after the first injection of MSU, mice had a similar cell profile in the 
peritoneum as naïve mice, containing mast cells and lymphocytes but a slightly 
higher percentage of macrophages in MSU-treated mice (F4/80hi in naïve mice and 
F4/80lo in mice 2 days after MSU) (Table 6.1 and Fig. 6.10A; 0h).  However, total 
numbers of macrophages were similar in naïve and MSU-treated mice (Fig. 6.10B; 
0h).  When mice were restimulated with MSU in vivo a more rapid recruitment of 
both monocytes (Fig. 6.10B) and neutrophils (Fig. 6.10C) was observed.  However, 
the maximum cell numbers were comparable in both groups of mice and peaked at 
8h after MSU stimulation in both cases (Fig. 6.10A-C).  In restimulated mice, 
macrophages (F4/80lo) also disappeared from the peritoneal lavage fluid, consistent 
with activation and adhesion to surrounding membranes and tissues following MSU 
treatment (Fig. 6.10B; 2h). 
 
Increased cellular infiltration did not appear to correlate with higher levels of IL-6, 
TNFα and MCP-1 production within the first 2h of MSU treatment (Fig. 6.10D).  In 
fact, cell infiltration occurred faster despite a slightly lower cytokine production, 
indicating that F4/80lo macrophages may be sensitised to low concentrations of 
cytokines, or that other factors may be at play.  Although recruitment following a 
second MSU confirmed that monocytes differentiated into pro-inflammatory F4/80lo 
macrophages, it did not explain why recruitment was accelerated.  Therefore, to 
investigate the possible contribution from surrounding tissue, tissue sections were 
prepared from the peritoneal membranes of naïve mice and from mice after 
treatment with MSU.  Compared to membranes from naïve mice, the epithelial 
membranes of MSU-treated mice were still swollen and inflamed and had not 
recovered to a normal background even at 72h after MSU treatment (Fig. 6.11).  This 
poor tissue recovery indicated that although neutrophil-based inflammation has 
resolved by 48 hours, the surrounding non-hemopoietic tissue was still in a state of 
inflammation several days after the onset of gout inflammation.  The swollen 
epithelium therefore may have presented fewer physical barriers to a second 
neutrophil migration resulting in a much faster response despite lower cytokine 
levels in mice restimulated with MSU. 
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Figure 6.11 Hematoxylin and Eosin staining of peritoneal tissue 
Peritoneal tissue from naïve mice and from mice 72h after receiving an i.p. injection 
of MSU were harvested and Hematoxylin and Eosin stained sections prepared.  
Samples were taken from five separate mice per group. Arrow represents area of 
inflamed epithelium.  Original magnification 40x. Scale bar represents 100µm. 
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6.2.3 Investigating phagocytic capacity 
Phagocytosis is an important function of monocytes and macrophages allowing them 
to take up infectious organisms such as microbes, non-biological matter such as 
crystals, and dead and dying cells (Leenen and Campbell, 1993).  To investigate 
phagocytic capacity, I examined the expression of a phagocytosis receptor, CD206 
(the mannose receptor) as well as the ability of differentiating monocytes to 
phagocytose fluorescent beads. 
 
6.2.3.1 Expression of CD206 
The mannose receptor CD206 is commonly used as a marker of phagocytic 
capability (Kruskal et al., 1992).  To identify potential phagocytic activity of 
infiltrating monocytes CD206 expression was measured over the MSU-induced 
acute response in vivo.  As shown in Figure 6.12, CD206 did not appear to be 
expressed on newly recruited monocytes (Fig. 6.12; 4h).  However, the Gr-1+ 
monocytes began to upregulate CD206 around the same time that pro-inflammatory 
cytokine production ceased and peaked at the point when cell numbers – in 
particular, neutrophils – began to decline (Fig. 5.3A and Fig. 6.12).  It therefore 
appeared that phagocytic capacity of infiltrating monocytes was optimal during the 
period of neutrophil clearance indicating that monocyte-macrophages may contribute 
to the resolution phase of MSU-induced inflammation.  Interestingly, after 48h, 
corresponding to the period when F4/80 expression began to increase, CD206 
expression on monocyte-macrophages downregulated to levels comparable to 
resident macrophages, providing further evidence that monocytes differentiate into 
resident-like mature macrophages. 
 
6.2.3.2 Functional phagocytic bead assay 
To observe the phagocytic capacity of differentiating monocytes, the uptake of 
fluorescent beads was used as a direct measurement of phagocytosis.  I first sought 
to optimise the concentration of beads for the effective measurement of 
phagocytosis.  A bead titration was performed using a mixture of cells from the 
peritoneum on naïve mice, and from mice 8h after treatment with MSU. This cell
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Figure 6.12 Expression of the mannose receptor CD206 on F4/80+ cells over the 
course of an MSU-induced acute inflammatory response. 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and over 
the course of the response peritoneal exudate cells were harvested by lavage (3mL 
PBS).  Harvested cells were prepared and stained for surface markers and analysed 
by flow cytometry.  Monocytes were identified as cells expressing F4/80 and were 
also identified by Gr-1 and 7/4 where possible.  Results are representative of three 
separate experiments. 
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suspension contained a mixture of monocytes, macrophages, neutrophils and 
lymphocytes.  Since the original bead concentration was unknown, the concentration 
of beads was expressed as a dilution factor of the original stock solution. 
 
Monocyte/macrophages phagocytosed beads after 30 minutes incubation; and this 
could be visualised either on slides or by flow cytometry (Fig. 6.13A-B).  As 
determined by flow cytometry, the percentage of bead+ cells formed a sigmoid curve 
when plotted against bead dilution, with the steepest part of the curve occurring 
between dilution factors of 10-4 and 10-5.  Interestingly, not all cells phagocytosed 
beads, with only 35% of cells phagocytosing beads even at the highest bead 
concentration (Fig. 6.13C, dilution factor 5 x 10-2).  A bead dilution factor of 5 x 10-4 
was chosen to provide greatest sensitivity to changes in bead uptake by 
monocyte/macrophage populations. 
 
6.2.3.3 Phagocytic capacity of differentiating monocytes 
To investigate the phagocytic activity of infiltrating monocytes over time, peritoneal 
cells were harvested over the course of an in vivo MSU response and then exposed to 
fluorescent beads for 30 minutes. Peritoneal cells from a naïve mouse, containing 
mature macrophages, were included as a control.  Monocyte/macrophage 
populations were identified as F4/80+ cells, and neutrophils were identified and 
excluded using their phenotypic expression as F4/80-, Gr-1+ cells.  
 
As shown in Figure 6.14, 43% of peritoneal macrophages phagocytosed beads, and 
the majority of those macrophages phagocytosed more than one bead as determined 
by flow cytometry (Figs. 6.14 and 6.15).  At 4 hours after gout induction only 6% of 
infiltrating monocytes contained phagocytosed beads showing that infiltrating 
monocytes were only weakly phagocytic upon entry into the inflamed peritoneum 
(Fig. 6.14).  At 8 and 16 hours, infiltrating monocytes had become more phagocytic, 
with nearly 30% bead+ monocytes.  This increased again at 24 hours, with nearly 
40% of monocytes/immature macrophages phagocytosing beads.  Although the 
proportion of bead+ monocytes/immature macrophages at this time point was 
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Figure 6.13 Optimisation of bead concentration for use in the phagocytosis 
assay 
A cell suspension containing mixed samples of peritoneal exudate cells (1mL, 1 x 
106 cells) was incubated with various concentrations of fluorescent beads for 30 
mins.  Excess beads were then washed off and phagocytosis of beads visualised 
either by cytospin (A) or flow cytometry (B).  A dose titration was determined based 
on flow cytometry data (C).  Original magnification 40x.  Results are representative 
of two separate experiments. 
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Figure 6.14 Phagocytosis of fluorescent beads by monocyte-macrophages 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and over 
the course of the response peritoneal exudate cells were harvested by lavage (3mL 
PBS).  Harvested, washed peritoneal exudate cells from each time point (1mL, 1 x 
106 cells) were incubated with fluorescent beads for 30 mins.  Excess beads were 
washed off and cells were stained with surface markers and analysed by flow 
cytometry.  Results are representative of three separate experiments. 
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Figure 6.15 Enumeration of beads taken up by monocyte-macrophages 
Total F4/80+, bead+ cells in Figure 6.14 were divided into groups based on whether 
they had taken up one bead, two beads, or three or more beads using the peaks in 
flow cytometry histograms.  Measurements were performed in duplicate.  Values 
represent mean ± S.E.M.  Results are representative of three separate experiments. 
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Figure 6.16 Phagocytic capacity of macrophages from mice 72h after in vivo 
MSU treatment 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and after 
72h peritoneal exudate cells were harvested by lavage (3mL PBS).  Harvested, 
washed peritoneal exudate cells (1mL, 1 x 106 cells) were incubated with fluorescent 
beads for 30 mins.  Excess beads were washed off and cells were stained with 
surface markers and analysed by flow cytometry.  Results are representative of three 
separate experiments. 
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comparable to that of resident macrophages, resident macrophages exhibited greater 
phagocytic capacity with 45% phagocytosing three or more beads compared with 
20% of the immature macrophages.  This was consistent with recruited monocytes 
having an immature phenotype 24h after MSU treatment in vivo (Fig. 6.15).   
 
Based on earlier experiments indicating upregulation of F4/80 several days after 
MSU administration, the phagocytic capacity of both F4/80lo and F4/80hi cell 
populations was examined three days after MSU treatment.  Peritoneal cells 
harvested from mice three days after MSU treatment in vivo contained both F4/80lo 
immature macrophages and a population that had developed into an F4/80hi 
phenotype (Fig. 6.16).  F4/80hi macrophages in the population (R1) showed a greater 
proportion of bead+ cells as well as a higher uptake of beads per cell than F4/80lo 
macrophages in the same cellular exudate (R2).  This indicated that increased 
phagocytic capacity was associated with an increase in F4/80 expression and 
maturation. 
 
Collectively these data indicated that when Gr-1+ monocytes were first recruited into 
the peritoneum, they were not very phagocytic.  As they differentiated into immature 
macrophages they developed an increased phagocytic ability, which increased even 
further once they differentiated into F4/80hi phenotype, more closely resembling a 
mature resident phenotype. 
 
6.2.4 Investigating the effect of neutrophil uptake on monocyte responses 
The development of phagocytic capacity of monocytes in vivo, as well as the 
increased responsiveness of differentiating monocytes to MSU, did not appear to 
correlate with increased cytokine production in vivo.  Immature macrophages had 
become responsive to MSU by 24h after recruitment (Fig. 6.8), but by 24h the levels 
of cytokines found in vivo had returned to normal (Fig. 6.10) while the cell profile 
returned to levels comparable with naïve controls by 48h (Fig. 6.10 and Fig. 5.4). 
These in vivo data appeared to conflict with my other functional data showing that 
during the resolution phase of the inflammatory response, the immature macrophage 
population originating from the infiltrating monocytes shift towards a pro-
inflammatory phenotype (Figs. 6.8 and 6.10).  This led to the question as to what 
was causing a resolution of pro-inflammatory cytokine production.  
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Previous research has suggested that the uptake of apoptotic neutrophils by 
macrophages may be important in the clearance of a gout inflammation response 
(Rose et al., 2006).  Although this research showed prolonged inflammation in the 
absence of neutrophil uptake, the researchers had used a number of artificial and 
somewhat irrelevant systems to model resolving gout inflammation including 
thioglycollate-elicited macrophages and apoptotic thymocytes that contained a 
mixture of cell types.  In addition, they did not explore any differences in the 
production of pro-inflammatory cytokines from monocyte/macrophages following 
the uptake of apoptotic cells and subsequent exposure to MSU.  I therefore asked the 
question as to whether differentiating monocytes played a role in the resolution of 
gout through the phagocytosis of apoptotic neutrophils using monocytes and 
neutrophils recruited in response to MSU inflammation, thus providing more 
physiologically relevant observations. 
 
6.2.4.1 Monocyte phagocytosis of apoptotic cells 
To gain insight into whether monocyte/macrophages phagocytic capacity might be 
contributing to the resolution phase of acute gout, a means to measure the 
phagocytosis of neutrophils by infiltrating immature macrophages was sought. 
 
Neutrophils contain a high level of myeloperoxidase (MPO) within their azurophilic 
granules that can be detected using the histochemical dye o-dianisidine.  Using this 
dye, mononuclear phagocytes that have ingested neutrophils are readily identified by 
a brown staining within the cytoplasm, corresponding to the presence of MPO.  A 
clear advantage of this detection method is that it allows analysis of the normal 
inflammatory environment without the need for the uptake of pre-labelled cells. 
 
To investigate the phagocytic capacity of the infiltrating monocytes at different 
stages of differentiation, peritoneal cells were harvested at different time points after 
MSU treatment and stained for MPO and either immediately or after an in vitro 
culture for 18 hours.  Immediate staining of the peritoneal cells provided an “in situ 
snapshot” of the phagocytosis that was occurring in vivo; while staining following in 
vitro culture was carried out to determine the capacity of monocyte-macrophages to 
take up neutrophils.  Monocyte-macrophages were scored either MPO low or high.  
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Low MPO staining macrophages contained only a few particles of MPO staining, 
while high MPO staining cells either contained extensive MPO staining through the 
cytoplasm, or contained phagocytosed neutrophils within the cytoplasm. 
 
At 4 hours after MSU administration there were very few monocytes present, as had 
been shown in earlier investigations (Fig. 6.17; 4h and Fig 5.3B; 4h).  Peritoneal 
exudate cells were comprised mostly of neutrophils, and these neutrophils stained 
positively for peroxidase.  After in vitro incubation very few monocytes stained 
positively for peroxidase consistent with the earlier bead data that these monocytes 
were not phagocytic at this time point (Fig. 6.17; 4h and Fig. 6.18A and C).  MPO+ 
cells began to appear 8 hours after MSU treatment when stained immediately after 
harvest (Fig. 6.18A).  The percentage of MPO+ monocyte-macrophages continued to 
increase up to 24 hours.  When MPO+ monocyte-macrophages were separated as 
high and low staining, only a small proportion of cells were MPOhi, but this 
percentage steadily increased up to 24 hours. 
 
After in vitro incubation, monocyte-macrophages from 8 to 24h mice not only 
showed an increase in the percentage of MPO+ cells, but also showed a large 
increase in high MPOhi monocyte-macrophages, indicating the uptake of greater 
numbers of neutrophils per mononuclear phagocyte (Figs. 6.17 and 6.18C and D).  
These results showed that monocytes increased their uptake of apoptotic neutrophils 
in vivo over time, and have a high capacity for neutrophil uptake from eight hours 
on.  In cells from mice treated with MSU for 48h, there was very little peroxidase 
staining in macrophages and very few neutrophils consistent with resolution of the 
acute inflammatory response and neutrophil clearance in vivo. 
 
6.2.4.2 The uptake of apoptotic neutrophils leads to macrophage quiescence 
The uptake of apoptotic neutrophils has been shown in other systems to switch 
mononuclear cells from pro- to anti-inflammatory, leading to the production of 
cytokines involved in resolution including TGFβ (Fadok et al., 1998).  The uptake of 
apoptotic neutrophils in the in vivo gout model may therefore also be exerting an 
anti-inflammatory influence contributing to resolution of the inflammatory 
environment.   
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Figure 6.17 Peroxidase staining of peritoneal exudate cells 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and over 
the course of the response, peritoneal exudate cells were harvested by lavage (3mL 
PBS).  Cytospin slides of the cells were prepared either immediately or after 
incubation for 18h in vitro, stained with myeloperoxidase stain and counterstained 
with Diff-Quik.  Black arrows represent cells containing phagocytosed neutrophils.  
Original magnification 40x.  Results are representative of three separate 
experiments. 
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Figure 6.18 Percentage of myeloperoxidase positive (MPO+) monocyte-
macrophages in peritoneal exudate cells 
The percentages of monocyte-macrophages from Figure 6.17 containing MPO were 
determined by microscopic examination.  The percentage of MPO+ monocyte-
macrophages was determined immediately after harvesting either as total MPO+ cells 
(A) or divided into high and low MPO staining (B).  Alternatively, the percentage of 
MPO+ monocye-macrophages was determined after in vitro incubation for a further 
18h.  The percentage of MPO+ monocyte-macrophages was again determined 
immediately after harvesting either as total MPO+ cells (C) or divided into high and 
low MPO staining (D).  Measurements were performed in triplicate.  Values 
represent mean ± S.E.M.  Results are representative of three separate experiments. 
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To determine if the uptake of neutrophils initiated a more anti-inflammatory 
monocyte-macrophage cell-type in gout, peritoneal cells were harvested from mice 
treated with MSU for 18h (a time point corresponding to the resolution phase of 
inflammation).  Peritoneal leukocytes were then either stimulated immediately with 
MSU or incubated ex vivo for 4h and 22h (to allow neutrophil uptake) and then 
stimulated with MSU.  MPO staining of the immature macrophages showed that the 
percentage of MPO+ macrophages increased following 4h and 22h incubation ex vivo 
indicating an increased uptake of apoptotic neutrophils (Fig. 6.19A).  If neutrophil 
uptake were exerting a resolving effect on macrophages, then a lower level of MSU-
stimulated cytokine production would be expected. 
 
Out of all of the cytokines measured (TNFα, IL-6, MCP-1, IL-1β) only IL-1β was 
produced following exposure to MSU, indicating that these immature macrophages 
were only just acquiring responsiveness to MSU consistent with previous data that 
showed monocytes only became responsive to MSU between 16h and 24h (Fig. 6.8).  
In the case of IL-1β, there was a significant reduction in the responsiveness of the 
harvested cells to MSU stimulation, and this reduction was enhanced with a longer 
incubation with apoptotic neutrophils (Fig. 6.19B).  This phenomenon was also 
observed when the cells were stimulated with LPS, a result consistent with data 
previously reported in the literature (Fadok et al., 1998).  These results show that the 
uptake of apoptotic neutrophils by immature macrophages was associated with a 
decreased pro-inflammatory response to MSU and strongly implicates the uptake of 
neutrophils by immature macrophages as a potential shut-down mechanism for acute 
gouty inflammation. 
 
6.2.5 Monocyte-macrophages in the resolution of inflammation 
TGFβ is thought to play a central role in the resolution of gout inflammation.  It has 
been proposed that macrophages generate TGFβ in the resolution of gout 
inflammation, however this has not been shown in vivo.  Meanwhile, other studies 
have shown the production of TGFβ by macrophages as a result of neutrophil uptake 
in vitro. 
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Figure 6.19 IL-1β  production from peritoneal leukocytes following neutrophil 
uptake 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and the 
peritoneal cells harvested by lavage after 18h.  A. Cells were then stained for MPO 
either immediately, or after 4h or 22h incubation ex vivo.  The percentage of MPO+ 
staining monocyte-macrophages was determined by microscopic examination.  B. 
Cells (1 x 106/mL) were then stimulated with MSU (500µg/mL) or LPS (100ng/mL) 
either immediately, or after ex vivo incubation for either 4h or 22h.  Supernatants 
were collected after 8h and the level of IL-1β determined by ELISA.  * = P < 0.05 
and *** = P < 0.001 as determined by one way ANOVA and Tukey multiple 
comparisons test.  Results are representative of three separate experiments. 
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To determine whether TGFβ was exerting a role in the mouse model, lavage fluids 
were harvested from mice at different times over the MSU inflammatory response  
and were assayed for levels of TGFβ.  A total of 3mL of PBS was used to lavage the 
peritoneum, which meant that TGFβ was necessarily diluted.  The detectable levels 
of TGFβ were very low, the highest mean value being only 4ρg/mL (Fig. 6.20). 
Following MSU treatment there was a reproducible trend towards a decrease in 
TGFβ, yet the standard errors of the values were too high to show any statistical 
significance.  Another group (Rose et al., 2006) has also observed this same trend, 
indicating that there is a background level of TGFβ that decreases once MSU is 
administered.  This background TGFβ may exert a minor suppression on tissue 
macrophages that is released after MSU treatment.  However, it is also possible that 
TGFβ may not even participate in general suppression.  Interestingly, TGFβ levels 
did not return to homeostatic levels over the time resolution was observed in vivo 
(Fig. 6.20; 16-48h).  In addition, IL-10, an alternative suppressive mediator, was 
undetectable in the lavage fluid over the whole timecourse indicating that IL-10 does 
not play a role in gout resolution (data not shown).  In any case, the low levels of 
soluble TGFβ in vivo precluded the measurement of TGFβ as a direct measure of 
macrophages functioning as anti-inflammatory cells during resolution. 
 
6.3 Discussion 
This research provides the first comprehensive phenotyping and profiling of 
monocytes recruited in MSU-induced gout inflammation.  This characterisation was 
performed using changes in morphology, marker expression, and functionality.  
These changes are summarised in Figure 6.21.  
 
Monocytes that were recruited in response to MSU were of the “inflammatory” 
subtype and were macrophage precursors.  This study showed that as monocytes 
differentiated into macrophages, they went through at least two stages of 
differentiation, determinable by changes in marker expression.  In the first stage, 
monocytes differentiated into immature macrophages.  This was observed by a 
diminishing expression of myeloid differentiation antigens (Gr-1, 7/4) as well as an  
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Figure 6.20 TGFβ  levels in the peritoneum over the course of an MSU-induced 
acute inflammatory response. 
Mice were treated with an i.p. injection of MSU (3mg MSU, 0.5mL PBS) and over 
the course of the response the peritoneum was rinsed with lavage fluid (3mL PBS) 
and harvested.  Levels of TGFβ were determined by ELISA.  Measurements were 
performed in triplicate.  Values represent mean ± S.E.M.  Results are representative 
of three separate experiments. 
Chapter 6: Profiling monocyte differentiation in acute MSU-induced inflammation 
 
 
209 
 
 
 
 
Figure 6.21 Summary of the phenotypic and functional changes during the 
differentiation of monocytes to macrophages over the course of MSU-induced 
inflammation. 
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increase in size.  In the second stage, immature macrophages further differentiated 
into mature, resident-like macrophages, associated with increased expression of 
F4/80.   
 
The stages of monocyte differentiation into immature, and then to mature 
macrophages were also associated with changes in functional capacity.  When 
monocytes first entered the peritoneum they were not responsive to MSU and had 
poor phagocytic ability as shown by the phagocytosis of beads and of apoptotic 
neutrophils.  As they differentiated into immature macrophages they showed an 
increasing ability for phagocytosis from approximately 8h onwards.  However, 
further increases in phagocytic capacity and cytokine production potential occurred 
from 24h onwards as immature macrophages differentiated further into mature 
macrophages.  Therefore, the differentiation of monocytes into mature macrophages 
was associated with progressive increases in phagocytic ability, and pro-
inflammatory cytokine responses to MSU. 
 
The mannose receptor CD206 was transiently upregulated on differentiating 
monocytes indicating that phagocytic ability in terms of sensing mannosylated cell 
wall components reached an optimum, and then waned.  Yet phagocytosis of beads 
and cells demonstrated that monocytes that had differentiated into macrophages 
increased in the ability to phagocytose.  These data show that the use of CD206 is 
not so much a marker of phagocytosis, rather, it may be a hardwired mechanism 
whereby monocytes express CD206 as a surveillance mechanism to detect possible 
bacterial or other pathogenic infection.  Consequently, CD206 may have been 
downregulated in the absence of this stimulus (as MSU is a sterile inflammation).  It 
would be interesting to determine whether transient CD206 corresponds to some 
other important process contributing to the MSU response as CD206 is also known 
to be associated with type II macrophages, which can suppress type I inflammation 
(Stein et al., 1992, Gordon, 2003). 
 
Where the function of CD206 is known, and so a possible role for CD206 regulation 
suggested, other differentiation antigens such as F4/80 and 7/4 do not have a current 
known function.  The fact that these markers are regulated on differentiating 
monocyte/macrophages suggests that these molecules play an important role in 
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cellular functioning, yet the actual significance of these molecules has yet to be seen.  
For instance, despite F4/80 being a key marker of mononuclear phagocytes in mice, 
eosinophils are the only known human leukocyte to express an F4/80 ortholog 
(Hamann et al., 2007).  Whether this indicates that F4/80 is dispensable for 
inflammatory responses, or translates into an important functional difference 
between mouse and human mononuclear phagocytes is currently speculative.  Until 
the function of these molecules is known, it is difficult to hypothesis what their role 
would be in responses to MSU or in inflammation at large.  Nevertheless, they 
remain very useful tools for tracking differentiation states in mouse 
monocyte/macrophages. 
 
The differentiation of monocytes into macrophages that were pro-inflammatory 
rather than anti-inflammatory was not only confirmed in vitro but also in vivo in 
mice that had received a second dose of MSU at 48h after an initial MSU response.  
Mice that received a second dose of MSU displayed an inflammatory profile that 
was similar to the mice that had received only one.  These results contrast previous 
hypotheses (discussed in Chapter 5) that macrophages mount an anti-inflammatory 
response when stimulated with MSU (Yagnik et al., 2004).   
 
There are key differences in my experimental approach that may account for the 
differences observed.  The key difference is that most of their work was performed 
in vitro using either purified blood monocytes or mixed exudate cells from human 
blisters recruited from a stimulus that was not MSU (they used cantharidin).  My 
results were based on cells recruited using MSU as the stimulus in vivo, and so I 
have used and observed cells that were directly relevant to MSU-induced 
inflammation, thus representing the gouty condition more faithfully.  The cells in my 
study were not only recruited by the appropriate stimulus, but were exposed to 
conditions in the local environment in vivo that allowed the appropriate phenotypic 
and functional changes to be undertaken.  It can be argued that some of the 
differences observed may be partly explained by intrinsic differences between mouse 
and human cells, and it would be difficult to determine the extent of these 
differences.  However, the use of a mouse model clearly offers some advantages 
over the use of the blister technique alone for which it is difficult to create the 
appropriate conditions that reflect the in vivo system and provide enough cells to 
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carry out an extensive profiling to determine which mononuclear phagocyte type is 
actually being studied. 
 
An additional advantage of in vivo models is that they allow for extensive profiling 
of the inflammatory response so that the correct time points corresponding to the 
pro-inflammatory and resolution phases of the response can be identified.  In the 
skin blister study (Yagnik et al., 2004), two time points were arbitrarily chosen to 
represent cells from the pro-inflammatory (16h) and resolution phases (48h).  
However, in the mouse model, cells recruited in response to MSU were in the 
beginning stages of a resolving environment after 16 hours, with pro-inflammatory 
cytokines no longer elevated and cell numbers beginning to decline.  Therefore 
without profiling of the cells and inflammatory mediators in response to blister 
formation it is impossible to know whether the 16 hour time point chosen by the 
researchers actually corresponded to the inflammatory phase.  One way to improve 
the chances of choosing the correct time points and conditions in human studies is to 
use in vivo models to design better human experiments.  Since human studies are 
difficult to perform and reproduce given that subjects are not as easily available as in  
in vivo studies, in vivo models could be used to suggest appropriate time points and 
conditions to increase the likelihood that the conditions and time points chosen in 
human studies are more likely to have successful and relevant outcomes. 
 
The experiment exposing mice to a second MSU stimulation in vivo partially 
addressed an additional issue: that when monocytes developed the capacity to 
produce pro-inflammatory cytokines in vivo, there are paradoxically no measurable 
levels of cytokines produced in the peritoneum despite the presence of MSU crystals 
in the peritoneum for more than one week after injection (observational information 
from W. Martin).  These observations point to the notion that after initial 
recognition, MSU crystals in some way become unavailable and therefore unable to 
induce further inflammation such that resident macrophages that come into early 
contact with MSU are stimulated, but MSU crystals either become coated in proteins 
or ingested into cells where they are effectively walled off from further interaction 
with infiltrating cells.  In fact, it may be that the lack of an additional stimulus in the 
peritoneum when monocytes finally develop the capacity to produce pro-
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inflammatory cytokines to MSU prevents an on-going response allowing 
spontaneous resolution. 
 
Resolution of both cytokine levels and neutrophil numbers was well underway by 
the time monocytes developed a pro-inflammatory phenotype at 24h.  Therefore, 
factors other than non-responsiveness to MSU must be at play during the resolution 
phase.  Here I have shown that the uptake of apoptotic neutrophils was associated 
with a decreased responsiveness to both MSU and LPS after as little as four hours’ 
culture with neutrophils.  This meant that the uptake of apoptotic neutrophils exerted 
a suppressive influence on MSU-responsive macrophages and this process may serve 
as an active “shut down” mechanism in gout.  Although monocytes and immature 
macrophages themselves did not actively contribute to the generation of pro-
inflammatory cytokines and cell recruitment, the phagocytosis of apoptotic 
neutrophils may have shut down responses of any cytokine-producing macrophages 
that may be present. 
 
Differentiating monocytes showed evidence of neutrophil uptake as soon as 8h after 
recruitment, as determined my MPO staining, which increased over time until 
resolution was virtually complete at 48h.  This meant that as soon as monocytes 
developed phagocytic capability (which occurred from 8h onwards) they became 
sensitive to the presence of apoptotic neutrophils.  Hence, resolution may simply be 
an interplay between an evolving monocyte phagocytic function and an emerging 
neutrophil senescence in the absence of additional stimuli.  Although TGFβ has been 
thought to be involved in the resolution of gouty inflammation, either by being 
generated following neutrophil uptake or by other means, I was unable to detect a 
restoration in the levels of TGFβ.  This did not preclude the role of TGFβ in gout 
resolution; however, other methods such as quantitative PCR may need to be used in 
future studies to measure TGFβ in a meaningful way.  However, the lack of 
measurable soluble TGFβ supports the idea that factors other than TGFβ were at 
play during resolution.  Although my experiments did not prove that the uptake of 
neutrophils was the prime cause of the shut down in cytokine production, it provided 
a strong indication that this line of research warrants further investigation. 
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In summary, these data indicate that monocytes recruited in response to MSU do not 
produce inflammatory cytokines in response to MSU and are poorly phagocytic 
within the first few hours of recruitment.  Over the course of a few hours, these 
monocytes differentiate into immature macrophages as observed by a loss in Gr-1 
and 7/4 expression, an increase in phagocytic capacity, and an increasing ability to 
produce pro-inflammatory cytokines in response to MSU.  Despite developing the 
ability to produce pro-inflammatory cytokines to MSU, immature macrophages do 
not produce these cytokines in vivo; instead, resolution of inflammation is observed.  
Although this may be partly due to a lack of accessibility of MSU crystals in vivo, 
the uptake of phagocytic neutrophils in vivo may also inhibit the ability of immature 
macrophages to respond to MSU, thus leading to resolution.  After several days 
immature macrophages differentiate into mature macrophages, replenishing the local 
resident macrophage population. 
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Chapter 7 
General Discussion 
 
Innate immune cells have been recognised as important in acute gout for several 
decades.  As such, there have been many studies that have explored the involvement 
of neutrophils, monocytes, macrophages, and even endothelial cells in the acute gout 
response.  Here, this thesis offers a deeper insight into the involvement of each of 
these cell types in gout.  The use of a combination of in vitro, in vivo and ex vivo 
techniques provided a means whereby these cells could be studied both as purified 
populations, and as cells comprising one of a number of cell types representative of 
the mixed cellular conditions found during an acute gout attack in vivo.  Therefore, 
in addition to dissecting the contributions of individual cell types to acute gout, 
interactions between these cell types in the disease context could also be explored.  
Collectively these studies provide a bigger picture of the cellular events surrounding 
acute gout inflammation. 
 
7.1 Investigating mononuclear phagocyte function using in vivo models 
To date, most research into the function of mononuclear phagocytes has been 
performed in vitro using cells derived from human blood monocytes.  Although 
informative, this approach has several limitations that have been overcome by using 
in vivo mouse models in this study. 
 
Monocytes and macrophages by their very nature are cells with high plasticity that 
are influenced by their surrounding environment.  In vitro studies are therefore 
limited in their ability to simulate faithfully the factors present in the in vivo 
environment affecting mononuclear phagocyte function, response, and 
differentiation. In the first instance, in vivo models allow the correct stimulus to be 
used to set up the appropriate inflammatory conditions.  In vivo models also mimic 
the phenotypic adjustments that occur when mononuclear cells are exposed to 
recruiting cytokines, move through an endothelial layer, infiltrate into the site of 
inflammation, and are exposed to the factors and tissues that influence their 
differentiation.  Since cellular functions are likely to change as monocytes 
differentiate, extensive time courses are required so that changes are not overlooked 
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simply because an insufficient number of time points were observed. As there are no 
human models available to observe gouty inflammation in a routine and controlled 
way, mouse models provide a useful tool to allow all of these phenotypic changes to 
be measured. 
 
The use of in vivo models and primary cells revealed some unexpected findings that 
uncover important aspects of gout inflammation that contradict previously held ideas 
about the progression of gout inflammation, particularly around mononuclear 
phagocytes. 
 
7.2 Macrophages and the induction of gout inflammation 
The results of Chapter 5 demonstrated that macrophages are an important source of 
cytokines in gouty arthritis.  In particular, resident macrophages were a source of IL-
1β, which is pivotal in the recruitment of neutrophils in gout.  This was most clearly 
demonstrated in macrophage-depleted mice, which showed a reduction of IL-1β as 
well as a corresponding reduction in neutrophil recruitment compared to the 
responses of naive mice treated with MSU.  In addition to IL-1β, macrophages were 
also shown to be a source of IL-6, which also showed reduced levels in macrophage-
depleted mice.   
 
Although macrophages are an important source of pro-inflammatory cytokines, they 
are not an exclusive source of MSU-induced cytokine production in vivo.  Despite 
resident macrophages producing TNFα following MSU stimulation in vitro, there 
was no reduction in TNFα in macrophage-depleted mice suggesting an alternative 
primary source for TNFα in vivo – perhaps mast cells which contain pre-formed 
granules of TNFα are also known to be important in gouty inflammation (Getting et 
al., 1997, Gordon and Galli, 1990).  In addition, there were still small quantities of 
IL-1β and IL-6 produced in macrophage-depleted mice following MSU treatment.  
This was most likely derived from a small population of pro-inflammatory F4/80lo 
monocyte/macrophages migrating into the peritoneum following clodronate 
treatment.  Despite the presence of other cells that contribute TNFα in vivo, the 
overall reduction in cytokines and neutrophil recruitment following macrophage 
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depletion confirms these cells as being key in the initiation and driving of MSU-
induced inflammation. 
 
In previous research, one group proposed that monocytes contribute to the gout 
inflammatory response by producing pro-inflammatory cytokines in response to 
MSU, while mature macrophages instead produce anti-inflammatory cytokines 
(Dalbeth and Haskard, 2005).  Under this model it would be hypothesized that 
resident macrophages – a mature macrophage cell type - would produce anti-
inflammatory cytokines upon exposure to MSU.  Since the literature at large has 
reported conflicting evidence to suggest that macrophages can elicit both pro- and 
anti-inflammatory responses to MSU crystals (Section 1.10.11.1), it is surprising that 
in vivo confirmation of the hypothesis of pro-inflammatory monocytes and anti-
inflammatory macrophages has not been sought until now.  In contrast to the 
hypothesis of an anti-inflammatory function of macrophages, and in support of other 
groups reporting a pro-inflammatory response from MSU-stimulated macrophages in 
vitro, my findings clearly demonstrate that macrophages play a key pro-
inflammatory role in the induction of gouty inflammation.  
 
The conflicting results previously reported in the literature from a number of in vitro 
experiments highlight that mononuclear phagocytes can exhibit very different 
functions depending on the conditions used by researchers.  As such, care needs to 
be taken when interpreting data derived from in vitro results especially when they 
are generated from “artificial” cell types.  It had been previously shown that 
macrophages derived from in vitro differentiated CD14+ monocytes produced anti-
inflammatory TGFβ following exposure to MSU (Landis et al., 2002, Yagnik et al., 
2004).  In contrast, my results showed that resident macrophages produced pro-
inflammatory cytokines (IL-1β, IL-6, TNFα) in response to MSU consistent with 
previous reports showing pro-inflammatory activities from MSU-stimulated 
macrophages, such as the activation of the NALP3 inflammasome. 
 
Meanwhile, a number of other studies have routinely used other types of 
macrophages to study MSU-induced inflammation with varying results, further 
showing that macrophages can exhibit very different responses to MSU depending 
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on their phenotype.  For example, researchers have used macrophages elicited from 
an injection of thioglycollate broth into the peritoneum of mice, and these 
macrophage-like cells have often required exposure to priming amounts of additional 
stimuli such as LPS and muramyl dipeptide in order to elicit the desired IL-1β 
response on exposure to MSU (Martinon et al., 2006).  The response observed by 
resident macrophages in my research contrasted the response of thioglycollate-
elicited macrophages reported by others, in that resident macrophages did not require 
pre-exposure to an alternative priming stimulus in order to produce active IL-1β.  
My studies have also shown functional differences between resident macrophages 
and (immature) macrophages that have newly differentiated from inflammatory 
monocytes.  These immature macrophages did not exhibit the same capacity as 
resident macrophages to produce pro-inflammatory cytokines to MSU until several 
days following differentiation.  Although it may be possible that the differences in 
newly differentiated and mature resident macrophages may have completely 
appropriate functional consequences, these functions remain to be determined. 
 
It is also routine to produce macrophages in vitro from mouse bone marrow 
progenitor cells and human blood monocytes by exposure to GM-CSF and M-CSF 
over several days in vitro for study in MSU-induced or other kinds of inflammation.  
Although these cells feature in a number of studies, it has yet to be determined how 
closely these cells represent true primary macrophages in MSU induced 
inflammation. 
 
Collectively these data emphasize the high level of variability in macrophage 
responses that make it necessary to choose model systems that most accurately 
reflect the macrophage cell type of interest.  The use of primary macrophages in this 
study removed several elements that would potentially have had spurious effects on 
macrophage responses, such as effects introduced by irrelevant inflammatory stimuli 
such as thioglycollate, or the presence of cytokines such as GM-CSF and M-CSF in 
concentrations much higher than would be found in vivo.  Therefore, the use of 
primary macrophage cell types is a few steps closer to physiological relevancy. 
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The importance of macrophage activation in the onset of gout attacks identifies 
macrophages as a possible target for therapy in gout-susceptible individuals.  It also 
raises the question as to whether differences in individual susceptibilities to gout 
may be due to differences in the responsiveness of macrophages between 
individuals.  There is some evidence to suggest that blood monocytes from 
hyperuricemic patients that do not develop gout are less responsive to MSU than 
monocytes from normal patients, implying that these particular hyperuricemic 
individuals are protected from gout due to the low responsiveness of their monocytes 
(Schreiner et al., 2000).  However, there is as of yet no data to suggest that this is the 
case with macrophage cells.  It would be interesting to determine whether differing 
responses of macrophages from asymptomatic hyperuricemic and gouty individuals 
to MSU would explain the enigmatic phenomenon that some hyperuricemic 
individuals contract gout, while others do not. 
 
In the peritoneal model of MSU-induced inflammation, macrophages become active 
and adhere to MSU crystals and the surrounding tissue.  However, there is no 
evidence to suggest that adherent macrophages detach to reappear in the peritoneal 
cavity.  In fact, even when resident macrophages were pre-labelled with PKH26, 
there was no re-appearance of PKH26hi, F4/80hi macrophages as far as a week after 
MSU treatment.  Thus it remains to be determined whether these adherent, activated 
macrophages die, migrate, or assist in the resolution of inflammation while still 
adhering to MSU or surrounding tissue. 
 
7.3 Monocytes in gouty inflammation 
Until now, a study into the differentiation and functional phenotype of monocytes 
during the course of MSU-induced inflammation in vivo has not been undertaken.  
Here, I report that monocytes recruited in gout are macrophage precursors.  When 
monocytes are recruited, they go through at least two stages of differentiation.  The 
first is marked by a loss in the expression of Gr-1 and 7/4 within the first 24 hours.  
At this stage monocytes begin to take on the appearance of macrophages cells, 
increasing in size and forming a more circular shaped nucleus.  From 3-7 days these 
macrophages go through another phase of differentiation marked by an upregulation 
of F4/80 expression to the same level that is observed on mature resident 
macrophages.  These results contrast other reports where inflammatory monocytes 
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recruited to L. monocytogenes infection, or monocytes that take up beads in the skin 
and travel to the lymph node, differentiate instead into DCs (Auffray et al., 2007, 
Randolph et al., 1999). 
 
The differentiation of monocytes into immature macrophages and then to mature 
macrophages is also associated with functional changes.  Recruited monocytes do 
not produce inflammatory cytokines such as IL-1β, TNFα or IL-6 in response to 
MSU when first recruited in the peritoneum.  From 24 hours onwards, as immature 
macrophages, these cells become increasingly responsive to MSU, producing IL-1β, 
TNFα and IL-6 following exposure.  In addition to this increased ability for MSU-
stimulated cytokine production, monocytes also develop in their capacity for 
phagocytosis.  When monocytes are first recruited, they show very little phagocytic 
capacity, but this increases to a much higher capacity by 24 hours.  An additional 
increase in phagocytic capacity occurs when these cells become F4/80hi. These 
F4/80hi macrophages exhibit a similar phagocytic capacity to resident macrophages, 
adding weight to the idea that the acquisition of an F4/80hi phenotype marks a 
mature macrophage in the in vivo model.  In combination with the surface marker 
information, these data outline the first extensive characterisation of monocyte 
differentiation in MSU-induced inflammation in vivo. 
 
One of the novel findings from my experiments is the lack of monocyte cytokine 
production (IL-1β, TNFα, IL-6) in response to MSU within the first 16 hours of 
recruitment.  The inability to produce these cytokines in response to MSU does not 
appear to be dependent on the stimulus, as both in vivo MSU- and thioglycollate-
recruited cells did not produce IL-1β, TNFα and IL-6 in response to MSU 
stimulation in vitro.  Therefore, it would appear that recruited monocytes are, in 
general, unable to respond to MSU within the first few hours of recruitment. 
 
It has recently been shown that the phagocytic uptake of MSU crystals and the 
subsequent rupture of endosomes is important for the activation of the 
inflammasome and the production of IL-1β (Hornung et al., 2008).  My study shows 
that monocytes enter the peritoneum with low phagocytic capacity, and this lack of 
phagocytic capacity may prevent the uptake of crystals required for the rupture of 
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endosomes that activates the inflammasome.  Consistent with this, the acquisition (or 
reacquisition) of a high phagocytic capacity between 16-24 hours seems to correlate 
with the development of a pro-inflammatory response to MSU.  Confirmation of a 
requirement for phagocytic capacity could be achieved in future experiments through 
the use of the phagocytosis inhibitor, cytochalasin B (MacLean-Fletcher and Pollard, 
1980).  If phagocytosis were required for responsiveness, then the use of this 
inhibitor from 24h onwards would inhibit responses from newly differentiating 
macrophages.  
 
It is as of yet unknown whether rupture of endosomes is required for the production 
of other cytokines, such as TNFα and IL-6.  My study suggests that the ability of 
monocytes to produce the cytokines in response to MSU emerges for all cytokines at 
approximate 24 hours after MSU treatment, indicating that a similar process for 
MSU recognition may be required for the production of all of the cytokines 
measured.  The use of bafilomycin to stabilise the acidification of lysosomes, would 
confirm whether the rupture of acidified endosomes containing MSU is indeed 
required for responsiveness to MSU in the production of cytokines and chemokines 
other than IL-1β (Crider et al., 1994 ).  Besides activation through endosome 
rupturing, it remains possible that there may be cell activation or priming through 
receptor recognition of MSU, where absence of this unknown receptor on newly 
infiltrated monocytes prevents monocytes from responding to MSU.  
 
Even though newly recruited monocytes were not responsive to MSU, they were, in 
fact, sensitive to LPS stimulation.  MSU recruited monocytes were able to produce 
IL-6 and TNFα in response to LPS, demonstrating that monocytes were physically 
capable of producing cytokines.  This suggests that MSU that is formed under 
normal physiological conditions as a “danger signal” is simply a means of inducing 
cellular recruitment through the production of IL-1β.  In an ordinary infectious 
response, a second inflammatory stimulus would also be present – bacteria with 
bacterial cell wall products, for example - to help stimulate additional inflammatory 
events.  MSU crystals in gout appear to become walled off from incoming cells, 
hence, recruited cells may lack a secondary stimulus to stimulate the on-going 
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inflammation.  This lack of a secondary stimulus may contribute, at least in part, to 
the spontaneous resolution observed in gout in humans after 7-10 days.   
 
7.4 Resolution of gouty inflammation 
Increased phagocytic ability of immature macrophages coincides with the onset of 
neutrophil apoptosis in vivo, such that as immature macrophages become phagocytic, 
they ingest apoptotic neutrophils.  Immature monocytes stained for MPO showed an 
increased positive staining as neutrophils were cleared from the peritoneum.  In 
addition, uptake of neutrophils by immature F4/80lo macrophages made them less 
responsive to MSU as well as to LPS.  Hence, as has been previously proposed, it is 
possible that the uptake of neutrophils is involved in the general suppression of 
inflammation (Huynh et al., 2002, Rose et al., 2006).  The increase in phagocytosis 
of apoptotic neutrophils could possibly prevent inflammatory responses from 
otherwise responsive immature macrophages and potentially turn off existing 
cytokine producing macrophages present in the peritoneum or joint.  Therefore, the 
uptake of phagocytic neutrophils by immature macrophages may play a major role in 
actively driving resolution. 
 
Although it is thought that the resolution of inflammatory processes in gout involves 
the generation of TGFβ, in the in vivo model there was a low level of TGFβ present 
under normal homeostatic conditions that reduced following MSU administration, 
implying that any latent level of suppression being exerted by TGFβ was released 
following MSU challenge.  However, an increase in TGFβ levels to re-establish the 
normal homeostatic condition was not observed during resolution in vivo, despite a 
decline in local cytokine levels and leukocyte numbers.  Although this does not 
exclude TGFβ from functioning during resolution within this system, it does suggest 
that more in vivo work is required to determine whether TGFβ has is present and 
exerting any effect.  
 
7.5 Neutrophils in gout 
Neutrophils have been recognised for several decades as an important cell in gout.  
The results presented in this thesis add further insight into the activation and role of 
neutrophils in MSU-induced inflammation. 
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Previous gout research has focussed on the activation of neutrophils following 
contact with MSU.  My research instead has tested the hypothesis that neutrophils 
are also exposed to inflammatory mediators and signals prior to MSU contact that 
activate neutrophils completely independent of contact with MSU crystals.  The 
effect of soluble mediators was tested on three aspects of neutrophil activation: IL-8 
production, viability and superoxide production.   
 
It has long been known that MSU causes a delay in neutrophil apoptosis (Akahoshi 
et al., 1997).  It is also known that cytokines and chemokines affect neutrophil 
apoptosis; for instance, IL-8 and IL-6 delay it, while TNFα hastens it (Biffl et al., 
1996, Kettritz et al., 1997, Kettritz et al., 1998). In my experiments, exposure of 
neutrophils to conditioned media containing a mixture of soluble inflammatory 
mediators (including IL-8, IL-6, IL-1β and TNFα) caused a much greater delay in 
neutrophil apoptosis than direct contact with MSU.  In fact, the improvement in 
viability (i.e. delay in apoptosis) did not increase any further when contact with 
MSU was also included as a second stimulus.  Perhaps it is not surprising that an 
improvement in viability is observed in the presence of soluble mediators, however, 
this study is the first to indicate that neutrophil viability in MSU-induced 
inflammation may be more heavily influenced by soluble mediators than by direct 
MSU stimulation.   
 
Similarly, both MSU and cytokines have been shown independently to stimulate IL-
8 production from neutrophils (Hachicha et al., 1995, Strieter et al., 1992).  Again, 
my experiments showed that soluble mediators, rather than direct stimulation with 
MSU, had the greater effect on IL-8 production in neutrophils which further 
demonstrates the gathering evidence that neutrophil activation is affected by the 
cytokine environment, at least as much – if not more – than contact with MSU 
crystals. 
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Soluble mediators were not able to stimulate superoxide production, showing a 
requirement for MSU contact; however, exposure to soluble mediators primes 
superoxide production in response to MSU and thus soluble mediators influence the 
magnitude of the superoxide response.  This is similar to other neutrophil responses 
that have shown that IL-8, IL-1β, TNFα and IL-6 can prime neutrophil superoxide 
production in response to other stimuli, such as fMLP (Bajaj et al., 1992, Daniels et 
al., 1992, Kharazmi et al., 1989, Sullivan et al., 1989).  How soluble mediators 
influence neutrophil sensitivity to MSU crystals is yet to be determined.   
 
These results show that activation of neutrophils in MSU-inflammation is heavily 
influenced by factors independent of MSU-contact and that neutrophils responses are 
highly dependent on the pro-inflammatory responses generated from cells producing 
cytokines in response to MSU. 
 
In addition to the pro-inflammatory effect of soluble mediators, the serum 
environment of neutrophils alters superoxide production.  Whereas neutrophils in 
high serum and serum-free environments show a requirement for MSU contact, a 
low serum environment – as may possibly be found in the joint environment – 
triggers superoxide production indicating that MSU contact may also be unnecessary 
for neutrophil activation following recruitment in vivo.  Although MSU crystal 
contact may also play a role during gouty inflammation, the response to low serum 
environments suggests that neutrophils may be hardwired to respond to the 
environmental change that occurs during recruitment in vivo, such that superoxide 
production is automatic upon tissue infiltration and precedes contact with the 
physical inflammatory stimulus.  A pre-emptive strike upon infectious organisms 
would be the most likely benefit of such a response.  However, whether the serum or 
plasma environment of the knee spontaneously activates infiltrating neutrophils is 
dependent on the presence of the currently unknown protein or compounds in similar 
amounts to those observed in vitro.  Therefore, it cannot entirely be ruled out that the 
observed stimulatory phenomenon of low serum is a spurious function of in vitro 
conditions. 
 
All of these data suggest that after the initiation of inflammation in gout, by 
macrophages and perhaps mast cells as well, that activation of neutrophils in gout in 
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vivo may not even require interaction with MSU; that neutrophil activation occurs as 
a result of stimulation by cytokines, possibly in combination with recruitment from 
the high serum environment of the blood to the low serum environment of the joint. 
 
The activation of IL-8 production, improved viability, and a high superoxide 
response suggest that the principle function of neutrophils during gout inflammation 
is to accumulate in large numbers as ROS-producing cells in the joint.  IL-8 is 
known to be an important cytokine in the recruitment of neutrophils (Baggiolini and 
Clark-Lewis, 1992); therefore the production of IL-8 by neutrophils augments the 
recruitment of higher numbers of neutrophils into the joint space.  Since neutrophils 
are usually short-lived cells, the delay in apoptosis under MSU-inflammatory 
conditions causes an extended persistence at the inflammatory site further allowing 
the accumulation of large amounts of neutrophils.  Using the peritoneal model of 
gout, an acute accumulation of neutrophils was observed following MSU 
administration, and in addition, recruited neutrophils actively produced superoxide 
ex vivo without an additional stimulation and in the absence of serum in the culture 
conditions, indicating that recruited neutrophils were active superoxide producers 
upon recruitment.  Therefore, it appears that superoxide production is a major 
inflammatory activity of neutrophils in vivo.  
 
The idea that superoxide production is one of the main inflammatory functions of 
neutrophils in gout is supported by the observation that, other than IL-8, neutrophils 
were not a major source of other inflammatory cytokines following MSU 
stimulation.  Unlike human mononuclear cells, purified human blood neutrophils did 
not produce IL-1β, TNFα or IL-6 upon exposure to MSU.  In support of this finding, 
purified MSU-recruited mouse neutrophils were also shown not to produce IL-1β, 
TNFα or IL-6 upon re-exposure to MSU in vitro.  Although it is possible that other 
mediators may be released from neutrophils that are not being measured in these 
experiments (e.g. MIP, S100 proteins), cytokine production does not appear to be a 
principle function of recruited neutrophils in MSU inflammation.  
 
A limitation of the in vivo mouse model that prevented further investigation of IL-8 
in gout is that mice do not produce IL-8.  It could be argued that other IL-8R 
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agonists in mice such as KC and MIP-1 could be used to study the role of IL-8 in 
human neutrophil inflammation.  However, humans also contain KC and MIP-1, so 
it is likely that the study of these cytokines in mice would simply model human 
regulation of KC and MCP-1 rather than IL-8.  Nevertheless, the parallel findings in 
purified human and mouse neutrophils of a lack of cytokine production combined 
with heightened superoxide production support superoxide production rather than 
cytokine production as the primary role for neutrophils. 
 
7.6 Inhibiting superoxide production as a therapy for gouty inflammation 
The principle role of neutrophils as ROS-generating cells opened up the opportunity 
to develop anti-inflammatory compounds aimed at inhibiting neutrophil superoxide 
production.  This is particularly relevant in gout since MSU is a sterile inflammatory 
stimulus, making the generation of anti-microbial ROS physiologically irrelevant.  
Therefore, I investigated whether superoxide production could be inhibited by 
sesquiterpene dialdehyde compounds.  Sesquiterpene dialdehydes were able to 
inhibit superoxide production from human neutrophils stimulated with both PMA 
and MSU crystals in vitro.  These compounds were able to inhibit superoxide 
production in vivo when administered prior to MSU crystal administration in the 
mouse model of gout confirming these compounds to be potential anti-
inflammatories to neutrophil activation in vivo. 
 
In addition to the inhibition of superoxide production, some sesquiterpene 
dialdehydes also inhibited neutrophil recruitment in vivo.  Since neutrophil activation 
is heavily influenced by cytokines produced from MSU-responsive cells such as 
macrophages, this implied that the compounds were affecting other cellular targets 
involved in neutrophil recruitment.  My results showed that sesquiterpene 
dialdehydes were able to inhibit MSU-stimulated cytokine production from 
macrophages in vitro, and were also able to inhibit NADPH oxidase activity in 
superoxide-producing epithelial cells: two processes known to be associated with 
neutrophils recruitment.  Thus, these studies identify three promising sesquiterpene 
dialdehydes as compounds for development as anti-inflammatories targeting not only 
superoxide production, but also neutrophil recruitment.  
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Despite being involved in the pro-inflammatory phase of gout inflammation, 
neutrophils are also involved in the resolution phase of gout.  As mentioned above, 
neutrophils undergoing apoptosis are taken up by (immature) macrophages and this 
process inhibits the responsiveness of macrophages to MSU and also to LPS 
allowing resolution of inflammation.  It has yet to be directly determined whether 
this process is also responsible for the reduction of cytokine production observed in 
vivo during the resolution of the cytokine response where reduction in pro-
inflammatory cytokine production occurs before maximal cell infiltration. 
  
7.7 Dissecting the roles of inflammatory cells in gout 
The major body of this thesis was focussed on the role of monocytes, macrophages 
and neutrophils to the MSU-inflammatory response, and as such, the contributions of 
each of these cell types has been outlined in this discussion thus far.  The outcomes 
of this research also revealed potential contributions of epithelial cells to MSU-
induced inflammation. 
 
MSU crystals were able to stimulate epithelial cells to produce MCP-1, both as 
whole excised epithelial tissue and as purified cells cultures.  When compared 
against stimulated resident leukocytes, epithelial tissue was the main source of 
MSU-stimulated MCP-1 over the acute cytokine-producing period.  As MCP-1 is 
important in the recruitment of monocytes, this implies that epithelial cells may be 
responsible for monocyte recruitment.  In line with this observation, monocyte 
recruitment was unaffected by macrophage depletion, indicating that cells other than 
macrophages were responsible for monocyte recruitment. 
 
It is also possible that superoxide production by epithelial cells is somehow involved 
in MSU-induced cellular recruitment.  I have shown that sesquiterpene compounds 
with anti-inflammatory activity against NADPH oxidase were able to inhibit the 
production of superoxide from stimulated HUVECs, and this activity may have 
contributed to the reduced neutrophil recruitment.  Superoxide production by MSU-
stimulated HUVECs has been previously reported (Falasca et al., 1993) and 
HUVECs exposed to MSU promoted neutrophil adhesion to these endothelial cells 
(Reinhardt et al., 1996).  Hence there is a growing understanding that MSU-
stimulated epithelial cells, including endothelium, contribute to the recruitment of 
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monocytes and/or neutrophils during the gout inflammatory response.  Further 
research into the contribution of epithelial cells in cellular recruitment would help to 
identify which arm of the inflammatory response is affected or initiated by these 
cells. 
 
7.8 Future directions 
The findings of this study filter into an important question that remains to be 
answered in gouty arthritis; that is: why do 75% of individuals with hyperuricemia 
not develop gout (Campion et al., 1987)? The answer to this question is particularly 
important for groups such as Maori, who suffer a particularly high incidence of gout, 
and therefore may be a part of the 25% of hyperuricemics that are prone to gout.  If it 
can be determined what aspects influence risk in hyperuricemic conditions, then 
diagnostic tests may be developed to identify at risk individuals, and new treatments 
developed for both prophylaxis and disease mitigation.  But which biological 
elements are likely candidates for exploring the above question? 
 
The results of this study identify a number of elements that may be explored in 
future studies.  For instance, resident macrophages were shown in Chapter 5 to be 
important in the induction of gouty arthritis: could it be that macrophages of people 
who develop gout can detect very small quantities of MSU crystals? Support for a 
role of macrophages in exerting control over responses to MSU is also found in 
Chapter 3, where soluble mediators in the surrounding milieu influenced neutrophil 
function in response to MSU.  Therefore, it may also be possible that macrophages 
from individuals that develop gout may produce higher amounts of pro-
inflammatory cytokines in response to MSU, leading to exacerbated inflammatory 
responses from downstream inflammatory players such as neutrophils. 
 
The importance of soluble mediators on neutrophil function also begs the question of 
whether sufferers of gout have a higher than normal systemic level of particular pro-
inflammatory cytokines that may cause neutrophils to exist in a primed state even 
during normal homeostasis.  An extensive clinical study of this has not been 
reported, and as such, this kind of study may help to explain why gouty attacks 
appear to become more acute and intense as gouty attacks increase. 
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The effect of hyperuricemia on inflammatory responses was not a subject of this 
thesis, yet may itself be playing a role in gout over and above providing a pool of 
uric acid from which MSU crystals may be formed.  It is possible that the responses 
of macrophages – and indeed, of other cells including neutrophils - may be affected 
by the presence of high soluble uric acid.  Soluble uric acid may be having an effect 
on leukocyte responses in vivo that has yet to be demonstrated in the literature.  
Since mice have functional uricase, and uricase knockout mice develop severe 
pathology and high lethality, the use of a murine model for responses in 
hyperuricemic conditions has not been extensively studied.  Recently, the use of the 
uricase inhibitor, oxonic acid, to induce hyperuricemia in rats has been reported, 
opening the way to study the effect of hyperuricemia on MSU-induced inflammation 
(Mazzali et al., 2001).  Although this model is likely to yield interesting results – 
including the secondary effects of hyperuricemia on other metabolic disorders - 
hyperuricemia is a common factor for both hyperuricemia groups that either contract 
and do not contract gout, and therefore it is not likely that hyperuricemia is the sole 
cause of the exacerbated responses observed in gouty individuals. 
 
The results of Chapter 6 show that monocytes differentiate into macrophages, which 
then ingest apoptotic neutrophils, and as a result, the uptake of neutrophils prevents 
pro-inflammatory responses.  Many studies have shown that the uptake of apoptotic 
neutrophils causes the release of TGFβ that contributes to the observed resolution 
(Fadok et al., 1998, Huynh et al., 2002).  I was unable to detect high enough levels of 
TGFβ using the procedures available to me; however, future work would involve 
alternative methods of measuring TGFβ including quantitative PCR to measure the 
levels of TGFβ message.  This might help determine whether the production of 
TGFβ by mononuclear phagocytes truly plays a role in resolution. 
 
One of the principal reasons for interest in the processes surrounding resolution in 
gout is that if it was known what processes control resolution, then these processes 
could be used to expedite and even prevent gouty attacks.  It is entirely possible that 
pro-resolution processes that do not involve TGFβ may also be at play.  It was 
recently shown that apoptotic neutrophils upregulate chemokine receptors while 
undergoing apoptosis, sequestering chemokines via these receptors and then being 
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taken up as a whole by macrophages (Ariel et al., 2006).  This process was 
hypothesised to be important in the clearance of chemokines during inflammatory 
resolution.  Whether this process also occurs during resolution in gouty arthritis is a 
subject for future investigation. 
 
7.9 Conclusion 
This research, focussed on the innate immune cells involved in the gout response, 
enables a new overview of acute gout inflammation to be drawn that outlines the 
initiation, progression, and resolution of a gout attack. 
 
The formation of MSU crystals activates macrophages to produce pro-inflammatory 
cytokines such as IL-1β, TNFα and IL-6.  Epithelial cells are also activated and 
produce MCP-1.  The production of these cytokines produced by MSU-stimulated 
cells initiates the recruitment of cells into the joint (Fig. 7.1A). 
 
Neutrophils are recruited in response to the production of macrophage-derived 
cytokines. Both in the blood and in the joint, neutrophils are exposed to elevated 
cytokine levels and this exposure leads them to produce IL-8, delay homeostatic 
apoptosis and primes them for superoxide production, all potentially before contact 
with MSU.  As neutrophils infiltrate into the joint, the movement from the high 
serum environment of the bloodstream to the low serum environment of the joint 
may further augment the production of superoxide that occurs following neutrophil 
interaction with MSU, adding to the inflammatory environment in the joint (Fig. 
7.1B). 
 
Monocytes are also recruited to the joint, through a process that is not dependent on 
macrophage activation.  Monocytes infiltrate into the joint but do not produce pro-
inflammatory cytokines.  By the time monocytes have differentiated into immature 
macrophages capable of responding to MSU crystals, MSU in the joint has already 
been walled off such that monocytes do not interact with MSU.  Instead, as
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Figure 7.1 Model of acute gouty inflammation. 
A. MSU crystals stimulate the induction of acute gout inflammation, resulting in the 
recruitment of neutrophils and monocytes.  Resident macrophages produce pro-
inflammatory cytokines including IL-1β and IL-6 that result in the neutrophil 
recruitment.  Monocyte recruitment occurs via a separate mechanism that potentially 
involves the production of MCP-1 by endothelial cells.  B. During MSU-induced 
inflammation, neutrophils are exposed to pro-inflammatory cytokines, which causes 
them to become activated (green), producing IL-8 and delaying apoptosis which 
augments the accumulation of neutrophils in large numbers prior to contact with 
MSU.  Recruited neutrophils are exposed to at least three inflammatory stimuli in the 
joint. The first, is cytokine exposure that leads to activation and priming (green).  
The second is physical contact of cytokine-primed neutrophils with MSU, resulting 
an intense production of superoxide (yellow).  The third stimulus is the movement 
into a low serum environment resulting in superoxide production independent of 
MSU contact (yellow).  C.  Monocytes recruited to MSU-induced inflammation do 
not produce large amounts of cytokines upon recruitment, nor are they “responsive” 
to MSU during the inflammatory phase.  Instead, they differentiate into immature 
macrophages and participate in the resolution of inflammation by phagocytosing 
apoptotic neutrophils.  After several days, immature macrophages differentiate into 
resident macrophages, replenishing the resident population once inflammation has 
subsided. 
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immature macrophages they phagocytose the neutrophils that have been recruited 
and have become apoptotic.  This uptake of neutrophils further prevents their ability 
to respond to MSU.  The uptake of neutrophils by cytokine producing cells may also 
turn off existing cytokine production, facilitating resolution.  After approximately a 
week, immature macrophages differentiate into resident-like macrophages 
replenishing the local resident population (Fig. 7.1C). 
 
In summary, this research provides significant clarification on the roles of 
monocytes, macrophages and neutrophils in gout and dissects their various 
contributions and interactions in gout inflammation over the course of an MSU-
induced response.  
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Technical Resources - Media Formulations
Dulbecco's Phosphate-Buffered Saline (D-PBS) (1X) liquid
Contains calcium and magnesium.
Catalog Number(s): 14040075 ,14040083 ,14040091 ,14040117 ,14040133 ,14040141 ,14040158 ,14040166
,14040174 ,14040182 ,14040216
COMPONENTS Molecular Weight Concentration (mg/L) Molarity
Inorganic Salts
Calcium Chloride (CaCl2) (anhyd.) 111 100 0.900901
Magnesium Chloride (MgCl2-6H2O) 203 100 0.492611
Potassium Chloride (KCl) 75 200 2.666667
Potassium Phosphate monobasic (KH2PO4) 136 200 1.470588
Sodium Chloride (NaCl) 58 8000 137.93103
Sodium Phosphate dibasic (Na2HPO4-7H2O) 268 2160 8.059702
Related Products
Copyright © 2008 Invitrogen Corporation. All rights reserved.
Print This
Technical Resources - Media Formulations
Hanks' Balanced Salt Solution (HBSS) (1X) liquid
Contains calcium and magnesium.
Balanced salt solutions are based on the physiological saline first developed by Ringer. They are composed of
inorganic salts and may be supplemented with glucose. Balanced salt solutions have been designed to maintain
cells in a viable state for short periods of time rather than to promote growth. Balanced salt solutions are used
for washing tissues and cells and as diluents for treating cells and tissues with various agents, while maintaining
a physiological pH and osmotic pressure. Hank's Balanced Salt Solution is buffered with phosphate. Therefore
the solution will maintain its physiological pH at atmospheric conditions. For this reason it is the primary solution
used in enzymatic treatments of cells and tissue and the final rinse of cells prior to the suspension of the cells in
a complete growth medium.
Catalog Number(s): 24020018 ,24020034 ,24020059 ,24020067 ,24020075 ,24020083 ,24020091 ,24020109
,24020117 ,24020125 ,24020133 ,24020141
COMPONENTS MolecularWeight
Concentration
(mg/L) Molarity
Inorganic Salts
Calcium Chloride (CaCl2) (anhyd.) 111 140 1.261261
Magnesium Chloride (MgCl2-6H2O) 203 100 0.492611
Magnesium Sulfate (MgSO4-7H2O) 246 100 0.406504
Potassium Chloride (KCl) 75 400 5.333334
Potassium Phosphate monobasic (KH2PO4) 136 60 0.441176
Sodium Bicarbonate (NaHCO3) 84 350 4.166666
Sodium Chloride (NaCl) 58 8000 137.93103
Sodium Phosphate dibasic (Na2HPO4)
anhydrous 142 48 0.338028
Other Components
D-Glucose (Dextrose) 180 1000 5.555555
Phenol Red 376.4 10 0.026567
Related Products
Copyright © 2008 Invitrogen Corporation. All rights reserved.
Print This
Technical Resources - Media Formulations
Advanced RPMI Medium 1640 (1X) liquid
Contains 2,000 mg/L D-glucose, non-essential amino acids (NEAA), and 110 mg/L sodium pyruvate, but
no L-glutamine.
RPMI (Roswell Park Memorial Institute) Media 1640 are enriched formulations with extensive applications for
mammalian cells. They were originally formulated for suspension cultures or monolayer cultures of human
leukemia cells.
Catalog Number(s): 12633012 ,12633020
COMPONENTS MolecularWeight
Concentration
(mg/L) Molarity
Amino Acids
Glycine 75 10 0.133333
L-Alanine 89 8.9 0.1
L-Arginine 174 200 1.149425
L-Asparagine 132 50 0.378788
L-Aspartic acid 133 20 0.150376
L-Cystine 2HCl 313 65 0.207668
L-Glutamic Acid 147 20 0.136054
L-Histidine 155 15 0.096774
L-Hydroxyproline 131 20 0.152672
L-Isoleucine 131 50 0.381679
L-Leucine 131 50 0.381679
L-Lysine hydrochloride 146 40 0.273973
L-Methionine 149 15 0.100671
L-Phenylalanine 165 15 0.090909
L-Proline 115 20 0.173913
L-Serine 105 30 0.285714
L-Threonine 119 20 0.168067
L-Tryptophan 204 5 0.02451
L-Tyrosine disodium salt 225 29 0.128889
L-Valine 117 20 0.17094
Vitamins
Ascorbic Acid phosphate 289.54 2.5 0.008634
Biotin 244 0.2 0.00082
Choline chloride 140 3 0.021429
D-Calcium pantothenate 477 0.25 0.000524
Folic Acid 441 1 0.002268
Niacinamide 122 1 0.008197
Para-Aminobenzoic Acid 137 1 0.007299
Pyridoxine hydrochloride 206 1 0.004854
Riboflavin 376 0.2 0.000532
Thiamine hydrochloride 337 1 0.002967
Vitamin B12 1355 0.005 0.000004
i-Inositol 180 35 0.194444
Inorganic Salts
Calcium nitrate (Ca(NO3)2 4H2O) 236 100 0.423729
Magnesium Sulfate (MgSO4) (anhyd.) 120 48.84 0.407
Potassium Chloride (KCl) 75 400 5.333334
Sodium Bicarbonate (NaHCO3) 84 2000 23.809525
Sodium Chloride (NaCl) 58 6000 103.44827
Sodium Phosphate dibasic (Na2HPO4)
anhydrous 142 800 5.633803
Zinc sulfate (ZnSO4-7H2O) 288 0.874 0.003035
Proteins
AlbuMAX® II 400 ∞
Human Transferrin (Holo) 7.5 ∞
Insulin Recombinant Full Chain 10 ∞
Trace Elements
Ammonium Metavanadate 116.98 0.0003 0.000003
Cupric Sulfate 250 0.00125 0.000005
Manganous Chloride 198 0.00005 0
Print This
Sodium Selenite 173 0.005 0.000029
Other Components
D-Glucose (Dextrose) 180 2000 11.111111
Ethanolamine 97.54 1.9 0.019479
Glutathione (reduced) 307 1 0.003257
Phenol Red 376.4 5 0.013284
Sodium Pyruvate 110 110 1
Related Products
Copyright © 2008 Invitrogen Corporation. All rights reserved.
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Resident Macrophages Initiating and Driving Inflammation in a
Monosodium Urate Monohydrate Crystal–Induced
Murine Peritoneal Model of Acute Gout
William John Martin, Michaela Walton, and Jacquie Harper
Objective. To determine whether infiltrating
monocytes, neutrophils, or resident macrophages con-
tribute to the early inflammatory response to monoso-
dium urate monohydrate (MSU) crystals in vivo.
Methods. MSU crystal–induced inflammation
was monitored using a peritoneal model of acute gout.
The production of proinflammatory cytokines
(interleukin-1 [IL-1], tumor necrosis factor 
[TNF], IL-6) by resident macrophages, infiltrating
monocytes, and neutrophils during the onset of gout was
determined by flow cytometry. Infiltrating and resident
peritoneal cells were cultured with MSU crystals ex vivo,
and proinflammatory cytokine production was deter-
mined by multiplex cytokine array. Activated macro-
phages on the visceral epithelial lining of the perito-
neum were identified by immunofluorescence
histochemistry. The inflammatory immune response to
MSU crystals was then compared with the inflamma-
tory response in mice depleted of resident macrophages
by pretreatment with clodronate liposomes.
Results. The production of cytokines in vivo pre-
ceded the influx of Gr-1intermediate7/4 monocytes.
Monocytes and neutrophils recruited during the inflam-
matory phase of the response to MSU crystals failed to
produce proinflammatory cytokines either in vivo, or ex
vivo following restimulation with MSU crystals. Stimu-
lation of the naive peritoneal resident cell population
with MSU crystals ex vivo resulted in positive staining
of resident macrophages for the proinflammatory cyto-
kines IL-1, TNF, and IL-6. Depletion of the resident
macrophage population resulted in a significant de-
crease in both MSU crystal–induced neutrophil infiltra-
tion and proinflammatory cytokine production in vivo
despite the presence of infiltrating monocytes.
Conclusion. These data indicate that resident
macrophages, rather than infiltrating monocytes or
neutrophils, are important for initiating and driving the
early proinflammatory phase of acute gout.
Gout is an inflammatory arthritis induced by the
precipitation of monosodium urate monohydrate
(MSU) crystals in articular joints and periarticular tis-
sues, where it presents as a severe acute inflammation
that spontaneously resolves after 7–10 days (1,2). The
early inflammatory phase of acute gout is associated
with the production of proinflammatory cytokines
(interleukin-6 [IL-6], tumor necrosis factor  [TNF],
IL-1) and the infiltration of leukocytes, including neu-
trophils and monocytes (3–6).
Previous in vitro and ex vivo studies indicate that
the differentiation state of mononuclear phagocytes
plays a key role in the type of cytokines produced in
response to MSU crystals and therefore in the initiation
and progression of an attack of gout. In those studies,
monocyte-like cells were reported to produce proinflam-
matory cytokines such as TNF and IL-1, whereas
macrophage-like cells produced the antiinflammatory
cytokine transforming growth factor  (TGF) (7–9). A
similar pattern of proinflammatory to antiinflammatory
cytokine production has been reported following differ-
entiation of humanCD14 bloodmonocytes intomacro-
phages (7). In addition, unpurified leukocyte infiltrates
isolated from blisters during the course of an inflamma-
tory response to cantharidin also exhibit cytokine
“switching” following stimulation with MSU crystals in
vitro (7). Together these data have led to the hypothesis
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that in an acute gout attack infiltrating monocytes drive
the inflammatory response, while macrophages with a
differentiated phenotype mediate the resolution of in-
flammation. As a result, previous gout research has
mostly ignored the potential of resident macrophages to
induce inflammation.
Recent literature now indicates a possible proin-
flammatory role of macrophages in gouty inflammation.
Macrophages treated with MSU crystals have been
reported to induce proinflammatory cytokines such as
IL-1 (10,11), whereby signaling through the IL-1 recep-
tor is required for activation of nonhemopoietic cells to
induce neutrophilia (10), a key characteristic of gouty
inflammation (12). Other proinflammatory activities
such as the production of TNF, monocyte chemotactic
protein 1, IL-18, and inducible nitric oxide synthase and
the up-regulation of triggering receptor expressed on
myeloid cells 1 (TREM-1) on macrophages provide
evidence of the potential involvement of this cell type in
gout (10,11,13–15). This would be consistent with find-
ings in other acute inflammatory conditions that rely
heavily on macrophages in the onset of inflammation
(16,17).
Both macrophages and monocytes appear to pro-
duce the key proinflammatory cytokines IL-1, IL-6,
and TNF following in vitro stimulation with MSU
crystals; however, the relevance of these findings with
respect to the initiation and progression of inflammation
in vivo has not been established. Therefore, studies that
distinguish between the different phenotypes of mono-
nuclear phagocyte populations over the course of the
inflammatory response in vivo are needed to provide a
more accurate depiction of the function of these cells in
the context of gouty arthritis.
Although neutrophil infiltration is a hallmark
feature of gout, little is known about the ability of these
cells to subsequently respond to MSU crystals at the site
of inflammation and produce IL-1, IL-6, or TNF
during the early phase of inflammation in vivo. Using a
murine peritoneal model of acute gout, we have inves-
tigated the production of the gout-associated proinflam-
matory cytokines IL-1, IL-6, and TNF by infiltrating
neutrophils, monocytes, and resident macrophages dur-
ing the initiation and early phase of MSU crystal–
induced inflammation. Our results showed that resident
macrophages, rather than infiltrating monocytes or neu-
trophils, were primarily responsible for the production
of the proinflammatory cytokines IL-1 and IL-6 and
the infiltration of neutrophils in vivo during the onset of
MSU crystal–induced inflammation. Contrary to the
current dogma, infiltrating monocytes did not produce
proinflammatory cytokines in response to MSU crystals
in the initial stages of acute inflammation.
MATERIALS AND METHODS
Mice. Male C57BL/6 mice were bred and housed in a
conventional animal facility at the Malaghan Institute of
Medical Research, Wellington, New Zealand. All animals used
for the experiments were age 8–10 weeks. All experimental
procedures were approved by the Victoria University Animal
Ethics Committee in accordance with their guidelines for the
care of animals.
Reagents. Uric acid, lipopolysaccharide (LPS), and
saponin were obtained from Sigma (Auckland, New Zealand).
Cytokine Bead Array kits, chamber slides, GolgiStop, and
phycoerythrin-conjugated anti-mouse IL-6 and allophyco-
cyanin-conjugated anti–Gr-1 monoclonal antibodies were ob-
tained from BD Biosciences (North Ryde, New South Wales,
Australia). Anti-mouse IL-1, biotin-conjugated anti-mouse
IL-1, anti-mouse TNF, anti-mouse IL-6, and biotin-
conjugated mouse anti-rat IgG monoclonal antibodies were
obtained from eBioscience (San Diego, CA). Anti-F4/80 and
fluorescein isothiocyanate (FITC)–conjugated 7/4 antibodies
were obtained from Serotec (Oxford, UK). Bio-Plex multiplex
arrays were purchased from Bio-Rad (Hercules, CA). The
mouse IL-1 enzyme-linked immunosorbent assay (ELISA)
kit was obtained from R&D Systems (Minneapolis, MN). The
Limulus amebocyte cell lysate assay kit was obtained from
Associates of Cape Cod (East Falmouth, MA). Heparin was
obtained from Mayne Pharma (Melbourne, Victoria, Austra-
lia). Low cell binding plates were purchased from Nunc
(Rochester, NY). Diff-Quik was obtained from Dade Behring
Diagnostics (Newark, DE). AnalySIS Life Science extended
focal imaging software was obtained from Olympus (Auckland,
New Zealand). All other products were obtained from Invitro-
gen (Auckland, New Zealand) unless otherwise stated.
Preparation of MSU crystals. MSU crystals were
prepared by crystallization of a supersaturated solution of uric
acid under mildly basic conditions. Briefly, 250 mg uric acid
was added to 45 ml of double-distilled water containing 300 l
of 5M NaOH, and the solution was boiled until the uric acid
was dissolved. The solution was passed through a 0.2-M filter,
and 1 ml of 5M NaCl was added to the hot solution, which was
then stored at 26°C. After 7 days the resulting MSU crystals
were washed with ethanol and acetone. The resulting triclinic,
needle-shaped MSU crystals were 5–25 m in length and were
birefringent to polarized light. All MSU crystals were deter-
mined to be endotoxin free (0.01 EU/10 mg) by Limulus
amebocyte cell lysate assay.
MSU crystal–induced peritonitis. C57BL/6 mice were
administered an intraperitoneal (IP) injection of a 3-mg slurry
of MSU crystals in 0.5 ml phosphate buffered saline (PBS). At
different time points mice were euthanized by CO2 adminis-
tration, and the peritoneal exudate cells were harvested by
lavage with 3 ml PBS containing 25 units/ml heparin and 10%
fetal bovine serum (FBS). Cells were retrieved from the lavage
fluid and analyzed by flow cytometry and by Diff-Quik staining
of cytospin samples. Lavage fluid was retained for cytokine
assay.
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Thioglycolate-induced peritonitis. C57BL/6 mice were
administered an IP injection of 4% thioglycolate (0.5 ml).
After 4 hours the mice were euthanized by CO2 administra-
tion, and the peritoneal exudate cells were harvested as
described above for MSU crystal–induced peritonitis.
Purification of MSU crystal–elicited neutrophils. Mice
were administered an IP injection of MSU crystals (3 mg in 0.5
ml PBS). After 4 hours the mice were euthanized by CO2
administration, and the peritoneal exudate cells were har-
vested by lavage with 3 ml PBS containing 25 units/ml heparin.
Cells were retrieved from the lavage fluid and stained for
F4/80, Gr-1, and 7/4. Neutrophils (F4/80–Gr-1high7/4) were
isolated by fluorescence-activated cell sorting (FACS) using a
BD FACSVantage Diva (Becton Dickinson, San Jose, CA).
Neutrophils were determined to be 99% pure by flow
cytometry and Diff-Quik analysis of cytocentrifuged samples.
Neutrophil viability was confirmed to be 99% by trypan blue
exclusion.
Restimulation assay. Harvested peritoneal exudate
cells were cultured in RPMI 1640 and 10% FBS at 1  106
cells/ml in 96-well plates and treated with PBS, 200 g/ml
MSU crystals, or 100 ng/ml LPS for 16 hours at 37°C.
Supernatants were then harvested for cytokine analysis.
Cytokine analyses. Cytokine levels in harvested lavage
PBS and from culture supernatants were assayed by Cytokine
Bead Array and analyzed on a FACSCalibur flow cytometer
(BD Biosciences), by Bio-Plex multiplex array and analyzed on
a Bio-Plex flow cytometer, or by ELISA.
Intracellular staining. Total peritoneal exudate cells
from mice treated with MSU crystals for 4 hours were har-
vested by peritoneal lavage and quickly suspended at 106
cells/ml in RPMI 1640 containing 10% FBS, PenStrep, Glu-
tamax, and 1:1,500 GolgiStop and transferred into 24-well low
cell binding plates. Positive controls were stimulated with 1
g/ml LPS, after which all cells were incubated for a further 4
hours at 37°C to allow for intracellular accumulation of
cytokines. Cells were permeabilized with 0.1% saponin and
stained for intracellular IL-6. The cells were washed and
resuspended in FACS buffer, then stained for the surface
markers F4/80, Gr-1, and 7/4. Cells were analyzed by flow
cytometry using a FACSCalibur flow cytometer. Cytospin
samples of exudate cells were also prepared by Diff-Quik
staining to complement differential cell counts determined by
flow cytometry.
Immunofluorescence. Resident peritoneal cells from
naive mice were suspended at 106 cells/ml in RPMI 1640
containing 10% FBS, PenStrep, and Glutamax and placed into
8-well chamber slides. After incubation at 37°C for 1 hour,
1:1,500 GolgiStop was added. Cells were stimulated with 200
g/ml MSU crystals, 1 g/ml LPS, or PBS and incubated for 4
hours, then treated with zinc fixative for 30 minutes. Endoge-
nous biotin was blocked using a biotin blocking kit (Invitrogen)
in accordance with the manufacturer’s instructions. Nonspe-
cific IgG binding sites were then blocked using 5% mouse
serum or 5% FBS, followed by incubation overnight with
anti-mouse IL-6, anti-mouse TNF, biotinylated anti-mouse
IL-1, or the appropriate isotype control. Cells treated with
anti-mouse IL-6 or TNF were then incubated with a biotin-
ylated mouse anti-rat IgG antibody. Excess antibody was
removed by washing with PBS, and the samples were stained
with Alexa Fluor 555–conjugated streptavidin, FITC-
conjugated anti-F4/80, and Hoechst 55542, mounted in
Vectashield antifade (Vector, Burlingame, CA), and examined
using a BX51 fluorescence microscope (Olympus, Tokyo,
Japan).
Isolation of visceral peritoneal tissue. Mice were
treated with an IP injection of 3 mg MSU crystals as described
above. After 4 hours the skin was removed from the abdomen,
the peritoneum was cleared of leukocytes by lavage with 3 ml
PBS, and the ventral tissue covering the peritoneal cavity was
excised and placed into cold RPMI 1640. The tissue was rinsed
in PBS and fixed in acetone for 10 minutes at –20°C. The
visceral lining of the peritoneum was harvested from the fixed
tissue by carefully stripping the lining off as a single piece. The
harvested visceral tissue was cleaned of fascia, and nonspecific
IgG binding sites were blocked with a solution containing 10%
FBS. Endogenous biotin was blocked using a kit. The tissue
was stained for the surface markers 7/4 and F4/80 and mounted
onto slides with Vectashield antifade. Slides were analyzed by
fluorescence microscopy, and images were processed using
AnalySIS Life Science extended focal imaging software.
Clodronate liposome depletion of resident macro-
phages. Clodronate liposomes were prepared as previously
described (18). Mice were treated by IP injection of 200 l of
either clodronate liposomes or PBS. Three days later, macro-
phage depletion in liposome-treated mice was confirmed by
flow cytometry, following which mice were immediately chal-
lenged with an IP injection of 3 mg of MSU crystals.
RESULTS
Profile of MSU crystal–induced inflammation in
vivo. To identify the cell populations in the peritoneal
lavage fluid of naive and MSU crystal–treated mice over
time, cells were stained for the macrophage differentia-
tion marker F4/80 and the myeloid differentiation anti-
gens Gr-1 and 7/4 (Figure 1). Neutrophils were identi-
fied as Gr-1high7/4, and monocytes were identified as
Gr-1intermediate7/4 cells expressing low levels of F4/80.
Resident macrophages were identified as F4/80high cells
staining negative for Gr-1.
To establish the acute inflammatory profile of
peritoneal inflammation in response to MSU crystals,
we monitored leukocyte infiltration and the production
of the proinflammatory cytokines IL-1, IL-6, and
TNF over 72 hours. Infiltration of both monocytes and
neutrophils into the peritoneum was observed after 4
hours and peaked at 16 hours after injection of MSU
crystals (Figure 2A). Neutrophil infiltration was notably
faster and greater than that of monocytes. As shown in
Figures 2B–D, IL-6, IL-1, and TNF levels were
elevated in the peritoneum of MSU crystal–treated mice
within 2 hours of administration of MSU crystals, peak-
ing at 4 hours for all 3 cytokines. The inflammatory
response was self limiting, with leukocyte cell numbers
and cytokine levels returning to normal within 48 hours.
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Based on peak cytokine production combined with early
leukocyte infiltration, we chose to focus on the first 4–8
hours to determine which cell types (neutrophils, mono-
cytes, and/or macrophages), were driving the early in-
flammatory response to MSU crystals.
Cytokine production by infiltrating monocytes
and neutrophils. To investigate the potential contribu-
tion of infiltrating monocytes and neutrophils to early
inflammation following exposure to MSU crystals, we
collected peritoneal lavage fluid from mice 4 hours after
treatment with MSU crystals and examined the capacity
of infiltrating Gr-1intermediate7/4 monocytes and Gr-
1high7/4 neutrophils to produce the proinflammatory
cytokine IL-6 4 hours after MSU crystal treatment
(Figure 3A). Surprisingly, the infiltrating monocyte pop-
ulation did not produce IL-6 in response to MSU
crystals, although monocytes were still able to produce
inflammatory cytokines in response to LPS stimulation.
Infiltrating neutrophils did not produce IL-6 in response
to either MSU crystals or LPS (Figure 3A). In fact, none
of the cells isolated from the peritoneal lavage fluid
appeared to be producing large amounts of IL-6 (Fig-
ure 3A).
To confirm that the cells in the peritoneal exu-
date from MSU crystal–treated mice were unable to
produce proinflammatory cytokines in response to MSU
crystals, they were restimulated with MSU crystals
ex vivo, and the supernatants were analyzed for the
presence of IL-6, IL-1, and TNF. None of these
cytokines was elevated following MSU crystal treat-
ment (Figure 3B), indicating that infiltrating cells were
not the source of cytokine production illustrated in
Figure 2B. Serum components in cell culture have been
shown to inhibit MSU crystal–induced neutrophil super-
oxide production (19) and could therefore affect neutro-
phil cytokine production. However, isolated neutrophils
restimulated with MSU crystals also failed to produce
IL-6, TNF, or IL-1 under low serum conditions (data
Figure 1. Identification of cell types involved in the monosodium urate monohydrate (MSU) crystal
response in vivo. Mice were treated with MSU crystals intraperitoneally (3 mg in 0.5 ml phosphate
buffered saline [PBS]). After 4 hours peritoneal cells were harvested by lavage with 3 ml PBS, and the cell
types were identified by flow cytometry. Neutrophils were identified as Gr-1high7/4 (gate R1), and
monocytes were identified as Gr-1intermediate7/4 cells (gate R2) expressing low levels of F4/80 (gate R3).
Resident macrophages in untreated mice were identified as F4/80high cells staining negative for Gr-1 (gate
R4).
Figure 2. Monosodium urate monohydrate (MSU) crystals induce
cellular infiltration and cytokine production in vivo. Mice were treated
with MSU crystals intraperitoneally (3 mg in 0.5 ml phosphate
buffered saline [PBS]), and at different time points the peritoneal cells
were harvested by lavage with 3 ml PBS. A, Numbers of monocytes
(triangles) and neutrophils (squares) infiltrating the peritoneum were
determined by flow cytometry over 72 hours. B–D, Supernatants from
the peritoneal lavage fluid were analyzed for interleukin-6 (IL-6) (B),
IL-1 (C), and tumor necrosis factor  (TNF) (D) using Cytokine
Bead Arrays. Results are representative of 3 independent experiments.
Values are the mean and SEM (n  3 mice per group).
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available online at http://www.malaghan.org.nz/research/
arthritis/arthritis-publications/), confirming that the lack
of cytokine production was not serum dependent.
Monocytes recruited following IP administration
of thioglycolate also failed to produce significant levels
of inflammatory cytokines in response to restimulation
with MSU crystals (data available online at http://
www.malaghan.org.nz/research/arthritis/arthritis-
publications/), indicating that the lack of inflamma-
tory response to MSU crystals may be a common
feature of newly recruited monocytes in acute inflam-
mation. However, peritoneal cells from naive mice did
produce significant amounts of inflammatory cyto-
kines following exposure to MSU crystals ex vivo
(Figure 3C), indicating that one or more of the
resident cell populations was responsible for cytokine
production following administration of MSU crystals.
Activation and adherence of resident macro-
phages following MSU crystal administration in vivo.
The absence of cytokine-producing cells from the peri-
toneal lavage fluid of MSU crystal–treated mice led us to
investigate changes in total cell numbers during the
course of the inflammatory response to MSU crystals.
We observed an initial drop in the total number of
peritoneal cells within the first 2 hours following admin-
istration of MSU crystals (Figure 4A) and before the
infiltration of neutrophils and monocytes (Figure 2A).
Between 60% and 70% of cells in the peritoneum of
naive mice are resident macrophages; therefore, any
significant drop in cell number is likely to be associated
with a decrease in this population. Flow cytometric
analysis of the F4/80highGr-1–7/4– resident macrophage
population showed complete disappearance of this pop-
ulation from the peritoneal lavage fluid after 2 hours
(Figure 4B).
Cell adhesion is a common feature of macro-
phage activation, and the absence of macrophages
shortly after administration of inflammatory stimuli has
been reported as the “macrophage disappearance reac-
tion” in other models of acute inflammation (20–22). To
confirm that macrophage adherence was occurring in
vivo following administration of MSU crystals, we iso-
lated visceral peritoneal membranes from mice 4 hours
after MSU crystal administration and stained for the
presence of F4/80high7/4– resident macrophages, using
immunofluorescence. Following MSU crystal treatment,
Figure 3. Infiltrating leukocytes do not produce inflammatory cytokines in response to monosodium
urate monohydrate (MSU) crystals. Mice were treated with MSU crystals intraperitoneally (3 mg in 0.5 ml
phosphate buffered saline [PBS]), and after 4 hours the peritoneal exudate cells were harvested by lavage
with 3 ml PBS. A, MSU crystal–elicited peritoneal cells were treated with GolgiStop alone or with
lipopolysaccharide (LPS; 1 g/ml) and were analyzed by flow cytometry for the presence of interleukin-6
(IL-6)–positive monocytes or neutrophils. B and C, Peritoneal cells were isolated from mice 4 hours after
intraperitoneal administration of MSU crystals (B) or from untreated mice (C) and restimulated with 200
g/ml MSU crystals ex vivo. Shaded bars represent cells restimulated with MSU crystals; open bars
represent PBS-treated controls. Supernatants from cell cultures were analyzed for IL-6, tumor necrosis
factor  (TNF), and IL-1 using Cytokine Bead Arrays. Values are the mean and SEM (n  3 mice per
group). Results are representative of 3 independent experiments.   P  0.01;   P  0.001.
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we observed on the peritoneal membrane adherent
resident macrophages that were not present on tissue
from untreated mice (Figure 5A), indicating that mac-
rophage activation and adherence had occurred in re-
sponse to treatment with MSU crystals. In vitro cultures
of the naive peritoneal cell population identified the
F4/80 resident macrophages as producing not only
IL-6 but also TNF and IL-1 in response to exposure
to MSU crystals (Figure 5B), indicating that resident
macrophages were the likely source of inflammatory
cytokines following MSU crystal treatment in vivo.
Peritoneal macrophage depletion abrogates early
MSU crystal–induced inflammation in vivo. Next, we
sought to determine the importance of MSU crystal–
induced activation of resident macrophages to the in-
flammatory response in vivo, by depleting the resident
macrophage population in the peritoneum prior to MSU
crystal administration. Resident peritoneal macrophages
were depleted using clodronate-loaded liposomes, with
liposome pretreatment causing 80% depletion of F4/
80 cells (Figure 6A and data not shown). Following
MSU crystal treatment, monocyte infiltration was the
same in both macrophage-depleted mice and nonde-
pleted mice (Figure 6A). However, in macrophage-
depleted mice there was a significant reduction in neu-
trophil infiltration (Figure 6B). The production of IL-6
and IL-1 was also significantly reduced in macrophage-
depleted mice, although TNF levels remained the same
(Figure 6C).These results confirmed that residentmacro-
Figure 4. Disappearance of resident macrophages from peritoneal
lavage fluid following administration of monosodium urate monohy-
drate (MSU) crystals. Mice were treated with MSU crystals intraperi-
toneally (3 mg in 0.5 ml phosphate buffered saline [PBS]), and at
different time points the peritoneal cells were harvested by lavage with
3 ml PBS. A, Total cell numbers were determined. B, Harvested
peritoneal cells were analyzed by flow cytometry for the presence of
F4/80high resident macrophages. Values are the mean and SEM (n 
3 mice per group). Results are representative of 3 independent
experiments.   P  0.001.
Figure 5. Resident macrophages adhere to the epithelial membrane and are a source of proinflammatory cytokines in response to monosodium
urate monohydrate (MSU) crystals. A, Mice were treated with MSU crystals intraperitoneally (3 mg in 0.5 ml phosphate buffered saline), and after
4 hours the visceral epithelial lining of the peritoneum was harvested, fixed, and stained with anti-F4/80 (green) and 7/4 (red) to identify resident
macrophages (F4/807/4–). B, Resident peritoneal cells were harvested from naive mice by lavage and incubated with 200 g/ml MSU crystals in
the presence of GolgiStop for 4 hours. Cells were then stained with anti-F4/80 (green) to identify resident macrophages producing the following cytokines
(red): interleukin-1 (IL-1), tumor necrosis factor  (TNF), and IL-6. Bars  100 m. Results are representative of 3 independent experiments.
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phages play an essential role in the production of the
key proinflammatory cytokines IL-6 and IL-1 and
in neutrophil recruitment in MSU crystal–induced in-
flammation.
DISCUSSION
Our results show that resident tissue macro-
phages, which have a highly differentiated phenotype,
play a significant role in triggering acute MSU crystal–
induced inflammation, whereby resident macrophages
are a key source of proinflammatory cytokines including
IL-1 and IL-6. In addition, the resident macrophage
population appears to play an essential role in the
initiation of neutrophil infiltration, as illustrated by the
significant reduction in neutrophil infiltration following
in vivo depletion of this population.
Once recruited to the site of inflammation, nei-
ther neutrophils nor monocytes appear to contribute to
the proinflammatory cytokine production observed dur-
ing the early stages of the acute inflammatory response
to MSU crystals. The monocyte results were surprising
in light of previous studies showing MSU crystal–
induced proinflammatory cytokine production by mono-
cytes treated with MSU crystals in vitro and by leukocyte
infiltrates from cantharidin-induced blisters treated with
MSU crystals ex vivo (7). However, in addition to using
a different inflammatory stimulus for recruitment of
cells, the cantharidin study investigated later-stage cel-
lular infiltrates (16 hours compared with 4–8 hours) that
likely differ in cellular composition and phenotype com-
pared with the initiation phase of MSU crystal–induced
inflammation. In fact, phenotypic differences between in
vivo MSU crystal–recruited monocytes and isolated
monocytes and monocytic cell lines may also explain why
our results differ from earlier in vitro data.
The lack of proinflammatory response to MSU
crystals does not arise as a result of an inability to
produce proinflammatory cytokines, since MSU crystal–
elicited monocytes readily produce IL-6 in response to
LPS. The difference in responsiveness of infiltrating
monocytes to MSU crystals and LPS suggests that the
proinflammatory response to MSU crystals, unlike that
to LPS, does not occur via Toll-like receptor 4 (TLR-4).
This is consistent with earlier work showing that knock-
Figure 6. Depletion of resident macrophages inhibits monosodium urate monohydrate (MSU) crystal–
induced neutrophil infiltration and proinflammatory cytokine production in vivo. Mice were not
pretreated or were pretreated with clodronate liposomes to deplete peritoneal F4/80 macrophages, 3
days prior to intraperitoneal administration of MSU crystals (3 mg in 0.5 ml phosphate buffered saline
[PBS]). At different time points, peritoneal cells were harvested by lavage with 3 ml PBS and analyzed by
flow cytometry for the presence of macrophages and monocytes (A) and neutrophils (B). Cytokine levels
in the lavage fluid were measured by Bio-Plex multiplex array and by enzyme-linked immunosorbent assay
(C). Light bars represent liposome-treated mice; dark bars represent PBS-treated control mice. Values are
the mean and SEM (n  5 mice per group). Results are representative of 3 independent experiments.
  P  0.05;   P  0.001. IL-6  interleukin-6; TNF  tumor necrosis factor .
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ing out the gene encoding TLR-4 does not ablate the
inflammatory response to MSU crystals (10). In addi-
tion, thioglycolate-elicited cells are also unresponsive to
MSU crystal restimulation, showing that desensitization
to MSU is unlikely to be the reason for the absence of
cytokine production. In fact, the lack of the proinflam-
matory response to MSU crystal restimulation may be a
common phenotype of early infiltrating monocytes re-
gardless of how they are elicited.
Our study pinpoints the resident macrophage
population as a primary source of the proinflammatory
cytokines IL-1 and IL-6 in the early response to MSU
crystal exposure. Although the resident macrophages
produce TNF in response to exposure to MSU crystals,
they do not appear to be an essential source of TNF in
vivo. Our findings are consistent with a key involvement
of resident macrophages in the initiation of other forms
of acute inflammation (16,17,23).
Although earlier in vitro studies have indicated
that differentiated macrophages produce “antiinflam-
matory” cytokines such as TGF following exposure to
MSU crystals, more recent reports have shown that
MSU crystals can activate differentiated macrophages,
leading to the activation of the NALP3 inflammasome,
the production of IL-1, the up-regulation of TREM-1,
and the production of cytokine-induced neutrophil che-
moattractant (also called KC or CXCL1) (10,11,13).
These later findings support our in vivo results showing
that the resident macrophage population initiates in-
flammation in response to MSU crystals. In our model it
appears that MSU crystal–activated resident macro-
phages adhere to the surrounding tissues, produce
proinflammatory cytokines, and initiate recruitment of
neutrophils from the blood during the early inflamma-
tory response.
The proinflammatory response of the resident
macrophage population to MSU crystals does not pre-
clude differentiated macrophages from playing a role in
the resolution of inflammation at a later point in time.
The plasticity of the macrophage phenotype is well
known, and macrophage switching from a “proinflam-
matory” to an “antiinflammatory” phenotype over time
remains a viable mechanism of action for resolution of
acute inflammation. However, TGF-producing macro-
phages have yet to be identified in vivo.
In part, the lack of proinflammatory cytokine
production by infiltrating monocytes in response to
MSU crystals could contribute to the self-limiting nature
of the disease. Classically, infiltrating monocytes would
augment and further prolong or amplify an inflamma-
tory response by producing increased amounts of proin-
flammatory cytokines. Since recruited monocytes did
not exhibit a proinflammatory response to MSU crystals
in our model, it is also possible that augmentation of the
early inflammatory response to MSU crystals by infil-
trating monocytes does not occur in gout.
Mononuclear phagocytes are highly diverse in
phenotype and function, making them difficult to model
faithfully in vitro. Although care needs to be taken when
extrapolating findings from the peritoneal model of
inflammation to joint inflammation in gout, the unma-
nipulated peritoneal environment allows for the complex
interplay between resident and infiltrating immune cells,
which is not provided by in vitro studies. Therefore, the
in vivo model provides greater insight into the true
effector phenotypes in the context of the inflammation
that occurs in acute gout. To this end, this approach has
shown that infiltrating monocytes elicited by MSU crys-
tals in vivo behave differently from monocytes derived
by other methods.
The immune response to MSU crystals is multi-
faceted in nature, making it difficult to account for all
aspects of the response in one study. Although macro-
phages play a pivotal role, they obviously do not control
the entire inflammatory response to MSU crystals. For
example, macrophage activation and neutrophil infiltra-
tion do not appear to be a requirement for monocyte
infiltration in our model, highlighting another aspect of
the inflammatory response to MSU crystals that war-
rants further investigation. Taken together, our findings
bring us a step closer to clearly identifying which im-
mune cells are likely to be critically involved in different
aspects of early inflammation in gout.
In summary, our work identifies resident macro-
phages, not infiltrating monocytes or neutrophils, as
triggering and driving early MSU crystal–induced in-
flammation in the context of IL-1 and IL-6 production
and the initiation of neutrophil infiltration. Based on
these findings, macrophages are also likely to be key
cells involved in initiating and driving inflammation in
gouty arthritis, suggesting the need to revisit the current
understanding of induction of acute gout.
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